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The development of the vulva of the nematode Caenorhabditis elegans is 
induced by a signal from the anchor cell of the somatic gonad. Activity of the 
gene lin-3 is required for the Vulval Precursor Cells (VPCs) to assume vulval 
fates. It is shown here that lin-3 encodes the vulval-inducing signal. 
lin-3 was molecularly cloned by transposon-tagging and shown to encode 
a nematode member ofthe Epidermal Growth Factor (EGF) family. Genetic 
epistasis experiments indicate that lin-3 acts upstream of let-23, which 
encodes a homologue of the EGF-Receptor. 
lin-3 transgenes that contain multiple copies of wild-type lin-3 genomic 
DNA clones confer a dominant multivulva phenotype in which up to all six of 
the VPCs assume vulval fates. The properties of these trans genes suggest 
that lin-3 can act in the anchor cell to induce vulval fates. Ablation of the 
gonadal precursors, which prevents the development of the AC, strongly 
reduces the ability of lin-3 transgenes to stimulate vulval development. A 
lin-3 recorder transgene that retains the ability to stimulate vulval 
development is expressed specifically in the anchor cell at the time of vulval 
induction. 
Expression of an obligate secreted form of the EGF domain of Lin-S from 
a heterologous promoter is sufficient to induce vulval fates in the absence of 
the normal source of the inductive signal. This result suggests that Lin-S 
may act as a secreted factor, and that Lin-S may be the sole vulval-inducing 
signal made by the anchor cell. 
lin-3 transgenes can cause adjacent VPCs to assume the 1 o vulval fate 
and thus can override the action of the lateral signal mediated by lin-12 that 
normally prevents adjacent 1 o fates. This indicates that the production of 
Lin-3 by the anchor cell must be limited to allow the VPCs to assume the 
proper pattern of fates of so 3° 2° P 2° so. 
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Section I. Pattern formation in C. elegans vulval development. 
(This section is to be published as a review in Development) 
Section II. The EGF-like growth factors. 
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Section I. 
Cell fate patterning during C. elegans vulval development 
Russell J. Hill and Paul W. Sternberg 
British Society for Developmental Biology 
1993 Symposium 
Signals, Polarity , and Adhesion in Development. 
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I. Cell fate patterning during C. elegans vulval development. 
Summary. 
Precursors to the vulva of the C. elegans hermaphrodite choose 
between two vulval fates (1 ° and 2°) and a non-vulval epidermal fate (3°) in 
response to three intercellular signals. An inductive signal produced by the 
anchor cell induces the vulval precursors to assume the 1 o and 2° vulval fates. 
This inductive signal is an EGF-like growth factor encoded by the gene lin-3. 
An inhibitory signal mediated by lin-15 , and which may originate from the 
surrounding epidermis, prevents the vulval precursors from assuming vulval 
fates in the absence of the inductive signal. A short range lateral signal, that 
acts through the gene lin-12, regulates the pattern of 1 o and 2° fates assumed 
by the induced vulval precursors. 
The combined action of the three signals precisely directs the six vulval 
precursors to adopt a 3° 3° 2° 1 o 2° 3° pattern of fates. The amount of 
inductive signal produced by the anchor cell appears to determine the 
number of vulval precursors that assume vulval fates. The three induced 
vulval precursors are proposed to adopt the 2° 1° 2° pattern of fates in 
response to a gradient of the inductive signal, and in response to lateral 
signalling that inhibits adjacent VPCs from both assuming the 1 o fate. 
Introduction. 
The nematode Caenorhabditis elegans has been used to study the 
mechanisms that control cell fate determination (reviewed in Greenwald and 
Rubin 1992, Lambie and Kimble 1991). The development of C. elegans 
follows a largely invariant cell lineage (Kimble and Hirsh 1979, Sulston and 
Horvitz 1977, Sulston 1976, Sulston et al. 1980, Sulston et al. 1983). 
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Although some of the cell lineages of C. elegans appear to be specified by cell-
autonomous mechanisms, other lineages are specified by cell-cell interactions. 
Some of these interactions were first noted from instances of naturally 
occurring variation in the lineage in which the development of a cell 
correlated with its position, thus suggesting that the cell was responding to 
environmental cues (Sulston et al. 1983). Other examples of cell-cell 
interactions have been defined by experiments in which groups of cells are 
ablated by irradiation with a laser micro beam to see if the development of the 
remaining cells is affected by the change in their environment (Kimble 1981, 
Schnabel1991, Sulston et al. 1983, Sulston and White 1980). C. elegans is 
well suited for genetic analysis (Brenner 197 4) and many mutations that 
affect its cell lineage have been identified (Horvitz 1988). The genetic 
analysis of these mutations and the characterization of the corresponding 
genes with the techniques of molecular biology has been a driving force in 
elucidating the mechanisms that control cell fate in C. elegans . 
The development of the hermaphrodite vulva has been extensively 
studied by cell ablation experiments and by genetic analysis. The results of 
these studies support a three signal model of vulval development summarized 
below (and reviewed in Horvitz and Sternberg 1991) (Fig. 1). The vulva 
normally develops from three of six ectodermal blast cells called Vulval 
Precursor Cells (VPCs) that are located within the ventral epidermis. 
Although in wild-type development each of the VPCs always assumes a 
particular fate, a variety of experiments indicate that each of the VPCs is 
equivalent in its ability to assume either of three fates and thus that the 
VPCs constitute an equivalence group (Sternberg and Horvitz 1986, Sulston 
and White 1980, Thomas et al. 1990). Each fate consists of a distinct cell 
lineage that produces a particular set of cell types (Fig. 2). The 1 o and 2° 
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fates both produce vulval tissue although they contribute to different regions 
of the vulva. The 3° fate produces non-vulval epidermis (Sulston and Horvitz 
1977, Sulston 1976). The fate chosen by a VPC depends upon three 
intercellular signals. The anchor cell ofthe somatic gonad produces a signal 
that induces the three more proximal VPCs to assume the 1 o and 2° fates 
(Kimble 1981). An inhibitory signal inhibits the VPCs from assuming vulval 
fates in the absence of the inductive signal (Herman and Hedgecock 1990). A 
lateral signal among the induced VPCs regulates the pattern of 1 o and 2° 
fates (Sternberg 1988a). In wild-type development the combined action of the 
three signals causes the six VPCs to assume a 3° 3° 2° 1 o 2° 3° pattern of 
fates. In the following sections, each of the three signals is discussed 
separately. This is then followed by a discussion of how the pattern ofVPC 
fates is controlled by the three signals. 
The inductive pathway. 
Cell ablation experiments indicate that the vulva develops as the 
result of an inductive interaction between the somatic gonad and the vulval 
precursors (Sulston and White 1980). Kimble showed that the anchor cell of 
the somatic gonad is necessary and sufficient to induce vulva development 
(Kimble 1981). If the anchor cell or its precursors are ablated, then the three 
VPCs that would normally assume the 1 o and 2° fates instead assume the 3° 
fate (Table 1C). This induction occurs one to three hours before the VPCs 
divide (Kimble 1981). If the anchor cell is ablated after the VPCs have 
divided, the cell lineage of their daughters is unaffected (Kimble 1981, 
Sternberg and Horvitz 1986). A large number of mutations that disrupt 
vulva induction have been characterized (reviewed in (Sternberg and Horvitz 
1991)). The cloning of several ofthese genes indicates that this induction is 
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mediated by an Epidermal Growth Factor (EGF)-like signalling pathway that 
includes an EGF-like growth factor encoded by lin-3 (Hill and Sternberg 
1992) and a EGF-Receptor like molecule encoded by let-23 (Aroian et al. 
1990). 
lin-3 encodes the inductive signal. 
lin-3 is proposed to be a nematode member of the Epidermal Growth 
Factor (EGF) family of growth factors (Hill and Sternberg 1992). This family 
includes ligands of the EGF-Receptor (EGF-R) such as EGF (Gregory 1975, 
Savage et al. 1972) , Transforming Growth Factor-alpha (TGF-a) (Derynck et 
al. 1984), Heparin Binding-EGF (HB-EGF) (Higashiyama et al. 1991), 
amphiregulin (Shoyab et al. 1989); and also ligands ofneu/HER2, a 
homologue ofthe EGF-R, (Holmes et al. 1992, Wen et al. 1992); and the 
predicted product of the spitz locus of Drosophila (Rutledge et al. 1992). The 
EGF growth factors are usually made as membrane spanning proteins that 
contain at least one extracellular EGF domain (reviewed in (Carpenter and 
Wahl 1990)). EGF domains are a sequence motif of approximately 50 amino 
acids that consist of six cysteine residues with semi-conserved spacing 
(reviewed in (Davis 1990 )). In many cases it is known that the EGF domain 
can be processed away from the rest of the protein to produce a secreted 
factor that can activate its receptor (reviewed in (Carpenter and Wahl1990)). 
In the case ofTGF-a, the EGF domain can also activate the receptor without 
being released from the membrane (reviewed in (Massague 1990) ). 
The gene lin-3 was identified by reduction-of-function mutations that 
cause a recessive, vulvaless phenotype in which up to all three of the VPCs 
that usually assume vulval fates instead assume epidermal fates (Ferguson 
and Horvitz 1985, Horvitz and Sulston 1980, Sulston and Horvitz 1981). 
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Thus, wild-type lin-3 activity is required for vulval induction. In contrast, 
animals bearing lin-3 transgenes (transgenes made up of wild-type genomic 
DNA cloned from the lin-3 locus) can have a dominant multivulva phenotype 
in which up to all six of the VPCs assume vulval fates (Hill and Sternberg 
1992). The multi vulva phenotype of the trans genes is proposed to be a gain-
of-function phenotype because the transgenes are created by a method that 
concatenates hundreds of copies of the injected DNA into an 
extrachromosomal array (Mello et al. 1991). Such an array would likely 
express levels of Lin-3 protein that are greater than the levels expressed by 
the two chromosomal copies of the lin-3 locus. Together, the reduction-of-
function and the gain-of-function phenotypes of lin-3 suggest that the dose of 
lin-3 activity controls the number ofVPCs that assume vulval fates. 
The analysis of lin-3 transgenes suggests that lin-3 can act in the 
anchor cell to cause the VPCs to assume vulval fates (Hill and Sternberg 
1992). A trans gene in which the lacZ gene of E. coli is inserted in frame 
within a lin-3 genomic DNA clone directs expression of ~-galactosidase 
activity specifically in the anchor cell at the time of vulval induction. This 
transgene, which should produce a fusion protein that contains the 
extracellular and transmembrane domains ofthe Lin-3 protein and a 
cytoplasmic domain consisting of the ~-galactosidase protein, retains the 
ability to induce vulval fates. This result suggests that expression of lin-3 in 
the anchor cell is sufficient to induce vulval fates. This hypothesis is further 
substantiated by the results of ablation experiments. Ablation of the four 
gonadal precursor cells at hatching, which prevents the development of the 
anchor cell, greatly reduces the ability of lin-3 transgenes to induce vulval 
development. 
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It has been proposed that the inductive signal is a secreted factor 
because induction of vulval fates can occur without apparent direct contact 
between the anchor cell and the induced VPCs (Sternberg and Horvitz 1986, 
Sulston and White 1980, Thomas et al. 1990). As mentioned previously, the 
EGF growth factors can produce secreted factors that consist of an EGF 
domain. We have made a transgene to test whether a secreted form of the 
EGF domain of Lin-3, without the rest of the Lin-3 protein, would be 
sufficient to induce vulval fates (Hill and Sternberg, manuscript in 
preparation). This transgene uses a heat shock promoter that should express 
the Lin-3 EGF domain in a tissue general manner (Stringham et al. 1992). 
This transgene is able to stimulate 1 o and 2° vulval fates even when the 
gonadal precursors have been ablated prior to the development of the anchor 
cell. This result suggests that lin-3 can act as a secreted factor in a manner 
similar to the EGF growth factors . Since overexpression of the EGF domain 
ofLin-3 is sufficient to induce vulval fates in the absence of the gonad, it is 
possible that lin-3 is the only vulval inducing signal made specifically by the 
anchor cell. It is not yet known if the Lin-3 protein is normally processed in 
vwo. 
The response pathway of the VPCs. 
A pathway of genes has been characterized that is believed to mediate 
the response of the VPCs to the inductive and inhibitory signals (Fig. 3). This 
pathway includes the following genes which are believed to act in the 
following order on the basis of genetic epistasis experiments: let-23, which 
encodes a homologue of the EGF-Receptor (EGF-R) (Aroian et al. 1990); sem-
5, which encodes an adapter protein that contains SH2 and SH3 domains 
(Clark et al. 1992); let-60, which encodes a ras protein (Han and Sternberg 
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1990); and lin-45, which encodes a rafserine-threonine kinase (Han et al. 
1993). Wild-type activity of each ofthese genes is required for vulval 
induction. A reduction of function mutation in let-23 is epistatic to the ability 
of lin-3 transgenes to stimulate vulval fates indicating that let-23 acts 
downstream of lin-3 (Hill and Sternberg 1992). This pathway is similar to 
pathways studied in other experimental systems. a ras protein, a rafkinase, 
and a Sem-5-like adapter protein also act downstream of the receptors 
encoded by the torso (N. Perrimon, this Volume) and the sevenless (E. Hafen, 
this volume) genes of Drosophila, and also downstream of growth factor 
receptors in mammals (McCormick 1993). 
A number of other genes have been implicated in the process of vulval 
induction. The genes lin-2, lin-7, and lin-1 0 are required for wild-type levels 
of vulval induction (Ferguson and Horvitz 1985). These genes may act at a 
step near let-23 in the pathway of vulval induction (Ferguson et al. 1987). 
The gene lin-10 encodes a novel protein (Kim and Horvitz 1990). The gene 
lin-1 acts downstream of lin-45(Han et al. 1993). Wild-type lin-1 activity acts 
to repress vulval fates. (Ferguson and Horvitz 1985, Ferguson et al. 1987). 
lin-3 and let-23 are both required for vulval induction, larval viability 
8 (Aroian and Sternberg 1991, Clark, et al. 1988, Ferguson and Horvitz 1985, 
Herman 1978x, and R. Hill and P. Sternberg, unpublished results), 
hermaphrodite fertility (Aroian and Sternberg 1991, Ferguson and Horvitz 
1985) and proper specification of cell fate in the male B lineage (H. 
Chamberlin and P. Sternberg, unpublished results). This suggests that the 
same growth factor and receptor are used together in multiple decisions 
during the development of C. elegans . let-23 is also required for proper cell 
fate specification in the P11-P12 equivalence group (Aroian and Sternberg 
1991) , but it has not been demonstrated whether lin-3 is also required for 
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P11-P12 fate specification. sem-5 (Clark et al. 1992), let-60 (Beitel et al. 
1990, Clark et al. 1988, Han et al. 1990), and lin-45 (Han et al. 1993) are also 
required for larval viability and a simple model is that they act downstream 
of let-23 in all tissues that use the lin-3 let-23 pathway. lin-2, lin-7, and lin-
10, are unique in that they are only required for vulval induction (Ferguson 
and Horvitz 1985). In contrast, sem-5 may be a generalized signal 
transduction component that acts downstream of multiple receptors since 
sem-5 activity is required for the proper positioning of the sex myoblasts 
(Clark et al. 1992), a process that does not require lin-3 or let-23. 
The inhibitory pathway. 
Genetic experiments suggest that a pathway of genes that includes lin-
15 (Ferguson and Horvitz 1985, Ferguson and Horvitz 1989) produces an 
intercellular signal that inhibits vulval fates (Herman and Hedgecock 1990). 
Loss-of-function mutations in the lin-15 locus cause a multivulva phenotype 
in which all six VPCs can assume vulval fates (Table 1E1). lin-15 mutant 
hermaphrodites display a multi vulva phenotype even if the anchor cell has 
been ablated (Table 1E2). Thus, lin-15 does not act only in the anchor cell 
(Ferguson et al. 1987). Genetic mosaic experiments indicate that lin-15 does 
not act cell autonomously in the VPCs, and therefore that lin-15 is part of an 
intercellular signalling pathway (Herman and Hedgecock 1990). The overall 
pattern of mosaic phenotypes is complex and has been interpreted to indicate 
that lin-15 can act in the epidermal syncytium hyp7, a tissue generated by 
several different cell lineages (Herman and Hedgecock 1990). hyp7 is the 
main body epidermis and surrounds all of the VPCs. Thus a simple model is 
that the inhibitory signal would affect all of the VPCs equivalently and would 
thus provide no spatial specificity. 
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The inhibitory signal appears to act in parallel to the inductive signal 
to regulate the activity of the response pathway of the VPCs. Reduction-of-
function mutations in the let-23 locus that confer a vulvaless phenotype are 
epistatic to the multivulva phenotype of lin-15 mutations (Aroian and 
Sternberg 1991, Ferguson et al. 1987, L. Huang and P. Sternberg, 
unpublished). Therefore, lin-15, like the inductive signal, is an upstream 
regulator of let-23. The inductive and inhibitory signals can regulate vulval 
fates independently of each other suggesting that they act in parallel. First, 
in a mutant animal that lacks lin-15 activity, P6.p will always assume the 1 o 
fate if the anchor cell is present, but can assume the 2° or 1 o fate if the anchor 
cell is absent (Table 1El,2). This indicates that the inductive signal can 
influence vulval fate choice independently of lin-15 (Sternberg 1988a). 
Second, the multivulva phenotype of putative null mutations of lin-15 are 
epistatic to the vulvaless phenotype of strong reduction-of-function lin-3 
genotypes. (Ferguson et al. 1987, R. Hill and P . Sternberg, unpublished 
results). This suggests that the inhibitory signal can affect vulval fates 
independently of the inductive signal encoded by lin-3 . The inhibitory signal 
does not appear to be a competitive inhibitor of the inductive signal since 
multicopy lin-15 transgenes that presumably overexpress the Lin-15 protein 
do not interfere with vulval induction (L. Huang and P. Sternberg, 
unpublished results). In wild-type development, a VPC that receives both the 
inductive signal and the inhibitory signal will assume a vulval fate. Thus, 
the inhibitory signal prevents the VPCs from assuming vulval fates only in 
the absence of the inductive signal. One possible interpretation of these 
observations is that the inhibitory signal negatively regulates the basal 
activity of let-23. The molecular mechanism by which this inhibitory 
pathway acts is not understood. 
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The lateral signal. 
In addition to the inductive and inhibitory signals that originate from 
tissues other than the VPCs, a lateral signal among the VPCs also regulates 
VPC fate choice. Evidence for this signal came from observations on the 
pattern ofVPC fates found in lin-15 mutant animals (Sternberg 1988a). As 
described above, all six VPCs assume 1 o and 2° vulval fates in a lin-15 
mutant animal due to a defect in an inhibitory signal from the surrounding 
epidermal tissue. In lin-15 mutant animals, it is commonly observed that 
adjacent VPCs both assume the 2° fate, but it is rarely observed that adjacent 
VPCs both assume the 1 o fate (Table 1E1). This suggests the action of a 
signal that prevents adjacent VPCs from both assuming the 1 o fate. The 
action of this signal can also be observed in experiments in which groups of 
VPCs are isolated in a lin-15 mutant animal by laser ablation of the other 
VPCs. A single isolated VPC in a lin-15 mutant animal assumes the 1 o fate 
(Table 1E3). However, when two adjacent VPCs are left after surgery, one of 
them will assume the 1° fate and the other will assume the 2° fate (Table 
1E4). The lateral signal acts only at a short range and may require direct cell 
contact since two isolated VPCs in a lin-15 mutant are only inhibited from 
both assuming the 1 o fate if they are close to each other (Table 1E5 ). 
This lateral signal is believed to act through the gene lin-12 (Sternberg 
and Horvitz 1989). lin-12 encodes a cell surface protein homologous to the 
protein encoded by the Notch locus of Drosophila (Greenwald 1985, Yochem 
et al. 1988). Both lin-12 and Notch function in lateral interactions that 
control cell fate choice between cells of equivalent developmental potential 
(Greenwald et al. 1983, Greenwald and Rubin 1992, seeP. Simpson, this 
volume). lin-12 acts during vulval development to promote the 2° fate. In 
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animals homozygous for lin-12 loss-of-function mutations, no VPCs assume 
the 2° fate, and in animals homozygous for lin-12 gain-of-function mutations, 
all six VPCs assume the 2° fate independently of the inductive signal (Table 
1F)(Greenwald et al. 1983, Sternberg and Horvitz 1989). lin-12 also promotes 
the 2° fate in the AC (1 o fate)-Ventral Uterine (VU) precursor (2° fate) 
equivalence group (Greenwald et al. 1983). Genetic mosaic analysis of lin-12 
activity in the AC-VU decision indicates that lin-12 acts in a cell autonomous 
manner to specify the 2° fate (Seydoux and Greenwald 1989). It has thus 
been predicted that the lin-12 product acts as the receptor for the lateral 
signal during vulval development. 
Lateral signalling acts through a separate pathway than the inductive 
pathway. It is not clear precisely where the two pathways converge to control 
VPC fate although it is likely downstream of lin-2, lin-7, and lin-10 
(Sternberg and Horvitz 1989). Currently other components of the lateral 
pathway including the ligand for lin-12 and genes that act downstream of lin-
12 are not well characterized. One explanation for this is that these other 
components of the lateral pathway may be required for an essential decision 
prior to the time ofvulval development. The C. elegans geneglp-1 is 
structurally very similar to lin-12 and both genes may have originated from a 
gene duplication of a common ancestor (Yochem and Greenwald 1989). glp-1 
is required zygotically for maintenance of the mitotic germline (Austin and 
Kimble 1987) and is required maternally for the proper fate specification of 
early blastomeres (Priess et al. 1987). The lin-12 glp-1 double mutant has a 
synthetic zygotic lethal phenotype called Lag (Lambie and Kimble 1991). 
This indicates thatglp-1 and lin-12 are functionally redundant for certain 
essential developmental processes. Other genes that can be mutated to give a 
Lag phenotype could be shared components of the lin-12 andglp-1 pathways 
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and thus might be required for lateral interactions during vulval 
development (Lambie and Kimble 1991). 
Patterning of vulval fates. 
Vulval development allows the examination of how different 
intercellular signals interact to control pattern formation. During vulval 
development, three intercellular signals direct the six VPCs to adopt the 
pattern of fates 3° 3° 2° 1 o 2° 3°. Mutations that disrupt any of the three 
signals affects the fates assumed by the VPCs. The wild-type pattern is 
precise in the number ofVPCs induced to assume the 1 o and 2° vulval fates, 
the position of the VPCs induced to assume vulval fates, and in the pattern of 
1 o and 2° fates assumed by the induced cells. This section summarizes our 
knowledge of what signals control the extent, location, and pattern of vulval 
induction. 
Extent. As mentioned previously, the genetic dose of lin-3 is proposed to 
control the number ofVPCs induced to assume vulval fates. This hypothesis 
is based on the observations that reduction-of-function mutations in lin-3 
reduce the number of the VPCs that assume vulval fates and that multicopy 
lin-3 transgenes that presumably overexpress the Lin-3 protein increase the 
number ofVPCs that assume vulval fates (Ferguson and Horvitz 1985, Hill 
and Sternberg 1992). In lin-12 mutant animals in which lateral signalling is 
disrupted, the number ofVPCs that assumes vulval fates is near the wild-
type level (Table lFl) (Sternberg and Horvitz 1989). Thus the lateral signal 
does not appear to regulate the number ofVPCs that assume vulval fates. 
The inhibitory signal acts in a spatially general manner to inhibit vulval 
fates, but the action of the inhibitory signal is overridden by the inductive 
A-15 
signal. Thus the inhibitory signal ensures that vulval fates are assumed only 
in response to the inductive signal, but does not itself determine the number 
ofVPCs that assume vulval fates. 
Location. The location ofthe anchor cell determines the location ofvulval 
development. This is illustrated by the pattern of fates assumed by the VPCs 
in dig-1 mutant animals. In dig-1 mutants the position of the gonad and the 
anchor cell can be shifted anterior and/or dorsal of their wild-type positions 
(Thomas et al. 1990). In animals in which the anchor cell is shifted anterior 
ofits wild-type position and remains ventral, the pattern ofvulval fates is 
shifted commensurably. For example, when the anchor cell is positioned over 
P5.p, P5.p assumes the 1° fate and the overall pattern ofvulval fates is 3° 2° 
1 o 2° 3° 3° (Table 1G). 
Pattern. 
As just discussed, in wild-type development, the induction of 1° and 2° 
vulval fates is limited to P5.p, P6.p and P7.p because the anchor cell is 
located above P6.p and because it only makes enough inductive signal to 
induce the three most proximal VPCs. What signals direct the three induced 
VPCs to assume a 2° 1 o 2° pattern of fates? The experimental analysis of 
animals that have only one VPC indicates that the inductive signal plays an 
important role in patterning. The fate of a single, isolated VPC correlates 
with its distance from the anchor cell: a single VPC that is relatively close to 
the anchor cell will assume the 1 o fate, a single VPC that is further away will 
assume the 2° fate, and a single VPC that is distant will assume the 3° fate 
(Table 1H) (Sternberg and Horvitz 1986, P. Sternberg, unpublished results, 
and M. Herman and H . R. Horvitz, personal communication). Since these 
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isolated VPCs have no neighboring VPCs, they should not be subject to the 
effects of the lateral signal. Thus, the fact that the fate of an isolated VPC 
correlates with its distance from the anchor cell suggests that there is a 
gradient of inductive signal centered on the anchor cell, and that the VPCs 
assume different fates in response to different levels of the inductive signal. 
The inhibitory signal mediated through the lin-15 pathway does not 
have an important role in vulval fate patterning. Although all six VPCs 
assume vulval fates in lin-15 mutant animals, the patterning of fates is still 
normal. In a lin-15 mutant animal, the inductive signal still promotes P6.p 
to assume the 1 o fate and the lateral signal still functions to prevent P5.p and 
P7.p from assuming the 1 o fate. Thus if the anchor cell is present in a lin-15 
mutant animal, then P5.p, P6.p, and P7.p, will assume the same 2° 1° 2° 
pattern of fates that they assume in wild-type animals (Table 1E1). However, 
if the anchor cell is ablated, then P5.p, P6.p, and P7.p can each assume either 
the 1 o or 2° fate (Table 1E2) (Sternberg 1988a). 
The lateral signal appears to play an important role in the patterning of 
vulval fates assumed by the induced VPCs. In lin-12 loss-of-function mutant 
animals, the pattern of fates is usually 3° 3° 1 o 1° 1 o 3° (Table 1F1). Thus, 
lateral signalling may be necessary to specify the 2° fate. Moreover, the 
lateral signal is believed to measure differences in the amount of inductive 
signal received between two VPCs and to act in response to this difference to 
direct the VPCs to assume different fates. This model is supported by 
indirect evidence that certain levels of the inductive signal can specify a VPC 
to have different fates depending upon the states of the VPC's neighbors. For 
example, a VPC in the position ofP5.p always assumes the 2° fate in wild-
type development. But an isolated VPC in this position has been observed to 
assume the 1 o fate in animals in which the other VPCs have been ablated (P. 
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Sternberg, unpublished observations). This isolated VPC may assume the 1 o 
fate for either of two reasons; it might be receiving more inductive signal than 
it does in wildtype because it lacks neighbors that absorb the inductive 
signal, or it may receive the same amount of inductive signal as it does in 
wildtype, but lacks lateral signalling from its neighbors that specify it to be 
2°. Another example is the pattern of vulval fates in dig-1 mutant animals in 
which the anchor cell is displaced to the dorsal side of the animal (Thomas et 
al. 1990) . In these animals the VPC closest to the anchor cell is at a distance 
equal to or greater than the distance ofP5.p is to the anchor cell in a wild-
type animal. Thus, no VPC in these dig-1 mutant animals should receive 
more inductive signal than P5.p in a wild-type animal. Yet, although P5.p 
always assumes the 2° fate in wild-type development, VPCs at an equivalent 
distance from the anchor cell in dig-1 mutants often assume the 1 o fate. Thus 
it is possible that there are intermediate doses of the inductive signal that 
will specify a VPC to have the 1 o fate in the context of neighboring VPCs that 
are receiving less inductive signal, but that will specify a VPC to have the 2° 
fate in the context of neighboring VPCs that are receiving more inductive 
signal. 
The action of the lateral signal in vulva development is also modeled on 
the role of lin-12 in the AC-VU equivalence group (Greenwald et al. 1983) . In 
this equivalence group, either the cell Zl.ppp or Z4.aaa can assume the fate of 
the anchor cell with approximately equal likelihood. Lateral signalling 
among these two cells mediates this decision without apparent influence from 
outside cells (Kimble 1981, Seydoux and Greenwald 1989). Although either 
cell can assume either fate, the lateral signal ensures that only one cell 
always assumes the fate of the anchor cell and that the other cell always 
assumes the fate ofVU (Kimble and Hirsh 1979) . Based upon this 
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observation, it has been proposed that the lateral signal acts in a feedback 
loop that establishes mutually exclusive states in adjacent cells. In this 
model both cells start with the ability to produce both the lateral signal and 
the receptor for the lateral signal. Cells that receive the lateral signal down-
regulate the activity of the lateral signal and up-regulate the activity of the 
receptor. Conversely, cells that produce the lateral signal up-regulate the 
activity of the lateral signal and down-regulate the activity of the receptor. 
This feedback mechanism should result in only one cell producing active 
lateral signal and with the other cell producing only active receptor (Seydoux 
and Greenwald 1989, Sternberg 1988b) . In vulval development, the outcome 
of lateral signalling among the VPCs is invariant and is believed to be biased 
by the inductive signal produced by the anchor cell. It is proposed the lateral 
signalling initially acts in proportion to the amount of inductive signal 
received by each VPC. The feedback mechanisms of the lateral signal then 
act to accentuate the differences in the amount of lateral signalling between 
the VPCs. This ensures that adjacent cells assume different fates in response 
to different levels of the inductive signal (Sternberg and Horvitz 1989). 
Another way of comparing the relative contribution of the inductive 
signal and the lateral signal in controlling pattern formation is by examining 
the genetic interactions of the two signals. In animals with lin-12 gain-of 
function mutations, all six VPCs usually assume the 2° fate. There is also 
usually no anchor cell in these animals and thus no inductive signal (Table 
1F2). However, in those lin-12 gain-of-function mutant animals that have an 
anchor cell, P6.p always assumes the 1 o fate (Table 1F3) (Sternberg and 
Horvitz 1989). Thus, for a single cell, the action of the inductive signal in 
specifying the 1 o fate overrides the action of the lateral signal in specifying 
the 2° fate. A function of the lateral signal in patterning though, is to prevent 
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two adjacent VPCs from both assuming the 1 o fate. Thus an important 
experiment is to determine if the lateral signal can still promote adjacent 
cells to assume different fates when they both receive high levels of the 
inductive signal. In lin-3 transgenic animals, which overexpress the 
inductive signal in the anchor cell, adjacent VPCs often both have the 1 o fate 
(Table li) (Hill and Sternberg, manuscript in preparation). In this situation, 
two adjacent VPCs both assume the 1 o fate, even though each of them should 
be laterally signalling their neighbors to be 2°. Thus, either a high level of 
the inductive signal specifies the 1 o fate and overrides the action of the 
lateral signal; or, alternatively, Lin-3 protein might bind to, and inhibit the 
action of, either the ligand or the receptor of the lateral signal. In either case, 
the dose of the inductive signal must be limited to achieve wild-type 
patterning in which P5.p and P7.p assume the 2° fate. 
Summary of 1° and 2° fate patterning. 
The pattern of 1 o and 2° fates assumed by the VPCs is determined both 
by the action of an inductive signal encoded by lin-3, and a lateral signal that 
acts though lin-12. The inductive signal appears to provide the specific 
information that sets up the pattern of fates assumed by the VPCs. First, the 
inductive signal originates only from the anchor cell and is the only signal 
that clearly provides spatially specific information. Second, the fact that the 
fate of an isolated VPC correlates with its distance from the anchor cell, 
suggests that different doses ofthe inductive signal promote the 1°, 2°, and 3° 
fates, and that a spatial gradient ofthe inductive signal promotes the VPCs 
to assume a graded pattern of fates. Third, a high level of the inductive 
signal specifies the 1 o fate and overrides the action of the lateral signal in 
specifying the 2° fate. This indicates that the production of the inductive 
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signal must be limited to get VPCs with the 2° fate. The properties of the 
lateral signal and lin-12 are intriguing. On the one hand the lateral signal 
seems to reinforce a pattern that has already been determined by the 
inductive signal; i. e., the lateral signal ensures that P5.p and P7.p assume 
the 2° fate in response to intermediate amounts of the inductive signal, and 
that P6.p assumes the 1° fate in response to high amounts ofthe inductive 
signal. On the other hand, wild-type activity of the gene lin-12, which is 
believed to encode the receptor for the lateral signal, is required to specify the 
2° fate. Thus a VPC that receives a dose of the inductive signal that 
promotes the 2° fate still apparently requires input from the lateral signal to 
assume the 2° fate. The mechanism by which an isolated VPC assumes the 
2° fate is unclear, since it lacks neighbors with which it can laterally signal. 
Such a VPC may engage in autocrine signalling through lin-12 to assume the 
2° fate. The inductive signal and the lateral signal appear to cooperate to 
promote the graded 2° 1 o 2° pattern of fates assumed by the induced VPCs. 
The use of two signals to promote this pattern may ensure that the process of 
pattern formation has a reproducible outcome. Thus for example, the lateral 
signal could ensure that the VPCs assume a 2° 1 o 2° pattern of fates over a 
broad dose range of the inductive signal, as long as the inductive signal is 
distributed in a gradient. 
Our current model ofVPC fate determination is summarized in Fig. 1. 
An inhibitory signal that arises in a spatially general manner inhibits the 
VPCs from assuming vulval fates in the absence of the inductive signal. 
Localized production of the inductive signal encoded by lin-3 controls the 
number and location ofVPCs that assume the vulval fates. Lateral signalling 
among the VPCs acts in response to a spatial gradient of inductive signal to 
specify P5.p and P7.p to assume the 2° fate. 
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Prospects. A question for the future is how the different signals interact 
to control the fate of the VPCs. The molecular cloning of several key genes in 
these intercellular pathways means that the interactions of these signals can 
be analyzed both genetically and by the techniques of molecular biology. The 
molecular mechanism by which the inhibitory signal represses the response 
pathway of the VPCs has not been established. Vulva development provides 
an example where the outcome of lateral interactions among cells of 
equivalent developmental potential appears to be controlled by the action of 
an outside signal. Elucidating the mechanisms by which the lateral signal 
and inductive signal interact to control the choice between 1 o and 2° will be a 
goal of future research. The use of genetics to identify additional components 
of the lateral signalling pathway will be important in understanding the 
mechanism of action of the lateral signal. Genetic screens for sup pressers of 
existing mutations that disrupt vulval development should be useful in 
identifying new genes involved in the pathways of vulval fate determination. 
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Section II. The EGF family of growth factors. 
The Epidermal Growth Factor (EGF)-like growth factors are inter-
cellular signalling molecules. The structural hall mark of the EGF -like 
growth factors is the EGF repeat, a self-folding structural domain of 
approximately 50 amino acids that has six cysteine residues with semi-
conserved spacing. The EGF-like growth factors are made as membrane-
bound precursors and can be proteolytically processed to release the EGF 
repeat as a secreted factor, although processing is not necessary for activation 
of the EGF-like growth factors. The EGF-like growth factors act through the 
EGF-Receptor (EGF-R) subfamily of tyrosine kinase receptors. Activation of 
the EGF-R results in a diverse set of physiological responses in different cell 
types including growth, inhibition of growth, induction and repression of gene 
expression, and differentiation. The EGF-like growth factors are generally 
implicated as important proto-oncogenes and are over-expressed or mis-
expressed by a wide variety of tumor cell lines. During development the 
EGF-like growth factors are expressed in a wide variety of tissues, but in 
general the function of these inter-cellular signalling molecules in 
development is not established. 
EGF/urogastrone 
The best characterized members of the EGF family of growth factors 
are Epidermal Growth Factor and Transforming Growth Factor-alpha (TGF-
a). Murine epidermal growth factor was discovered during the purification of 
Nerve Growth Factor (NGF) as a novel set of activities distinct from NGF 
(Cohen 1960, Levi-Montalcini and Cohen 1960). This activity was noted to 
have a direct mitogenic effect on epidermal cell types and was thus termed 
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epidermal growth factor (Cohen 1964). EGF was purified to homogeneity 
(Savage and Cohen 1972) and the primary sequence of the 53 amino acid 
EGF polypeptide was reported in 1972 (Savage et al. 1972). The sequence 
contains 6 cysteine residues which form disulfide bonds in the pattern 1 to 3, 
2 to 4, and 5 to 6 (Savage et al. 1973). Human EGF was characterized as 
urogastrone, which is an activity found in urine that inhibits gastric acid 
secretion ((Sandweiss 1943) cited in (Gregory 1975) ). The amino acid 
sequence of urogastrone was discovered to be identical to that of murine EGF 
at 38 of 53 positions. This result and the fact that murine EGF mediated the 
effects of urogastrone established urogastrone as the human EGF equivalent 
(Gregory 1975). 
The cloning of a eDNA for the EGF precursor revealed that it could 
encode a protein of over 1200 amino acids, relatively large compared to the 
size ofEGF (Gray et al. 1983, Scott et al. 1983). The precursor has two 
hydrophobic stretches similar to a signal peptide sequence and a trans-
membrane domain, which suggests that the EGF precursor is a membrane -
spanning protein. The sequence of mature EGF is located near, and to the 
amino terminus, of the membrane-spanning domain of the precursor. The 
EGF precursor was noted to contain 8 regions that have a primary amino acid 
structure and a spacing of six cysteine residues similar to that of mature 
EGF. The structural motif of these 6 cysteine residues was named an EGF 
repeat and are a lso called EGF-like domains (Doolittle et al. 1984, Gray et al. 
1983, Scott et al. 1983). To date there is no evidence that the other EGF 
repeats present in the EGF precursor are processed to form soluble factors . 
EGF repeats have since been noted to be present in the extracellular domains 
of a diverse set of proteins of different functions including many proteins that 
are not growth factors (reviewed in (Carpenter and Wahl1990, Davis 1990)). 
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Still, the EGF repeat is the defining structural feature of the EGF-like 
growth factors: it is the ligand domain of these factors, and the analysis of 
the structure of the precursors of different EGF-like growth factors (below) 
indicates that the EGF repeat is the only feature that all have in common. 
Transforming growth factor-alpha 
Transforming growth factor-alpha (TGF-a) was first characterized as 
sarcoma growth factor, an activity present in the conditioned media of 3T3 
cells transformed with Moloney murine sarcoma virus (De Larco and Todaro 
1978). Sarcoma growth factor was shown to be mitogenic for fibroblasts, and 
to inhibit the binding of 125I-EGF to its receptor, but to be immunologically 
distinct from EGF. Sarcoma growth factor also had the striking ability to 
allow normal rat fibroblasts to form colonies in soft agar, (De Larco and 
Todaro 1978), which EGF was not able to do, and was thus renamed 
transforming growth factor (De Larco et al. 1980). Similar activities were 
also found in the supernatants of several human tumor cell lines which 
indicated that transforming growth factor was likely of mammalian and not 
of viral origin (De Larco et al. 1980). During the purification of transforming 
growth factor it was demonstrated that its different activities were mediated 
by different molecules. TGF-a was shown to be a mitogen for fibroblasts, and 
to inhibit the binding of 125I-EGF to the EGF-R, but highly purified TGF-a 
preparations could not support soft-agar colony formation. TGF-13 could not 
inhibit binding of 125I-EGF, but could act either with TGF-a or with EGF to 
promote soft agar colony formation (Anzano et al. 1983). Further analysis 
confirmed that TGF-a acted through the same receptor as EGF (Carpenter et 
al. 1983, Massague 1983). The amino acid sequence ofthe 50 amino acid 
TGF -a polypeptide showed that it had 32-36% sequence identity with EGF 
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including the conservation of the spacing of the 6 cysteine residues 
(Marquardt et al. 1984, Marquardt et al. 1983, Massague 1983). The 
molecular cloning of a TGF-a eDNA showed that TGF-a was made as a 159 
(human) or 160 (rat) amino acid membrane spanning protein (Derynck et al. 
1984, Lee et al. 1985). The TGF-a precursor is palmitoylated and is found on 
the plasma membrane (Bringman et al. 1987). The TGF-a precursor contains 
only a single EGF repeat, and does not share sequence similarity to the EGF 
precursor outside of the EGF repeat. 
Viral EGF-like growth factors. 
A search through the protein databases for additional proteins that 
contained EGF repeats indicated that the previously determined nucleotide 
sequence of the LTR of the vaccinia virus (Venkatesan et al. 1982) could 
encode a 140 amino acid membrane spanning protein with an EGF repeat. 
The EGF repeat of this protein has 35% amino acid identity with EGF and 
TGF-a. On the basis ofthis observation, the supernatant ofvaccinia-virus-
infected cells was analyzed for the presence ofEGF-like growth factor 
activities. An activity called Vaccinia Virus Growth Factor (VVGF) was 
discovered which was mitogenic for 3T3 cells and which would competitively 
inhibit the binding of 125r-EGF to 3T3 cells. The direct amino acid sequence 
ofVVGF showed that it could be derived from proteolytic processing of the 
protein encoded within the LTR of vaccinia virus (Stroobant et al. 1985). Two 
other pox viruses have been noted to contain genes that could encode EGF-
like growth factors . Shope fibroma virus could encode a protein of 84 amino 
acids called Shope Fibroma Virus Growth Factor (SFGF) (Chang et al. 1987) 
and myxoma virus could encode a protein of 85 amino acids called Myxoma 
Virus Growth Factor (MVGF) (Upton et al. 1987). The EGF repeats ofSFGF 
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and MVGF show about 80% amino acid identity to each other and about 40% 
identity to the EGF repeat of murine EGF. MVGF and SFGF are unique 
among the EGF-like growth factors in that they both lack putative membrane 
spanning domains. Synthetic MVGF and SFGF can both competitively 
inhibit binding of 125I-EGF to human A-431 cells and are mitogenic for 
normal rat fibroblasts, although SFGF is 200-fold less active, and MVGF is 
10-fold less active than EGF in these assays (Lin et al. 1988, Lin et al. 1991). 
The lower activity of MVGF and SFGF could be due to the fact that both 
proteins are from viruses that infect rabbits and are being tested on human 
and rat cells. 
Ainphiregulin and EGF-like growth factors with basic regions. 
A number ofEGF-like growth factors that have basic regions have 
been characterized. The first member of this class is amphiregulin, which 
was purified from TPA-stimulated human breast carcinoma cells. 
Amphiregulin is a secreted factor of 84 or 78 amino acids. The carboxy 
terminus of the secreted factor contains an EGF repeat with 30% identity to 
human EGF. The amino terminus of amphiregulin extends farther than EGF 
and contains a 21 amino acid region with 14 basic amino acids (Shoyab et al. 
1989). Amphiregulin is derived from a 252 amino acid membrane-spanning 
precursor (Plowman et al. 1990). Schwannoma Derived Growth Factor 
(SDGF) is 76% identical to amphiregulin and the SDGF precursor is 70% 
identical to the amphiregulin precursor. Mature SDGF has a stretch of basic 
amino acids to the amino terminus of the EGF repeat that is identical to 
amphiregulin at 18 of 21 amino acid residues (Kimura et al. 1990). This high 
level of sequence similarity between the two molecules suggests that SDGF 
may be the rat orthologue of amphiregulin. Amphiregulin can competitively 
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inhibit, but not completely, the binding of 1251-EGF to A-431 cells (Shoyab et 
al. 1989) . Recent reports confirm that at least some of the activities of 
amphiregulin are mediated through the EGF-R (Johnson et al. 1993). 
Amphiregulin can mediate some of the activities of EGF but not others: 
amphiregulin is a mitogen for the murine keratinocyte cell line Balb/MK, but 
can not act with TGF-~ to promote colony formation in soft agar. 
Amphiregulin inhibits the growth of some human carcinoma cell lines, 
although the mechanism of growth inhibition is not clear (Shoyab et al. 1988). 
SDGF was purified by its ability to bind heparin columns (Kimura et 
al. 1990). Amphiregulin can also bind heparin based upon its identity with 
Keratinocyte Autocrine Factor (KAF). KAF is produced by and is a mitogen 
for normal human keratinocytes. KAF was purified on the basis of its ability 
to bind heparin and was shown to be identical in sequence to amphiregulin 
(Cook et al. 1991). Heparin-sulfate blocks the ability of purified KAF to 
competitively inhibit the binding of 1251-EGF and also the ability ofKAF to 
act as a mitogen for AKR-2B cells. Heparin-sulfate, however, does not block 
the mitogenic effect ofEGF on AKR-2B cells (Cook et al. 1991). The different 
activities of EGF and amphiregulin!KAF in bioassays could be due to factors 
that regulate the action of amphiregulin. 
Heparin-Binding EGF was purified from a human macrophage-like cell 
line on its ability to bind heparin. HB-EGF is a secreted factor generated 
from a 208 amino acid precursor. HB-EGF is distinct in sequence from 
amphiregulin but is similar to amphiregulin in that it has a stretch ofbasic 
amino acids to the amino terminus of the EGF repeat. HB-EGF is also a 
competitive inhibitor of 1251-EGF, suggesting that it also acts through the 
EGF-R (Higashiyama et al. 1991). 
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The EGF-R subfamily 
Three additional receptors have been identified in mammals that are 
members of the EGF-R subfamily called neu/HER2/p185erbB2 (Bargmann et 
al. 1986, Yamamoto et al. 1986), HER3/p16oerbB3 (Kraus et al. 1989, 
Plowman et al. 1990) and HER4/p18oerbB4 (Plowman et al. 1993). HER2 is 
not activated by EGF-R ligands (Yamamoto et al. 1986). The extracellular 
domains ofHER3 and HER4 are more related to each other than they are to 
HER2 and to the EGF-R (Plowman et al. 1993). The amino acid sequence of 
ligands of HER3 and HER4 have not been reported. HER4 is not activated by 
EGF or amphiregulin. A partially purified heparin-binding factor has been 
isolated that activates HER4, but which does not activate HER3, HER2 or 
EGF-R (Plowman et al. 1993). 
Ligands of neu!HER2 
Ligands ofHER2 have recently been described as Neu Differentiation 
Factor (NDF) (Wen et al. 1992), heregulin (Holmes et al. 1992), Glial Growth 
Factor (GGF) (Marcchionni et al. 1993), and betacellulin (Sasada et al. 1993). 
NDF was purified from ras transformed rat fibroblasts (Peles et al. 1992, 
Yarden and Peles 1991). NDF induces phosphorylation ofHER2 and cross-
linking studies show that it binds HER2. Heregulin was purified from 
human breast carcinoma cells (Holmes et al. 1992) and GGF was purified 
from bovine pituitary glands (Marcchionni et al. 1993). HER2-activating 
factors that may be the same protein as NDF have been biochemically 
characterized (Davis et al. 1991, Dobashi et al. 1991, Lupu et al. 1990). The 
ligands of HER2 do not activate the EGF-R, for example Heregulin-a does not 
compete with 1251-EGF for binding to A-431 cells (Holmes et al. 1992). There 
may be some cross-talk between the receptors, however, for example, 
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activation of the EGF-R by amphiregulin causes phosphorylation ofHER2 
(Johnson et al. 1993). 
The structure of the HER2 ligands indicates that they belong to the 
EGF family of growth factors but that they are structurally unique. NDF is 
an integral membrane protein that contains a single EGF repeat proximal 
and to the amino terminus of the trans-membrane domain. The EGF repeat 
of rat NDF meets the consensus for EGF repeats used as growth factors. It 
has 26% amino acid identity with the EGF repeat of rat TGF-a over 51 amino 
acids, whereas rat TGF-a shows 33% amino acid identity to rat EGF over the 
same interval. NDF, like SFGF and MVGF, contains 13 amino acid residues 
between the third and fourth cysteine residues, whereas EGF and most other 
EGF-R ligands have only 10 amino acids in this region. NDF also contains a 
single Immunoglobulin-like (Ig) domain that is present in the mature 
secreted forms ofthe molecules (Wen et al. 1992). None of the EGF-R ligands 
have an Ig domain. The analysis ofheregulin and GGF indicates that they 
are produced by the same gene as NDF and that this gene undergoes a 
complex pattern of alternative splicing. Surprisingly, different heregulin 
cDNAs would produce proteins that would differ in the carboxy-half of the 
EGF repeat. This half of the EGF repeat is usually the more conserved half 
of the EGF repeat, and for the EGF-R ligands is important in receptor 
recognition. The predicted heregulin proteins also differ in the 20 amino acid 
domain between the EGF repeat and the membrane-spanning domain, where 
proteolytic processing would need to occur to release the mature growth 
factor from the cell. Some heregulin cDNAs also contain a stop codon after 
the EGF repeat and before the membrane spanning domain (Holmes et al. 
1992). It is thus conceivable that different heregulin proteins would have 
different biological activities. None of the NDF or heregulin cDNAs would 
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encode a hydropathic amino terminal signal peptide(Holmes et al. 1992, Wen 
et al. 1992). The analysis of glial growth factor includes the sequence 
determination of bovine genomic DNA and the analysis of cDNAs from a 
variety of tissues and species (Marcchionni et al. 1993). These results 
indicate that there are additional 5' exons present that were not detected in 
the analysis ofheregulin and NDF. The most 5' exon could encode a signal 
peptide and a kringle domain. Novel transcripts were discovered that encode 
the kringle domain and the lg domain but not the EGF repeat. The three 
cytoplasmic exons of Glial Growth Factor also undergo alternative splicing. 
The functional significance of the diverse splice variants is not established. 
The heregulin-~3 and GGFH#B1 cDNAs that do not encode signal peptides 
and that contain stop codons between the EGF repeat and the 
transmembrane domains do not produce secreted protein in transfection 
studies (Holmes et al. 1992, Marcchionni et al. 1993). 
Processing of the EGF growth factors. 
The EGF-like growth factors can act as secreted factors that are 
derived by proteolytic processing from integral membrane proteins. Different 
EGF-like growth factors are processed at different types of amino acid 
sequences. For example, TGF-a is processed at small hydropathic sequences 
(Derynck et al. 1984, Lee et al. 1985) and EGF is processed at dibasic 
residues (Gray et al. 1983, Scott et al. 1983). The processing ofTGF-a has 
been studied most extensively. Immunolocalization experiments confirm that 
the TGF-a precursor (pro-TGF-a) is found on the plasma membrane of cells 
(Bringman et al. 1987). In transfected CHO cells that express pro-TGF-a, 
processing ofpro-TGF-a to release the sequence amino-terminal to the EGF 
repeat occurs quickly with a half-life of 30 minutes. The processing that 
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releases mature TGF-a from the membrane occurs slowly, with a half-life of2 
hours (Teixid6 et al. 1990). Stimulation of the transfected CHO cells with 
serum, or the calcium ionophore A23187, or with the phorbol ester PMA 
causes a rapid release ofTGF-a from the cell surface (Pandiella and 
Massague 1991, Pandiella and Massague 1991). These results suggest that 
the processing mechanisms that release TGF-a from a cell are regulated and 
can be activated by signal transduction pathways. The processing appears to 
occur at the cell surface. Treatment oftransfected CHO cells with brefeldin A 
which blocks golgi transport does not prevent the release of previously 
synthesized pro-TGF -a from the cell in response to PMA stimulation. But 
TGF-a made after the treatment with brefeldin A is not processed and 
released in response to PMA stimulation (Bosenberg et al. 1992). The agents 
chloroquine and leupeptin that disrupt lysosome function also do not prevent 
PMA from stimulating the release ofTGF-a from the cell (Bosenberg et al. 
1992). 
Site directed mutagenesis experiments indicate that the carboxy 
terminal Val residue of the cytoplasmic domain of the TGF-a precursor is the 
major recognition signal of this processing pathway (Bosenberg et al. 1992). 
The cytoplasmic domain of TGF -a is 34 amino acids long and is highly 
conserved (Derynck et al. 1984, Lee et al. 1985). Replacement of the carboxy 
terminal Val with Gly, Ser, or Glu blocks processing ofpro-TGF-a, 
replacement with Ala, Met, Phe, or Trp reduces processing, and replacement 
with Leu and Ile does not block processing (Bosenberg et al. 1992). In 
contrast most internal deletions of the cytoplasmic domain do not block 
processing. The processing pathway appears to be associated with the cell 
since supernatants from cells that are undergoing processing can not process 
the pro-TGF-a found on other cells (Bosenberg et al. 1992). CHO cells do not 
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normally express TGF-a and it has not been confirmed that TGF-a processing 
is regulated in a similar manner in cells that normally express TGF-a. The 
enzymes responsible for the processing of the precursors have not been 
identified for any of the EGF-like growth factors. 
Processing of the EGF-like growth factors does not appear to be 
required to allow the EGF repeat to bind the receptor. Two groups made site 
directed mutants ofTGF-a in which the processing sites were disrupted and 
demonstrated that cells which express these mutants do not release 
processed TGF-a into the culture media. Unprocessed mutant TGF-a purified 
from these cells can induce phosphorylation of the EGF-R, and can induce 
colony formation in soft agar in the presence ofTGF-~. Moreover, 
unprocessed mutant TGF-a on the surface oflive cells can induce 
phosphorylation of the EGF-R on other cells but the supernatant ofthe cells 
expressing the mutant TGF-a could not induce phosphorylation of the EGF-R 
on other cells (Brachmann et al. 1989, Wong et al. 1989). It has also been 
shown that purified full length EGF precursor is also biologically active 
(Mroczkowski et al. 1989). These studies raise the possibility that the EGF-
like growth factors act as membrane bound factors in vivo. 
TGF -a knockouts. 
Little is known about the function ofthe EGF-like growth factors in 
vivo and during ontogeny. The EGF-like growth factors are expressed in 
complex patterns which have been reviewed elsewhere (Carpenter and Wahl 
1990, Derynck 1992). Briefly, EGF is expressed at high levels in the mouse in 
the submaxillary gland and in the kidneys (Rall et al. 1985) and is believed 
not to be expressed in the embryo (Carpenter and Wahl1990). TGF-a RNA is 
detected in unfertilized mouse embryos but goes away after fertilization. 
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TGF -ex. RNA and protein is seen in the mouse blastocysts (Rappolee et al. 
1988). TGF-cx. RNA is detected by in situ hybridization at day 9-10, but not at 
days 12, 14, and 16 of mouse embryogenesis. It is detected in the otic vesicle, 
cells lining the oral cavity and pharyngeal pouch, the syncytiotrophoblast 
layer of the placenta, the first and second brachial arches, and the developing 
mesonephric tubules of the developing kidney (Wilcox and Derynck 1988). 
TGF-a TGF-cx. is produced by normal keratinocytes and is present in skin 
biopsies (Coffey et al. 1987) and is detected in vivo in wound macrophages 
(Rappolee et al. 1988). Glial Growth Factor is detected by in situ 
hybridization in the developing nervous system of the mouse, but not in non-
neural tissues. Expression appears to be high in developing motor neurons 
and primary sensory neurons (Marcchionni et al. 1993). 
Two groups have reported on the phenotypes of mice in which function 
of the TGF-cx. gene has been disrupted by homologous recombination 
(Luetteke et al. 1993, Mann et al. 1993). Despite the extensive expression of 
TGF-cx. in the embryo, mice homozygous for the TGF-cx. knockout are viable, 
fertile, healthy, and have normal wound healing. These mice show 
susceptibility to corneal inflammation, have a wavy coat, curly whiskers, and 
disorganization of the hair follicles, but otherwise appear to be normal. The 
TGF-cx. mutation is allelic to the mouse mutant waved-1. It is possible either 
that TGF-cx. has no important role in development other than those indicated 
by the phenotype ofwaved-1, or that TGF-cx. acts redundantly with other 
EGF-like growth factors during development. The analysis of the null 
phenotype of the other growth factors and their receptors will be necessary to 
determine the function of these proteins in development. 
EGF-like proteins in Drosophila. 
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The spitz locus of Drosophila encodes a 26-kD membrane spanning 
protein with a single EGF-like repeat that is structurally similar to TGF-a. 
and Lin-3 (Rutledge et al. 1992). The EGF repeat of spitz has 23% amino acid 
identity with the EGF repeat of human TGF-a and 32% amino acid identity 
with the EGF repeat ofLin-3. mRNA for spitz is expressed ubiquitously in 
the embryo and is present in high levels in the procephalic region, ventral 
midline, and mesodermal layers. A polyclonal antisera to a spitz -T7 fusion 
protein detects spitz protein ubiquitously in the embryo (Rutledge et al. 
1992). The spitz gene belongs to the spitz group ofmutations that also 
includes Star (8), single-minded (sim), pointed (pnt), rhomboid (rho), and the 
maternally-acting gene sichel (sic) (Mayer and Niisslein-Volhard 1988). 
Amorphic mutations of spitz cause a zygotic embryonic lethal phenotype in 
which there are defects in the specification of structures in the ventral-lateral 
blastoderm. This includes a loss of the Keilin's organs in the thoracic 
segments and a loss of ventral structures in the head. Pole cell 
transplantation experiments indicate that spitz is required for the 
development of the female germline (Mayer and Niisslein-Volhard 1988). 
spitz is also required in the development of the nervous system. In spitz 
mutants the MGM glial cells fail to migrate which results in a fusion of the 
anterior and posterior commissures (KUimbt et al. 1991). The set of tissues 
that express spitz is wider than the set of tissues affected by loss of spitz 
function, and thus other genes may control where spitz is active (Rutledge et 
al. 1992) . 
The molecular identity of the spitz gene product suggests that it 
encodes a ligand of the Drosophila EGF-Receptor encoded by the DER locus 
(Livneh et al. 1985). It has not been yet been demonstrated that the spitz 
protein directly binds the DER protein or that spitz acts genetically upstream 
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of DER. DER performs a large number of developmental functions and has 
been genetically characterized as faint little ball (flb), alleles of which cause a 
zygotic embryonic lethal phenotype (Nusslein-Volhard et al. 1984, Schejter 
and Shilo 1989) as torpedo (top), alleles ofwhich cause a female sterile 
phenotype (Price et al. 1989, Schupbach 1987) and as Ellipse, alleles of which 
cause dominant defects in the development of the eye (Baker and Rubin 
1989). In flb mutant embryos, there is a defect in germ-band extension, a loss 
of anterior and ventral cuticle, degeneration of the amnioserosa, and a loss of 
ventral cuticle that is similar to, but more severe than, the defect caused by 
the spitz group of mutants (Clifford and Schupbach 1992, Nusslein-Volhard et 
al. 1984, Raz and Shilo 1992). An analysis using temperature-sensitive fib 
alleles indicates that DER function is required for sequential steps in the 
development of the CNS and that loss of DER function after the early steps 
confers a phenotype in which the commissures are fused in a manner similar 
to the spitz phenotype (Raz and Shilo 1992). The severe phenotype of 
amorphic DER mutations suggest that the Drosophila EGF-R is involved in 
more developmental processes than spitz , although maternal contributions of 
spitz could mask the full role of spitz in zygotic development. This could 
suggest that DER, like the EGF-R ofmammals uses multiple ligands. 
Amorphic mutations in the gurken locus confer a female sterile phenotype 
equivalent to the phenotype of the top alleles of DER (Schupbach 1987). It 
has been reported thatgurken encodes a TGF-a like protein and thus the 
gurken protein is a second candidate ligand for the DER protein (S. Neuman-
Silberberg, T. Schupbach, personal communication). gurken acts cell 
autonomously to the germline and DER acts cell autonomously to the soma 
which is consistent with the model that g urken and DER are involved in 
inter-cellular signalling during germ-line development (Schupbach 1987). 
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Figures. 
Figure 1. Three-signal model ofVPC fate determination. The six VPCs 
choose between three possible fates, 1 o , 2° and 3° in response to three 
intercellular signals. A spatially graded inductive signal made by the anchor 
cell induces the three more proximal VPCs to assume 1 o and 2° vulval fates. 
An inhibitory signal from the syncytial epidermis prevents the VPCs from 
assuming vulval fates in the absence of the inductive signal. A lateral signal 
acts among the VPCs to promote the 2° fate. Each VPC is believed to 
laterally signal its neighbors in proportion to the amount of inductive signal 























































































































































Figure 2. Schematic representation of the fates of the VPCs in wild-type 
vulval development. The name, relative position, and fate of each cell is 
shown. The lineage associated with each fate is drawn below the VPCs. 
Vertical lines represent cells and horizontal lines represent cell divisions. 
P5.p, P6.p, and P7.p contribute to the vulva and the other VPCs form 
epidermis. P3.p can assume the 3° fate or fuse directly to the syncytial 
epidermis without dividing (Sulston and Horvitz 1977, Sulston and White 
1980). A unique characteristic associated with the final division of each cell, 
or with the terminal progeny, is indicated by a single letter code beneath the 
lineage, (convention of Sternberg and Horvitz, 1986): S, cell fuses with the 
syncytial epidermis hyp7; L, nucleus divides longitudinally in the anterior-
posterior axis of the body, underline indicates that the daughter nuclei 
adhere to the ventral cuticle; T, nucleus divides transversely in the left-right 
































































































































Figure 3. Simplified pathway ofvulval induction. The gene lin-3 encodes a 
EGF-like growth factor made by the anchor cell that is proposed to activate 
let-23. lin-15 negatively regulates the basal activity of let-23. let-23 encodes 
an EGF-Receptor-like tyrosine kinase. An adapter protein encoded by sem-5 
is proposed to couple the action of let-23 to let-60. let-60 encodes a ras protein 
that acts upstream of the raf ser-thr kinase encoded by lin-45. Activity of 
this pathway eventually results in inactivation of lin-1. lin-1 promotes the 
epidermal fate and inhibits the vulval fates. 
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Figure 3. Simplified pathway 



















Table 1. Representative vulval fate patterns seen in different genotypes or 
after cell ablation. A. In wild-type development the six VPCs assume the 
pattern of fates 3° 3° 2° 1 o 2° 3° (Sulston and Horvitz 1977, Sulston 1976, 
Sulston and White 1980). B. The VPCs can display regulation of fates upon 
ablation of VPCs prior to the time of vulval induction. A cell that normally 
adopts the 3° or 2° fate can assume the P fate if the cell that normally 
assumes the 1° fate is destroyed. A cell that normally assumes the 3° fate 
can replace a 2° cell. A 1 o cell will not replace a 2° or 3° cell, and a 2° cell will 
not replace a 3° cell. The regulating cell will usually assume the position, as 
well as the fate, of the cell that it is replacing. The abilility of the VPCs to 
undergo replacement regulation supports the model that the VPCs are 
equivalent in their potential to assume either of the three fates (Sternberg 
and Horvitz 1986, Sulston and White 1980). C. Ablation of the AC or its 
precursors before or during the first several hours of the L3 stage prevents 
P5.p, P6.p and P7.p from assuming vulval fates. Therefore, the vulval fates 
are specified by an inductive signal from the AC of the somatic gonad 
(Kimble, 1981, Sulston and White, 1980) Dl. Recessive mutations in the 
genes lin-2, lin-3, lin-7, lin-1 0, lin-45, let-23, let-60, and sem-5, and dominant 
negative mutations in let-60 can cause a vulvaless phenotype in which fewer 
than the normal number ofVPCs assume vulval fates, even though the AC 
and the VPCs are present (Aroian and Sternberg, 1991, Beitel, et al., Clark, 
et al., 1992, Ferguson and Horvitz, 1985, Han, et al., 1990, Han, et al., 1993, 
Horvitz and Sulston, 1980, Sulston and Horvitz, 1981). These genes are 
involved either in the generation of the inductive signal by the AC, or the 
response to the inductive signal by the VPCs. D2. Recessive mutations in 
Zin-1, and lin-15, and gain-of-function mutations of let-60, confer a multivulva 
phenotype in which greater than the normal number ofVPCs assume vulval 
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fates (Beitel, et al. 1990, Ferguson and Horvitz 1985, Han, et al. 1990). E. In 
lin-15 mutant animals all six VPCs assume vulval fates (E1) and can do so 
independently ofthe inductive signal (E2) (Ferguson and Horvitz ,1985, 
Ferguson, et al., 1987). In lin-15 mutant animals it is commonly observed 
that two adjacent VPCs both assume the 2° fate, but it is rarely observed that 
two adjacent VPCs both assume the 1 o fate. This suggests the action of a 
lateral signal among the VPCs that prevents two adjacent VPCs from both 
assuming the 1 o fate. 1. In lin-15 mutant animals, the patterning of P5.p, 
P6.p, and P7.p is normal if the AC is present. P6.p always assumes the 1 o 
fate and P5.p and P7.p assume the 2° fate. 2. If the AC is absent, then the 
patterning ofP5.p, P6.p and P7.p is disrupted so that any of these cells can 
assume either the 1 o or 2° fate. Thus, the VPCs can still respond to the 
inductive signal in lin-15 mutant animals. 3. An isolated VPC in a lin-15 
mutant assumes the 1 o fate. 4,5. Two isolated VPCs in a lin-15 mutant 
animal will usually both assume the 1 o fate if they are not in close proximity 
to each other, but only one of the cells will assume the 1 o fate if they remain 
in close contact with each other. Thus, the lateral signal between the VPCs 
appears to act only at a close range and may require direct cell contact 
(Sternberg, 1988a). F. The lin-12 activity promotes the 2° fate in the VPC 
equivalence group and in the AC (1 °) VU (2°) equivalence group (Greenwald, 
et al. 1983). 1. In animals homozygous for null mutations of lin-12 
approximately three VPCs are induced to assume 1° lineages and there are 
often two or more ACs. 2. In animals with dominant gain-of-function 
mutations in lin-12, all six VPCs assume 2° fates and there is often no AC. 3. 
In some animals of the genotype lin-12(d) I lin-12(0) ACs are present. When 
an AC is present, P6.p assumes the 1 o fate and when the AC is absent P6.p 
assumes the 2° fate. Therefore the inductive signal can override the action of 
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lin-12(d) mutations to specify the 1 o fate (Sternberg and Horvitz 1989). G. 
The AC is the organizing center of vulval fate patterning. When the AC is 
shifted to a more anterior position in dig-1 mutant animals, the pattern of 
vulval development is usually commensurably shifted (Thomas, et al. 1990). 
H. The fate of an isolated VPC correlates with its distance from the AC. A 
VPC that is close to the AC will assume the 1 o fate, a VPC that is relatively 
further away will assume the 2° fate, and a VPC that is far from the AC will 
assume the 3° fate . This suggests that the inductive signal is distributed in a 
spatial gradient centered on the AC and that the VPCs can assume different 
fates in response to different levels of the inductive signal (Sternberg and 
Horvitz, 1986). I. In animals bearing multicopy lin-3 transgenes, which 
presumably overexpress Lin-3 protein from the anchor cell, adjacent VPCs 
often assume the 1 o fate. Therefore, high levels of the inductive signal can 
override the effect of the lateral signal and specify two adjacent cells to both 
have the 1 o fate (Hill and Sternberg, manuscript in preparation). AC: Anchor 
Cell. 
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Table 1. Vulval fate patterns. 
PS.p P4.p P 5.p P6.p P7.p PB.p 
A. wild-type AC 
so so 20 p 20 so 
B. Replacement Regulation : 
1. P 6.p ablation AC 
so 20 10 X 20 so 
2. P5.p ablation AC 
so 20 X 10 20 so 
C. AC ablation. X so so so so so so 
D. 1. vulvaless AC so so so so so so 
2. multivulva AC 
10 20 20 10 20 10 
E. 1. lin-15 AC + AC 
10 20 20 10 20 10 
2. lin-15 AC - X 
10 20 10 20 10 20 
s. lin-15 Isolated VPC X 
X X X X 10 X 
4. lin-15 VPCs close X 
X X X X 10 20 
5. lin-15 VPCs distant X 
X 10 X X p X 
F. 1. lin-12(0) ACAC so so 10 p 10 so 
2. lin-12(d) 
20 20 20 20 20 20 
S. lin-12(0) I lin-12(d) AC+ AC 
20 20 20 10 20 20 
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G. dig-1 anterior AC. AC 
30 20 10 20 30 30 
H. Isolated VPCs. 
1. Proximal VPC AC 
X X X 10 X X 
2. Intermediate VPC AC 
X X 20 X X X 
3. Distal VPC AC 
30 X X X X X 
I. lin-3 transgene. AC 
20 20 p 10 20 20 
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Chapter 2 
Molecular cloning of the gene lin-3. 
Note: This chapter was published previously as an article in Nature 358: 
470-476 (1992). The version given here is modified to include a more 
descriptive set offigure legends. 
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The lin-3 gene is necessary for induction of the C. elegans vulva 
by the anchor cell. It encodes a molecule similar to epidermal 
growth factor and to transforming growth factor-a and acts through 
the epidermal growth factor receptor homologue let-23. Expression 
of lin-3 in the anchor cell stimulates vulval induction; lin-3 may 
encode the vulval inducing signal. 
Induction is a general developmental mechanism in which one set of cells 
specifies the fate of another set of cells. The vulval development of C. elegans 
hermaphrodites is an intensively-studied example of induction (reviewed in 
(Horvitz and Sternberg 1991) ). The vulva normally forms from a subset of six 
tripotential cells called the vulval precursor cells (VPCs) that are located 
within the ventral epidermis. Each VPC can have an epidermal fate in which 
it produces two progeny that fuse with the syncytial epidermis, hyp7. 
Alternatively, each VPC can have either of two vulval fates in which it 
produces seven or eight vulval progeny. In a wild-type animal, the three 
VPCs that are closer to the anchor cell of the somatic gonad have vulval fates 
and the three VPCs farther from the AC have epidermal fates (Fig. 1a). If the 
anchor cell is destroyed early in development, then all six VPCs have the 
epidermal fate, indicating that the vulval fates are induced by a signal from 
the anchor cell (Kimble 1981). This vulval inductive signal can act directly on 
each VPC and may be spatially graded (Sternberg and Horvitz 1986). The 
vulval inductive signal may be a secreted factor because vulval induction can 
occur in dig-1 mutant animals when there is no apparent contact between the 
anchor cell and the VPCs (Thomas et al. 1990). 
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Many genes involved in the process of vulval induction have been defined 
by mutations that fall into two broad classes (Horvitz and Sternberg 1991). 
Vulvaless (Vul) mutations decrease the number ofVPCs that assume vulval 
fates , whereas multivulva (Muv) mutations increase the number ofVPCs that 
assume vulval fates. Mutations that partially lower lin-3 activity confer a 
Vul phenotype in which the VPCs that would normally form the vulva 
instead usually form epidermis, even though the anchor cell is present 
(Ferguson and Horvitz 1985, Ferguson et al. 1987, Horvitz and Sulston 1980, 
Sulston and Horvitz 1981). Although lin-3 affects other developmental 
processes, for example a putative null mutation in lin-3 results in lethality 
early in postembryonic development (Ferguson and Horvitz 1985), only the 
role of lin-3 in vulval development is characterized here. A genetic pathway 
of vulval induction has been derived from the epistasis displayed by the Vul 
and Muv mutations (Aroian and Sternberg 1991, Ferguson, et al. 1987, Han 
et al. 1990). These experiments suggest that lin-3 acts before let-23 and let-
60, which are other genes necessary for vulval induction. let-23 encodes a 
homologue of the epidermal growth factor receptor (EGF-R ) subfamily and is 
the proposed receptor for the inductive signal (Aroian et al. 1990, Aroian and 
Sternberg 1991), and let-60 encodes a ras protein that acts downstream of let-
23 as a switch to control VPC fate (Beitel et al. 1990, Han, et al. 1990, Han 
and Sternberg 1990). Several other genes that are believed to act 
downstream of lin-3 during vulval induction have been molecularly 
characterized: lin-10 encodes a novel protein (Kim and Horvitz 1990) that is 
necessary for wild-type levels of vulval induction; sem-5 encodes a novel 
protein with SH2 and SH3 domains (Clark et al. 1992). To establish further 
the role of lin-3 in vulval development, we have cloned the lin-3 locus and 
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examined the genetic properties of lin-3 transgenes. Our analysis indicates 
that lin-3 has a structure similar to certain mammalian growth factors, and 
that lin-3 can act as a signal in vivo. 
Cloning of the lin-3 locus 
We cloned the lin-3 locus by transposon tagging and DNA-mediated 
transformation (Fig. 2). We obtained the transposon-induced allele lin-
3(sy91::Tcl) by mating lin-3 males with hermaphrodites of the strain 
RW7096, which has high rates of transposition ofthe transposon Tel (Mori et 
al. 1988). sy91 confers a recessive Vul phenotype (Fig. 3b) and was recovered 
because it fails to complement the paternallin-3 mutation. Genetic mapping 
showed that the Tel insertion called syP 1 cosegregates with the mutation 
sy91 (Fig. 2 legend). DNA sequences that flank syP 1 were used to identify 
the genomic clones A.PS#l and A.PS#2. Two observations confirm that these 
genomic clones cover at least part of the lin-3 locus. First, A.PS#l detects the 
polymorphism syP2 associated with the mutation lin-3(n1058) and which is 
located 2.5 kilobases (kb) from the syP1 Tel insertion. Second, both genomic 
clones can rescue the Vul phenotype of lin-3 mutations when introduced as 
extrachromosomal multicopy transgenes. A 5-kb subclone called pRH9 and a 
3 .3-kb subclone called pRH19, both of which cover the location of syP1 and 
syP2, can also rescue lin-3. pRH19 was used to isolate the eDNA clones 
pRH39 and pRH40. We determined the nucleotide sequences ofthe eDNA 
clone pRH39 (Fig. 4) and of the genomic region equivalent to pRH19 (data not 
shown). The two cDNAs appear to encode full length Lin-3 proteins. The 
results of site-directed mutagenesis experiments confirm that pRH39 and 
pRH40 are lin-3 cDNAs. We introduced mutations into the genomic clone 
pRH9 that would change the sense of two codons of the transcription unit 
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defined by the cDNAs (Fig 4legend). These mutations abolish the ability of 
this clone to rescue the Vul phenotype of lin-3(n378) when introduced as a 
transgene (Fig 4 legend). Partial sequencing of lin-3 genomic DNA indicates 
that the region ofpRH39 and pRH40 that encodes the signal peptide is not 
located within pRH9 or pRH19. One explanation for the ability of these 
genomic clones to rescue lin-3 is that they contain a genomic region that has 
characteristics of a 5' exon that could encode an alternative signal-peptide-
like sequence (Fig. 4 legend). This region could be an alternative 5' end of the 
lin-3 locus or a cryptic 5' end used only by the transgenes. 
Lin-3 structure is similar to EGF-R ligands 
The Lin-3 protein predicted from nucleotide sequence is a membrane-
spanning protein of 438 or 423 amino acids with a single extracellular EGF 
repeat. Two forms of the protein are encoded by alternatively spliced 
transcripts and differ in the presence or absence of 15 amino acids between 
the EGF repeat and the transmembrane domain. The cytoplasmic domain of 
Lin-3 comprises 181 amino acids of novel sequence (Fig. 4). The EGF repeat 
ofLin-3 has statistically significant sequence similarity to many of the EGF 
repeats of other genes (Fig. 5). An EGF repeat is a motif consisting of six 
cysteine residues with semi-conserved spacing (reviewed in (Carpenter and 
Wahl1990)). EGF repeats are present in a variety of proteins of many 
different functional classes (Carpenter and Wahl1990, Davis 1990). Lin-3 
does not have overall sequence similarity to any characterized gene, and is 
most likely a new member of the EGF group of growth factors. The EGF 
repeat of Lin-3 has Tyr13 and Arg41, which are conserved preferentially 
among the EGF repeats u sed as growth factors (Fig. 5). Also, the overall 
structure of Lin-3 is most similar to the structure of the growth factor 
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precursors, which beyond the presence of at least one EGF repeat and a 
transmembrane domain have little sequence similarity common to the entire 
class. 
The EGF group of growth factors includes EGF itself (Gregory 1975, 
Savage et al. 1972), transforming growth factor-a. (TGF-a.) (Derynck et al. 
1984), heparin-binding EGF (HB-EGF) (Higashiyama et al. 1991), 
amphiregulin (Shoyab et al. 1989), and vaccinia virus growth factor (VVGF) 
(Stroobant et al. 1985), which are known ligands of the EGF-R, as well as rat 
neu differentiation factor (NDF) (Wen et al. 1992) and the human heregulins 
(Holmes et al. 1992), which are ligands of neu!HER2, one of two other 
members ofthe EGF-R subfamily. The membrane-proximal EGF repeat is 
known in several cases to be the receptor-binding domain of these growth 
factors. Most of these molecules can undergo proteolytic processing to release 
this EGF repeat as a secreted molecule. In the case ofTGF-a, the 
unprocessed membrane bound form can also activate the receptor (reviewed 
in (Massague 1990) ). Processing of Lin-3 has not been demonstrated. The 
alternative versions of the Lin-3 protein differ in the region between the EGF 
repeat and the membrane-spanning domain where processing would have to 
occur. The different Lin-3 proteins could differ in their ability to be 
processed. The use of alternative splicing to produce membrane bound 
ligands that differ in their ability to be processed has been demonstrated for 
the Kit-ligand (Flanagan et al. 1991), but has not been seen with the EGF 
group of growth factors . 
The phylogenie relationship of lin-3 to the EGF group of growth factors 
remains unclear. lin-3 is not a clear homolog of any one member of the group 
and a simple hypothesis is that lin-3 is diverged from a common ancestor of 
the diverse mammalian growth factors. By RDF2 analysis (Pearson and 
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Lipman 1988), the EGF repeat of Lin-3 is most similar to the EGF repeats of 
the growth factors from myxoma virus (MVGF) (Upton et al. 1987) and Shope 
fibroma virus (SFGF) (Chang et al. 1987). These two genes differ from the 
other EGF-like growth factors in that they lack possible membrane-spanning 
domains. MVGF has been shown to bind the EGF-R at a 200-fold lower 
affinity than EGF itself (Lin et al. 1991), but the function of SFGF is 
unknown. 
lin-3 transgenes cause excess vulval induction 
Transgenes containing wild-type lin-3 DNA confer a dominant multivulva 
(Muv) phenotype (Fig. 3c) in which up to all six of the VPCs have vulval fates. 
The transgenes are created by a method that concatenates about a hundred 
copies of the injected DNA into an extrachromosomal array (Mello et al. 1991) 
and thus are likely to express levels of a Lin-3 protein that are higher than 
the levels ofLin-3 expressed in a wild-type animal. We believe the 
transgenes cause excess vulval induction because the process of vulval 
induction is sensitive to overexpression of Lin-3. In contrast, mutations that 
lower lin-3 activity decrease the number ofVPCs that have vulval fates 
(Ferguson and Horvitz 1985, Ferguson, et al. 1987, Horvitz and Sulston 1980, 
Sulston and Horvitz 1981). Thus, the amount ofLin-3 protein produced may 
control the number ofVPCs that have vulval fates. 
The lin-3 transgenes act via let-23 
We ordered the action of lin-3 before the action of let-23 based on a test of 
genetic epistasis using the dominant Muv phenotype of the lin-3 transgenes. 
The let-23 mutation sy97 causes a highly penetrant Vul phenotype such that 
more than 99% of sy97 homozygotes fail to lay eggs (the Egl phenotype) 
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(Aroian and Sternberg 1991). 90% of animals bearing the transgene syEx13, 
which contains wild-type lin-3 DNA, are Muv. let-23(sy97) homozygotes 
carrying the transgene syEx13 are not Muv and 99.7% are Egl (see Fig. 3 
legend). Therefore the lin-3 transgenes can only stimulate vulval fates if let-
23 is functional and thus lin-3 is likely to be an upstream activator of let-23. 
Previous experiments in which Vul mutations of lin-3 and let-23 were 
indirectly ordered also suggest that lin-3 acts before let-23 (Ferguson, et al. 
1987). In contrast to the behavior of the lin-3 transgenes, multicopy let-60 
transgenes cause a Muv phenotype even in a let-23(sy97) mutant (Han and 
Sternberg 1990). 
Anchor cell expression of lin-3::lacZ 
To determine where the lin-3 transgenes are expressed, the lacZ gene of 
Escherichia coli was inserted in-frame into the first cytoplasmic exon of lin-3 
(Fig. 6). The lin-3::lacZ fusion should produce a protein consisting of the 
extracellular and transmembrane domains of lin-3 followed by a 13-
galactosidase domain encoded by lacZ. In transgenic animals this fusion 
produces detectable 13-galactosidase activity while maintaining the ability to 
stimulate excess vulval development. pRH36 contains the lin-3::lacZ fusion 
within a 5 kb lin-3 genomic region equivalent to pRH9, whereas pRH56 
contains an additional4.6 kb of 5' genomic sequence (shown in Fig. 2). A 
transgene derived from pRH36 shows specific expression of 13-galactosidase in 
the anchor cell. This expression is detectable during the lethargus between 
the L2 and L3 larval stages (Fig 6a, b) and remains detectable in the L4 stage 
when vulval morphogenesis is nearly complete (Fig 6d). Ablation 
experiments indicate that vulval induction occurs late in the L2 lethargus or 
early in the L3 (Kimble 1981) and thus the transgene is expressed before or 
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during the time of vulval induction. pRH56 directs other localized 
expressions (data not shown) as would be expected, given that lin-3 has other 
developmental phenotypes (Ferguson and Horvitz 1985). Nonetheless, the 
only expression near the VPCs is in the anchor cell. The expression patterns 
of pRH36 and pRH56 suggest that the 5 kb lin-3 region represented by pRH9 
could be a minimal region sufficient for vulval rescue which might not contain 
all control sequences required for other expressions. As the pRH36 transgene 
can stimulate excess vulval development (Fig. 6d) while displaying specific 
expression in the anchor cell, we infer that the anchor cell expression is 
relevant for vulval development. 
lin-3 transgenes may act in the anchor cell 
To test whether the ability of the transgenes to cause a Muv phenotype 
was dependent upon the inductive signal, we ablated the gonad precursors, 
and hence the anchor cell, in early L1 animals that carried lin-3 transgenes. 
Gonad-ablated syEx13 animals had an average of 23% induction compared 
with 143% induction in mock-ablated syEx13 animals (see legend of Fig. 3 for 
explanation of scoring). Specifically, 12 of 15 ablated animals had no vulval 
differentiation and three animals had three to five VPCs generating vulval 
progeny. 7 of 15 mock-ablated syEx13 animals had wild-type vulval induction 
and eight had vulval induction greater than wild-type (Fig. 3d). Therefore, 
the lin-3 transgene either acts in the gonad to stimulate vulval development, 
or acts elsewhere and requires the gonad to become active. Because syEx13 
contains the same lin-3 genomic region as a lin-3::lacZ fusion that is 
expressed specifically in the anchor cell, we believe that lin-3 acts in the 
anchor cell. These ablation studies do not indicate the site of action for the 
residual activity of the lin-3 transgenes in the three ablated animals with 
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vulval development. It is possible that the transgenes have erratic ectopic 
expression, or that the VPCs are responding to an overexpression ofLin-3 in 
other tissues that do not normally induce the vulva. We conclude that lin-3 
can act in a non-cell autonomous manner to stimulate vulval development. 
lin-3 as inductive signal 
We propose that lin-3 encodes the vulval-inducing signal from the anchor 
cell defined by the ablation experiments of Kimble (Kimble 1981). This 
hypothesis is supported by several observations. First, the vulvaless 
phenotype of mutations that lower lin-3 activity indicates that lin-3 is 
normally necessary for the specification of vulval fates (Ferguson and Horvitz 
1985, Ferguson, et al. 1987, Horvitz and Sulston 1980, Sulston and Horvitz 
1981). Second, presumptive overexpression of lin-3 by multicopy transgenes 
causes increased levels of vulval induction. Together these two facts suggest 
that the dose of lin-3 determines the extent of vulval development. Third, 
genetic epistasis experiments indicate that lin-3 acts genetically upstream of 
let-23 in a common pathway. Fourth, lin-3 appears to be a new member of 
the EGF group of growth factors and let-23 is homologous to the EGF-
receptor (Aroian, et al. 1990). Thus the molecular identities of lin-3 and let-
23 and their genetic order of action suggest that lin-3 could encode a ligand 
for the receptor encoded by let-23. Fifth, lin-3::lacZ fusions are expressed in 
the AC at the time of vulval induction. Sixth, ablation experiments indicate 
that the lin-3 transgenes can act in the gonad to stimulate vulval 
development. lin-3 has the correct genetic properties, molecular structure, 
and pattern of expression to be this inductive signal. 
In addition to the inductive signal encoded by lin-3, two other intercellular 
signals have been proposed to regulate the fates of the VPCs. First, a lateral 
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signal mediated through lin-12 regulates the pattern of fates assumed by 
induced VPCs and appears to act after lin-3 (Greenwald et al. 1983, 
Sternberg 1988, Sternberg and Horvitz 1989). Second, an inhibitory 
signalling pathway defined by mutations in lin-15 promotes epidermal fates 
(Ferguson and Horvitz 1985, Ferguson and Horvitz 1989, Sternberg 1988, 
Sternberg and Horvitz 1989). The inhibitory signal may originate from the 
surrounding epidermis and thus would inhibit all the VPCs equally (Herman 
and Hedgecock 1990). Genetic epistasis experiments indicate that lin-15, like 
lin-3, acts to controllet-23 activity (Aroian and Sternberg 1991, Ferguson, et 
al. 1987, and L. Huang & P . Sternberg, unpublished results) . Given that lin-
3 and lin-15 are both regulators of let-23, it is possible that they either act in 
parallel and antagonistically on let-23, or that they act in series such that lin-
3 is a negative regulator of lin-15. We propose that lin-3 and lin-15 act in 
parallel on let-23. First, the nature of the the lin-3 and let-23 proteins 
suggest Lin-3 could be a direct ligand ofLet-23. Second, the inductive signal 
can influence the fates ofVPCs in a lin-15 mutant suggesting that the 
inductive signal does not require functionallin-15 to influence the fates of the 
VPCs (Han, et al. 1990, Sternberg 1988). 
We propose that the VPCs possess a response pathway that originates 
with the receptor tyrosine kinase encoded by let-23 and that acts through let-
60 ras to specify vulval fates (Fig. 1b). In our view, the activity of this 
response pathway is controlled by two antagonistic upstream pathways. An 
inhibitory pathway mediated by lin-15 lowers the basal activity of the 
response pathway in all VPCs in the absence of the inductive signal. We 
propose that lin-3 is the inductive signal produced by the anchor cell and that 
binding ofLin-3 to Let-23 activates Let-23 and the response pathway. 
Because the inductive signal can apparently act at a distance (Thomas, et al. 
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1990) Lin-3 may be proteolytically processed to release the EGF repeat as a 
secreted factor. It is possible though, that some wild-type induction uses a 
membrane bound form of Lin-3. For example, the VPC directly beneath the 
anchor cell, P6.p, could be induced by membrane-bound Lin-3 while the VPCs 
one cell distal to the anchor cell, P5.p and P7.p, could be induced by secreted 
Lin-3. 
The lin-3 transgenes can stimulate all the VPCs in a given animal to have 
vulval fates. This observation confirms that each VPC is competent to 
respond to the inductive signal. Since this induction can occur when all six 
VPCs are present, we argue against the possibility that intercellular 
signalling among the VPCs has an absolute ability to limit the number of 
VPCs that differentiate as vulval tissue. Thus, during normal development 




Fig. 1. Model of vulval induction. 
a. A schematic diagram of the anatomy of an early L3 C. elegans 
hermaphrodite at the time of vulval induction. Each of six Vulval Precursor 
Cells (VPCs) located within the ventral epidermis have the potential to 
assume an epidermal fate or either of two vulval fates. The anchor cell (AC) 
is located ventrally in the somatic gonad and is the source of an inductive 
signal necessary for the VPCs to assume vulval fates. In wild-type vulval 
animals the three VPCs closest to the AC (P[5-7].p) assume vulval fates and 
the three other VPCs have epidermal fates. The AC and the VPCs are 
separated by the body cavity. The model of vulval induction is based on many 
studies reviewed in reference (Horvitz and Sternberg 1991). The drawing is 
based on anatomical studies described in reference (Wood 1988) and work by 











































































































Fig. 1. b. Schematic model of vulval induction. As described in the text, we 
propose that lin-3 is the inductive signal from the anchor cell that is 
necessary for the specification of vulval fates. lin-3 has structural 
similarities to the EGF group of growth factors and is expressed in the AC. 
The EGF repeat of lin-3 may be released from the surface of the AC by 
proteolytic processing to generate a secreted factor. lin-3 is genetically 
upstream of let-23 and let-60, which are proposed to act in the VPCs. let-23 
encodes a nematode homolog of the EGF-R and is proposed to be the receptor 
for the inductive signal. The binding of lin-3 to let-23 is proposed to activate 
let-23 which then stimulates vulval fates by activation of let-60 ras. Genetic 
experiments indicate that lin-15 inactivates let-23 in the absence of lin-3 
activity and suggest that lin-15 may act in the surrounding epidermis, hyp7. 
ECM, ExtraCellular Matrix. This model is based on the studies reviewed in 













Figure 2. Molecular m.ap of the lin-3 locus. 
A physical map of the lin-3 locus which illustrates the position of the two 
known lin-3 RFLPs (center), the ability of various genomic clones to provide 
lin-3 function (bottom), and an expanded view of part of the lin-3 
transcription unit (top). syPl is a Tel transposon insertion associated with 
lin-3(sy91). syP2 is an additional EcoRV site found in lin-3(n1058). The 
ability of genomic subclones (below) to rescue a lin-3 Vul phenotype and to 
cause a dominant Muv phenotype when introduced as transgenes is indicated 
in the columns on the right. The 3.3 kb genomic region subcloned as pRH19 
is the minimal region known to be sufficient for transgenic rescue. The 
genomic sequence of this 3.3 kb region has been determined (data not shown). 
The positions of lin-3 exons, shown by boxes above, was deduced from the 
genomic sequence and the sequence of two lin-3 cDNAs (See Fig. 4). The 
position of lin-3 exons outside of this 3.3 kb region are not known. The 
section of the transcript that encodes the EGF repeat is shown in solid black 
and the region that encodes the putative membrane spanning domain is 
stippled. The cosmid F17G6 links the lin-3 genomic clones to the physical 
map such that left in Fig. 2 corresponds to left on the genetic map of LG IV. 
The unique BamHI site is defined as position +1 of lin-3 genomic DNA. The 
restriction map ofB, Hand RV is complete for the entire region. All K, N , S, 
and Sp sites are only shown for the region from +0 kb to +5 kb. 
Abbreviations : ND, not determined; Bm, Bam HI; RV, Eco RV; H, Hind III; K, 
Kpn I; N, Nde I; S , Sa c I; Sp, Spe I. 
Methods. Transposon tagging of lin-3. A transposon-induced allele 
of lin-3 was found in a non-complementation screen. The screen allows a 
specific search for lin-3 mutations, which are rare among the set of mutations 
that cause an egg-laying defective (Egl) or vulvaless (Vul) phenotype. This 
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screen also allows the recovery of null alleles of lin-3, which confer lethality 
when homozygous, but which are viable and Vul in trans to lin-3(e1417) 
(Ferguson and Horvitz 1985). Three to four PS231 [lin-3(e1417) dpy-
20(e1362) I lin-3(e1417) unc-31(e169) IV; him-5(e1490)V] males were mated 
with four or five hermaphrodites of the mutator strain RW7096 [mut-6(st702) 
unc-22(st192::Tcl) IV] (Mori, et al. 1988). The parents were transferred to 
new plates every 24 hours and the progeny were examined every 12 hours for 
Egl animals. Hermaphrodite self-progeny are Unc-22 and cross progeny are 
non-Unc-22. Cross progeny of the mating are non-Egl if they receive a wild-
type allele of lin-3 from the mutator strain or Egl if they receive a 
transposon-induced allele of lin-3 from the mutator strain. A single 
mutation, lin-3(sy91::Tcl), was found among 10,000 hermaphrodite cross 
progeny and was recovered in the strain PS253 [mut-6(st702) lin-3(sy91) unc-
22(st192)]. sy91 confers recessive Vul and Egl phenotypes described in Fig. 
3b. 
Mapping of syPl. The Tel transposon insertion syPl was determined by 
genetic mapping to be inseparable from lin-3(sy91). PS253 was backcrossed 6 
times against N2 to reduce the number of RW7096-derived Tel elements that 
were unlinked to lin-3. At the last backcross with N2, a F2 segregant that 
was homozygous for lin-3(sy91) called PS388 was selected, and a F2 
segregant that was homozygous for the wild-type allele of lin-3 was selected. 
Genomic DNAs from these strains were analyzed for the presence of different 
Tel insertions on Southern blots. Genomic DNA (Wood 1988) was digested 
with Xbal, which does not cut within Tel sequence, and run on 20 em TAE 
gels for 40-50 hr at 1 V/cm, blotted, and hybridized with labeled Tel DNA 
(pTR14 a gift of Phil Anderson) according to standard methods (Ruvkun et al. 
1989, Sambrook et al. 1989). Six Tel insertions were identified that are 
B-20 
present in the lin-3(sy91) strains PS253 and PS388, but which are absent in 
N2 and the non-Lin-3 backcrossed derivative of PS253. These six insertions 
were genetically mapped to lin-3 by a multipoint mapping strategy described 
previously (Ruvkun, et al. 1989). N2 males were mated to TU355 [unc-
24(e138) mec-3(e1338) dpy-20(e1282)] hermaphrodites and Fl males of this 
mating were mated with PS388 hermaphrodites. non-Unc non-Mec Dpy 
recombinants were recovered from the heterozygote unc-24(e138) mec-
3(e1338) + dpy-20(e1282) + I + + lin-3(sy91) + unc-22(st192) and 
homozygous strains of each recombinant were established. Each recombinant 
strain was analyzed for its lin-3 genotype and for the presence of each of the 
six Tel elements using Southern blots as described above. Five of the Tel 
elements are located outside of the mec-3 dpy-20 interval because they are 
either present or absent in all recombinants while the sixth element, syP 1, 
maps within this interval. syP1 is a Tel insertion of 1.6 kb into a 390 bp 
Xbal fragment. syP 1 is present in all 18 recombinant strains that 
maintained lin-3(sy91) and absent in alll4 recombinant strains that lost lin-
3(sy91) . This places syP1 with a 95% level of confidence in an interval of 
0.046 map units (mu) to the left of lin-3 and 0.076 mu to the right of lin-3. 
This genetic interval is equivalent to about 120 kb of DNA given correlations 
between the physical and genetic maps in the vicinity of lin-3 (Sulston et al. 
1992) . The mapping indicated that syP 1 was the closest identified physical 
m arker to the lin-3 locus, and it was therefore used to identify genomic clones 
in the vicinity of lin-3 (below). The nucleotide sequence of a subclone 
containing the syP1 insertion (generated below) indicates that syP1 is a 
typical Tel insertion within a target site duplication of the sequence TA 
(Herman and Shaw 1987) located at positions 243-244 in genomic sequence. 
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This genomic sequence is an intron located between nucleotides 216 and 217 
of the composite eDNA sequence in Fig. 4. 
Isolation of lin-3 genomic clones. The sequence flanking the syP 1 Tel 
insertion was amplified from genomic DNA by inverse PCR (Ochman et al. 
1988). In this technique, a restriction fragment containing a transposon is 
circularized by self-ligation. The sequence abutting the transposon is then 
amplified from the circular fragment by PCR using a single primer 
complementary to the inverted repeat of the transposon. Parallel reactions 
were performed on DNAs isolated from two recombinant strains generated in 
the mapping of syP1 (above) that differ only in their syP1 and lin-3(sy91) 
genotype. The genomic DNAs were digested with Xbal, extracted with 
phenol, and ethanol precipitated. The digested genomic DNAs were then 
circularized by self-ligation at a concentration of 1.5 )lg/ml with T4 DNA 
ligase (New England Biolabs) at 1 U/Jll at l5°C for 22 hr. The DNA was 
purified after the ligation by phenol extraction and ethanol precipitation and 
special care was taken to remove excess salt. PCR was performed according 
to the standard protocol of Perkin Elmer/Cetus (Norwalk, Ct) with the 
following modifications: circularized genomic DNA was used at 7 )lg/ml and a 
single primer (5'-ACC AAA AGT GGA TAT CTT TTT GGC CAG C-3') specific 
to the inverted repeat of Tel (Rosenzweig et al. 1983) was used at 2 pmoles/)ll. 
Inverse PCR on both DNAs amplified a similar ladder of products except that 
only the DNA containing the syP 1 Tel insertion produced a 400 bp fragment 
that is the size of the wild-type Xbai fragment in which syP1 is located. This 
400 bp band was digested with EcoRV, which cuts within the sequence ofthe 
PCR primer and ligated into pBluescript SK+ to give the plasmid pRHl. The 
insert ofpRHl detects a 2.0 kb Xba I fragment in lin-3(sy91) strains and a 
400bp Xbal fragment in non-lin-3(sy91) strains, which confirms its identity as 
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syP 1 flanking DNA. pRH1 was used to isolate the recombinant A. phage 
A.PS#1 and A.PS#2 from a A.2001 genomic library (Coulson et al. 1986). 
Identification of syP2. The genomic clones identified by homology to 
syP1 were used to search for additionallin-3 RFLPs. Genomic DNAs were 
purified from different strains each containing one of the following ten lin-3 
alleles: e1417 (Horvitz and Sulston 1980); n378, n1058, and n1059 
(Ferguson and Horvitz 1985); s751 and s1263 (Clark et al. 1988); sy51, sy52, 
and sy53 (R.J.H. and P.W.S. unpublished); sy91 (this study). The DNAs were 
digested separately with each of six enzymes (BamHI, Clai, EcoRI, EcoRV, 
Hindiii, Xbai), blotted and hybridized with labeled DNA from A.PS#l. DNA 
from a lin-3(n1058) strain was found to possesses a novel EcoRV site at 
position +2.8 kb (data not shown). We refer to this RFLP as syP2. No other 
polymorphisms were detected. 
DNA mediated transformation and transgenic rescue of lin-3. The 
ability of genomic clones to rescue the Vul phenotype of lin-3 mutants and to 
cause a dominant Muv phenotype was tested by DNA mediated 
transformation (Mello, et al. 1991). This technique generates an 
extrachromosomal array containing approximately one hundred copies of the 
injected DNA. These arrays are heritable, but are lost at an appreciable 
frequency at both mitosis and meiosis. The presence of the trans gene is made 
observable with a marker plasmid that confers an easily observed dominant 
phenotype on the transgenic animals. The marker plasmid and the 
experimental DNA are incorporated together into the transgene. A variety of 
marker systems were used. For most injections we used pRF4, which causes 
a dominant Rol phenotype (Mello, et al. 1991). In other experiments, we used 
pMH86 (Han and Sternberg 1990), which rescues dpy-20 (D. Clark & D. 
Baillie, personal communication), or C14G10, which rescues unc-31 (R. 
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Hoskins, personal communication). Each genomic clone was tested by 
injecting 8-20 animals. All of the progeny of each injected animal were 
examined for the presence of the transgenic marker and their lin-3 
phenotype. All Fl transgenic animals were allowed to self-fertilize to test 
whether it possessed a heritable transgene. Approximately 1 of 25 Fl 
transgenic animals possessed a heritable transgene and yielded a stable line. 
We did not identify any transgenes that were integrated into the 
chromosomes. We determined the rescuing ability of most genomic clones by 
the analysis of multiple stable lines, although all stable lines derived from a 
given clone were qualitatively similar in their ability to rescue lin-3 and to 
cause a Muv phenotype, and differed only in their rate of transmission and 
penetrance. In the initial set of experiments different genomic clones were 
injected at a concentration of 50 ng/11l with pRF4 at 50 ng/111 into lin-3(e1417) 
unc-22(e66) I + + hermaphrodites. From these injections, Unc-22 Rol 
animals that should be homozygous for lin-3(e1417) and shold possess a 
transgene, were scored for their inability to lay eggs (Egl) and for the 
presence of ectopic pseudovulvae (Muv). Injection of A.PS#l, A.PS#2, pRH9, 
and pRH19 all yielded stable lines that could rescue lin-3 and cause a 
dominant Muv phenotype. Fl transients and stable lines from pRH22 or 
pRHlO could not rescue lin-3 or cause a dominant Muv phenotype. These 
experiments indicate that a 3.3 kb genomic region (pRH19) centered over the 
location of the lin-3 RFLPs is sufficient to stimulate vulval induction. 
Transgenes possessing genomic DNA 5' of the BamHl site at position 0 kb 
have the same vulval properties as pRH9 although they possess additional 
lin-3 genomic sequence. In other experiments, pRH9 was injected at 50 ng/11l 
with the cosmid C14G10 at 20 ng/11l into lin-3(+) unc-31(e169) animals. This 
injection yielded the transgene syEx13, which has a strong Muv phenotype 
B-24 
and which can rescue the Egland lethal defects of lin-3(sy53). syEx13 was 
used in the ablation and epistasis experiments. The ability of pRH9 to 
stimulate vulval development is thus not dependent upon a particular 
transgenic marker. For the remainder of the experiments DNA was injected 
into lin-3(n378) animals that had been phenotypically suppressed for their 
Egl defect by passage through the dauer stage (Ferguson and Horvitz 1985). 
pRH9 was injected at 50 ng/J.Ll with pRF4 at 50 ng/J.Ll, pRH35 was injected at 
75 ng/J.Ll and pRF4 at 50 ng/J.Ll, and pRH54 was injected at 42 ng/J.Ll with pRF4 
at 50 ng/J.Ll and pBluescript SK + at 22.5 ng/J.Ll. All trans genes recovered from 
these experiments could rescue lin-3 and cause a strong Muv phenotype. 
pRH9 contains a 5kb genomic insert cloned into pSK + and pRH54 was made 
by subcloning the insert of pRH9 into pMobKS (Strathmann et al. 1991). 
These two clones both rescue lin-3 but have different vector sequence 
adjoining the insert which indicates that adjoining vector sequence is not 
responsible for the ability of the 5kb genomic region to rescue lin-3 All other 
plasmid clones are derived from pSK + except for pRH36 and pRH56. pRH35 
and pRH54 were injected at the same molarity of lin-3 DNA and the derived 














































































































































































































































































































































Fig. 3. Nomarski photomicrographs of lin-3 phenotypes. 
a. An adult, wild-type C. elegans hermaphrodite. The position of the 
vulva is marked by an arrowhead. The vulva is necessary for copulation with 
males and for egg laying. Anterior is left. The animal is photographed with a 
20x Neofluor objective. The scale bar is equal to 100 J..lM. 
b. An adult, vulvaless lin-3(sy91::Tcl) hermaphrodite. Mutations that 
lower lin-3 activity, like sy91, result in decreased levels of vulval induction. 
The lack of a vulva prevents egg laying, but does not prevent internal self-
fertilization of the eggs (Horvitz and Sulston 1980). The individual shown 
has no vulva (Vul) and is retaining embryos in the three-fold stage which 
indicates that it has an egg laying defect (Egl). Anterior is right. The 
animal is photographed with a lOx Neofluor objective and 1.25x optovar. The 
scale bar is equal to 100 J..lM. 
c. A young adult, multivulva syEx13 hermaphrodite. The transgene 
syEx13 is an extrachromosomal array containing multiple copies of wild-type 
lin-3 DNA. The transgene causes excess vulval induction, which we believe is 
due to overexpression of lin-3. Ectopic pseudovulvae are often visible as 
bumps on the ventral side of an adult worm when more than the wild-type 
number ofVPCs assume vulval fates (Horvitz and Sulston 1980, Sulston and 
Horvitz 1981). The animal shown has three pseudovulvae which are marked 
by arrowheads and has a phenotype common for the transgenic lin-3 Muv 
animals. No chromosomal mutations of lin-3 that confer a Muv phenotype 
exist. Anterior is left. The animal is photographed with a 20x Neofluor 
objective. The scale bar is equal to 100 J..lM. 
d. An adult, gonad-ablated, vulvaless syEx13 animal. Ablation of the four 
gonad precursors Zl-Z4 prevents the development of the AC, which is the 
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source of the inductive signal. Ablation of the gonad precursors in syEx13 
animals lowers the ability of the transgenes to stimulate vulval induction 
such that most ablated animals are Vullike the one pictured. The ablation 
also destroys the germline. Anterior is left. The animal is photographed with 
a lOx Neofluor objective. The scale bar is equal to 100 f.LM. 
Control mock-ablated syEx13 animals had an average of 143% induction. 
Seven animals had wild-type induction ofP[5-7].p, one animal each had P[4-
7].p, P[4-7].p and P8.pa, or P[4-8].p forming vulval tissue, and five animals 
had six VPCs forming vulval tissue. Ablated syEx13 animals had an average 
induction of 23%. 12 animals had no induced VPCs, in 2 animals P[3-5].p 
developed as vulval tissue, and in one animal P4.p, P5.pp, and P[6-8].p 
developed as vulval tissue. 
Methods. Photographs were taken using an Axioplan microscope 
equipped with N omarski objectives. Ventral is down in all photographs and 
anterior is left in a., c., and d., and right in b. The scale bar is equal to 100 
f.Lm. in all photographs. All animals except for Fig. 3c are anaesthetized on 
an agar pad containing 1. 7 mM Sodium Azide. Ablation of the four gonad 
precursors Zl-Z4 of syEx13 Ll hermaphrodites was performed as previously 
described (Avery and Horvitz 1987, Sternberg 1988, Sulston and White 1980). 
Animals were observed 12-24 hours after ablation to confirm that no VPCs 
had been destroyed by the surgery and to confirm the destruction of the 
gonad. The fate of all six VPCs was determined by direct observation of the 
anatomy at different timepoints throughout development. VPCs that went 
through at least two rounds of division or VPC daughters that went through 
at least one more round of division were scored as having a vulval fate. The 
extent of induction was defined as in (Aroian and Sternberg 1991) where 
three induced VPCs per animal is equal to 100% induction. Induction can 
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range from 0% when no VPCs are induced per animal to 200% when 6 VPCs 
are induced per animal. Since the syEx13 transgene can be lost mitotically, 
only animals that were non-Unc-31 through the L4 stage and that thus 
presumably still possessed the transgene past the time of normal vulval 
development were included in the analysis. Any individual non-Unc-31 
animal could lack the syEx13 transgene in the appropriate tissue for vulval 
induction due to somatic loss of the transgene. The proportion of control, 
unablated, non-Unc-31 animals that have wild-type patterns of vulval 
development should represent a maximal estimate for the frequency of such 
chimeric animals. 
The epistasis of syEx13 and let-23(sy97) was tested by constructing the 
double mutant. Spontaneous unc-31(e169); syEx13 (non-Unc) males were 
mated with let-23(sy97) unc-4(e120) I mnCl [dpy-10(e128) unc-52(e444)]; unc-
31(e169) hermaphrodites. non-Unc-31 L4 hermaphrodite cross progeny were 
selected as individuals. Unc-4 non-Unc-31 F2 survivors were picked from F1 
mothers that segregated let-23(sy97) dead larvae. All such worms were Egl 
as adults, and segregated no Muv progeny. These worms segregated non-
Unc-31 individuals and more than one fourth dead larvae which confirms 
their genotype as sy97; syEx13. Therefore let-23(sy97) is epistatic to syEx13. 
To quantify the epistasis, L4 non-Unc-31 hermaphrodites were picked as 
individuals and rescored as adults for their Muv and Egl phenotypes under a 
dissecting microscope. 89% ofL4 non-Unc-31 progeny from an unc-31(e169); 
syEx13 mother were Muv as adults (n= 100). 0% ofL4 non-Unc-31 progeny 
from a let-23(sy97) unc-4(e120); unc-31(e169); syEx13 mother were Muv as 
adults and only one was capable oflaying eggs (n= 348). Alllet-23(sy97) 
animals are Egl (Aroian and Sternberg 1991). Routine genetic manipulations 
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Fig. 4. Sequence analysis of lin-3. A composite sequence of lin-3 cDNAs 
and the deduced lin-3 protein sequence is shown with key features noted. 
The two main hydrophobic stretches of the lin-3 protein are underlined. 
These two stretches appear to be a signal peptide and a transmembrane 
domain. The single EGF repeat is boxed and is described in further detail in 
Fig. 5. The extent of the repeat is chosen arbitrarily as it is not known if the 
EGF repeat of lin-3 can be proteolytically processed away from the rest of the 
protein. Sequences similar to the sites at which EGF and TGF-a are 
processed (Carpenter and Wahl1990) are overlined where present in the 
extracellular domain of lin-3. A stretch of 15 amino acids between the EGF 
repeat and the transmembrane domain which is encoded by an alternatively 
spliced region of RNA is underlined in bold. A potential N-glycosylation site 
is located at position 161, which is within the EGF repeat. The region of the 
lin-3 protein after the signal peptide and before the EGF repeat is composed 
of aproximately 50% proline, glutamate, serine, and, threonine. Regions 
enriched in these amino acids, termed PEST domains, have been proposed to 
mark a protein for rapid turnover (Rogers et al. 1986). PEST domains have 
been noted in cytoplasmic and nuclear proteins and the significance of this 
feature in what would be the extracellular domain of lin-3 is unclear. 
Compared to the rest of the lin-3 protein, however, this region is only 
enriched in the amino acid glutamate. The presence of a region rich in the 
amino acids S, T, and P amino terminal to the EGF of the growth factor 
amphiregulin has been noted (Shoyab, et al. 1989) and may also be present in 
HB-EGF (Higashiyama, et al. 1991). lin-3 differs from these two molecules in 
that this domain is much larger and richer in glutamate in lin-3 and in that 
lin-3 lacks a stretch of basic amino acids amino terminal to the EGF repeat as 
significant as that seen in amphiregulin and HB-EGF. 
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Translation is predicted to start at position 162 because of the location of 
the leader sequence and because of the presence of upstream in frame 
termination codons. eDNA sequence from position 217 to 1400 is present 
within the genomic sequence of pRH19 and thus eDNA sequence from + 1 to 
+216 is located to the left ofthe BamH1 site at genomic position +1 in Figure 
1. The signal peptide of the protein predicted above is encoded by this region 
of the eDNA. Therefore, the clones pRH9, pRH19, and pRH36 could not 
encode the protein predicted above, although these clones can provide lin-3 
function as transgenes. A possible explanation for the ability of these clones 
to function is that they include a genomic region called ExB, which if 
transcribed, could splice in frame to the eDNA and encode a possible signal 
peptide like sequence. ExB is located at position +196 to +248 of genomic 
DNA and has the sequence 5'-TAA ATG TTC GGT AAA TCG ATT CCT GAA 
CGA CTT CTA GTC GCA TTT GGT ATG TC-3'. A splice donor consensus at 
position 239 to 248 would splice nucleotide 241 of ExB to nucleotide 217 of 
the eDNA sequence (located at position +299 in genomic DNA). This splice 
would encode OchMetPheGlyLysSer IleProGluArgLeuLeu VaWaPhe Val and 
translation would continue with Ser20 of the protein predicted above. 
The nucleotide sequence is a composite of the cDNAs pRH39 and pRH40. 
pRH39 starts at position 117 and ends at position 1844. pRH39 contains the 
alternatively spliced region of 792 to 836 while pRH40 lacks this region such 
that nucleotide 791 is spliced next to nucleotide 837. 
Methods. Sequencing. We determined genomic sequence from the 
BamH1 site at position 1 to position +3734, which is inclusive of the minimal 
region necessary for transgenic rescue (data not shown). pRH9 and 
derivative subclones were sequenced using the T3 and T7 primers specific to 
the vector and several gaps were filled by primer walking. Synthetic 
B-33 
oligonucleotides designed from the genomic sequence were used for the 
sequencing of eDNA clones. Sequencing of the eDNA clone pRH39 has been 
determined for both strands except for nucleotide 353 which is only 
determined for the sense strand. Only the unique regions of pRH40 have 
been sequenced. We found no discrepencies between the sequence of the 
cDNAs and the sequence of the genomic exons. Double stranded DNA 
sequencing reactions were performed on CsCl-banded plasmid DNA using 
Sequenase v2.0 and other reagents from U.S. Biochemical (Cleveland, Ohio) 
and standard protocols (Ausubel et al. 1992, Sambrook, et al. 1989). 
Sequence analysis. Sequence was assembled using the Mac Vector 
software package of IBI (New Haven CT). Analysis was performed using 
MacVector and the software of the Genetics Computer Group v7.0 (Devereux 
et al. 1984). The signal peptide is predicted by a GCG program using the 
method of von Heijne (von Heijne 1986). Database searches ofGenbank 
v70.0 were performed using the BLAST program (Altschul et al. 1990) and 
were run at the National Center for Biotechnology Information. The EGF 
repeat was first detected with the program MacPattern (Rainer Fuchs, EMBL 
data library, Postfach 10.2209, D-6900 Heidelberg, FRG) and is also detected 
by BLAST. The statistical significance of regions of sequence similarity found 
by database searches was assessed by RDF2 analysis (Pearson and Lipman 
1988). 
Site-directed mutagenesis. To confirm that the protein predicted above 
is responsible for the ability of the transgenes to rescue lin-3, point mutations 
were introduced into the transgenes using the method of Kunkel (Kunkel 
1985) and reagents from Promega (Madison, Wisconsin). Mutations were 
introduced into the transgene pRH9 that would change the third and fifth 
cysteine residues of the EGF repeat to serine residues. This would block the 
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formation of two ofthe three predicted disulfide bonds of the EGF repeat. 
The introduction of these mutations into the trans gene completely blocked 
the ability of the transgene to rescue the Egl phenotype of lin-3 and the 
ability of the transgene to cause a Muv phenotype (below). This observation 
strongly suggests that the transgenes produce an EGF repeat protein that is 
providing the lin-3 function. Oligo Cys3 (5' AC TTC CAC GTG GGA CGT 
CGC GTT GTG A 3') changes nucleotide 650 to G and nucleotide 652 to C, 
which introduces a novel Aatll site, causes a silent change in Thr163, and 
changes Cys164 to Ser. Oligo Cys5 (5' TTC CCA ACC CTG CGG AGA ACT 
GCA AAA AG 3') changes nucleotide 709 to C and nucleotide 713 toG, which 
destroys a BstXI site, causes a silent change in Pro185 and changes Cys184 
to Ser. The plasmid pRH43 contains the 5 kb lin-3 region with both sets of 
mutations. Transgenes were created as described in Fig. 2 by microinjecting 
a lin-3 plasmid at 50 ngi, .. Ll and pRF4 at 50 ng/J..Ll into lin-3(n378). 20% of 
n378 animals bearing the transgene derived from pRH9 were Egl and 72% 
were Muv (n= 50) while 99% of n378 animals bearing the transgene derived 
from pRH43 were Egl and 0% were Muv (n= 76). 97% of lin-3(n378) 
hermaphrodites are Egl without any transgenes (Ferguson and Horvitz 
1985). 
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' TTT TGC ATC CTT CTA CTC TTT ATG CCT CAA TTT ACA GTT TCA GAA Phe Cys Ile Leu Leu Leu Phe Met Pro Gln Phe Thr Val Ser Glu 
TCG TGT CTC CCT TCG TGG TTT CGT CAA GAA CGT AGT GCT CCC GAA 
Ser Cys Leu Pro Ser Trp Phe Arg Gl n Glu Arg Ser Ala Pro Glu 
CAG CTT CAA TCT GCA GAG AAT GCA GCT GAA AAT AGT GGC TCT GTA 
Gl n Leu Gln Ser Ala Glu Asn Ala Ala Glu Asn Ser Gly Ser Val 
CCA CCC GAT ACT TCT CGA AAT TCT CTA GAA ACA AAC GAA ATA GGT 
Pro Pro Asp Thr Ser Arg Asn Ser Leu Glu Thr Asn Glu Ile Gly 
GAT GCA CCG TCG TCG ACT TCG ACA CCT GAA ACA CCT ACT GAA ACT 
Asp Ala Pro Ser Ser Thr Ser Thr Pro Glu Thr Pro Thr Glu Thr 
ACG ATT TCC GAA GCT GGA GAC GAT GAA AAA CGA ACT GAA GAG GTT 
Thr Ile Ser Glu Ala Gly Asp Asp Glu Lys Arg Thr Glu Glu Val 
' GCA AAF. GAA TTA ATC GAG AAA GAA GCA GAA TAT GAG GGT GAA TAT Ala Lys Glu Leu Ile Glu Lys Glu Ala Glu Tyr Glu Gly Glu Tyr 
GAA GAT GAA AAG GTT GAT GAA GAA GTA GAA GAA GCG TTA AAA TAT 
Glu Asp Glu Lys Val Asp Glu Glu Val Glu Glu Ala Leu Lys Tyr 
AAT GAA GAT GCC ACT CAA GAT GCC ACG TCG ACT CTT AAA CCG GCG 
Asn Glu Asp Ala Thr Gln Asp Ala Thr Ser Thr Leu Lys Pro Ala 
GTT CGG AAG GAA ATC GAG AAG TTG AAA GAA GCA AAA TGC AAA G~C 
Val Arg Lys Glu Ile Glu Lys jLeu Lys Glu Ala Lys Cys Lys Aspj 
TAC TGT CAT CAC AAC GCG ACA TGC CAC GTG GAA GTG ATA TTC CGT 
fTyr Cys H1s H1s Asn Ala Thr Cys Hls Val Glu Val Ile Phe Argj 
GAA GAT AGA GTT TCA GCA GTT GTT CCT TCT TGC ciT TGT CCA CAG 
plu Asp Arg Val Ser Al a Val Val Pro Ser Cys His Cys Pro Glnl 
GGT TGG GAA GGC ACT CGT TGT GAT CGT CAC TAC GTT CAG GCG TTC 
ply Trp Glu Gly Thr Arg Cys Asp Arg His Tyr Val Gln Al a Phe j 
TAT GCC CCA ATC AAC GGC AGA TAT AAT b TA CGT TTG AGC ACG ATG 
ifyr Ala Pro j Ile Asn Gly Arg Tyr Asn Val Arg Leu Ser Thr Met 





































ATT CCT GCG TTC GCA TTT CTC ATT GTC ATG CTC ATC ATG TTT ATA 
Ile Pro Ala Phe Ala Phe Leu Ile Val Met Leu Ile Met Phe Ile 
l 
ACA ATT GTT GTT TAT GCT TAT AGA AGA ATG TCT AAA CGA TCG GAT 
Thr Ile Val Val Tyr Ala Tyr Arg Arg Met Ser Lys Arg Ser Asp 
GAT ATG ACA TAT ACA ATG AGT CAT ATG TGC CCA CCA GAA GCA TTC 
Asp Met Thr Tyr Thr Met Ser Hi s Met Cys Pro Pro Glu Ala Phe 
AAT GTC CTC AAA ACA CCA AAT GGA CGA CAT ATT CCA GTT CAT CAA 
Asn Val Leu Lys Thr Pro Asn Gly Arg His Ile Pro Va l His Gln 
ATT CCA TCA TGT TCT TAT ACT ATC CCA ACA CCG GGT ACA GTA CCT 
Ile Pro Ser Cys Ser Tyr Thr Ile Pro Thr Pr o Gly Thr Val Pro 
CCA AAT ATA TCA TCA ACT CCT GGA TCA AGA ATA CCC ACT CGT CAA 
Pro Asn Ile Ser Ser Thr Pro Gly Ser Arg Ile Pro Thr Arg Gln 
CAA GCT ATT CGA AAT AAT GAA CAA GCA CGG AAC AAC TTT TTC AGC 
Gln Ala Ile Arg Asn Asn Glu Gln Ala Arg Asn Asn Phe Phe Ser 
ATT CTC AGA AGT CAA GGT ACC ATT CCA TCC AGb AGT ATC AAT GAC 
Ile Leu Arg Ser Gln Gly Thr Ile Pro Ser Arg Ser Ile Asn Asp 
GAC GAC ACG CCG AAG CAC TAC AAG TCA GTG CCA CGT GTT GAA GTT 
Asp Asp Thr Pro Lys His Tyr Lys Ser Va l Pro Arg Val Glu Val 
TCA GCA ATT AAT TAC TCT GGC CAC ATT GAT TTT TCA ACA GTA TCA 
Ser Ala Ile Asn Tyr Ser Gly His Ile Asp Phe Ser Thr Val Ser 
l 
TAT CAG TCG ACT GAA TCA GAA GTT TCA AAA GCA TCA GTA ACA TGT 
Tyr Gln Ser Thr Glu Ser Glu Val Ser Lys Ala Ser Val Thr Cys 
CCA CCA CCG GCG CAC ACT GTA ATT AAT ATC GAG TTG GAT TCT GCA 
Pro Pro Pro Ala His Thr Val Ile Asn Ile Glu Leu Asp Ser Ala 
GAT ACGT AAT TTT CGA TCC CCG TCT CGA AGT TCT GGA GAA CAA GGA 
Asp Thr Asn Phe Arg Ser Pro Ser Arg Ser Ser Gly Glu Gln Gly 
TCA CCA GCA ACA TGT GAA CCA ATG ATT CGA CAC ACA TGAAATTATAA 










Fig. 5. Comparison of the EGF repeat of lin-3 to ligand and non-
ligand EGF repeats. 
The EGF repeat of lin-3 is aligned with EGF repeats known or believed to 
be used as soluble ligands of growth factor receptors. lin-3 matches the 
consensus sequence C-X-C-X5-G-X-R-C ofEGF repeats. lin-3 shows 
conservation or conservative substitutions of many of the residues conserved 
in EGF repeats including: tyrosine 13, glycine 39, arginine 41, alanine for 
glycine 18, tryptophan for tyrosine 37, and valine for leucine 4 7. The 
residues Tyr13 and Arg41 are conserved preferentially among the EGF 
repeats that are growth factors. The spacings between the last three 
cysteines is conserved between lin-3 and the ligand EGF repeats. The 
spacing between the first and 2nd, and the 3rd and 4th cysteines of lin-3 is 
unique. lin-3 lacks the consensus for Ca++ binding by EGF repeats which is 
Asp/Asn2, Asp/Asn4, Gln/Glu5, Asp/Asn22, Tyr/Phe29 and Glu38 (Handford 
et al. 1991, Rees et al. 1988). None ofthe EGF repeats used as growth factors 
contain this consensus. EGF, TGF-a, HB-EGF, SDGF, Amphiregulin, and 
VVGF are all soluble factors derived from precursors with putative 
transmembrane domains, and which inhibit the binding of EGF to the EGF 
receptor. SVGF and MVGF are viral genes with a structure similar to VVGF. 
An analysis with the program RDF2 (Pearson and Lipman 1988) indicates 
there is statistically significant sequence similarity between the EGF repeat 
of lin-3 and some of the EGF repeats of other proteins. This and other 
statistical analyses do not clearly indicate that the EGF repeat of lin-3 is 
most similar to the EGF repeats of a particular functional class of molecule. 
The results of the RDF2 analysis, using 500 shuffles, a ktup of 1, and uniform 
shuffling are tabulated with the repeats: z is the (optimal score- the mean 
ofthe optimal alignment of shuffled sequences) I standard deviation ofthe 
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optimal alignment of shuffled sequences; R is the ratio of the optimal 
alignment to the best optimal alignment of a shuffled sequence. Suggested 
minimal values for significance (Pearson and Lipman 1988) are z = 3 and R = 
1. Some EGF repeats found in non-growth factors have good matches to the 
EGF repeat of lin-3 including residues 426-465 of crumbs (z = 4.6 R = 62/60) 
(Tepass et al. 1990) and residues 406-447 ofLin-12 (z = 6.3. R = 73/63) 
(Y ochem et al. 1988). References and abbreviations: amino acid sequence of 
hEGF (human Epidermal Growth Factor) (Gregory 1975), amino acid 
sequence of mEGF (murine EGF) (Savage, et al. 1972), deduced amino acid 
sequence ofhTGF-a., (human TGF-a.) (Derynck, et al. 1984), direct amino acid 
sequence ofHB-EGF, (Heparin-Binding EGF) (Higashiyama, et al. 1991); 
amino acid sequence of ampi, (human amphiregulin) (Shoyab, et al. 1989); 
deduced amino acid sequence ofVVGF (Vaccinia Virus Growth Factor) 
(V enkatesan et al. 1982); deduced amino acid sequence of SFGF (Shope 
Fibroma virus Growth Factor) (Chang, et al. 1987); deduced amino acid 
sequence ofMVGF (Myxoma Virus Growth Factor) (Upton, et al. 1987). 
Amino acid residues that are known to be the amino terminal or carboxyl 
terminal of processed factors are underlined. If the amino terminal residue is 
not underlined, then its position within the deduced amino acid sequence of 
the precursor is given. The EGF repeats are aligned manually. For purposes 




























































































































































































































































































































































































































































































































































































































































































































































































































































































































Fig. 6. Expression patterns of lin-3::lacZ transgenes. 
Nomarski photomicrographs of animals carrying a lin-3::lacZ pRH36 
transgene that have stained for 13-galactosidase (blue color). A. An L2 
lethargus animal showing specific expression of 13-galactosidase in the anchor 
cell. The old cuticle is apparent near the head and tail thus identifying this 
worm a s a late molt. 20 minute glutaraldehyde fixation. Anterior is left. 40x 
Neofluor objective. The scale bar is equal to 20 J.LM. B. A L2 molt animal 
with all six VPCs in focus and expression of 13-galactosidase in the AC. This 
expression of 13-galactosidase is detected prior to any divisions of the VPCs 
and is before or during the time of vulval induction. The six VPCs (P[3-8].p) 
are marked by vertical lines. 20 minute glutaraldehyde fixation. Anterior is 
right. lOOx Neofluor objective. The scale is same as Fig6.c. C. [3-
galactosidase activity is still detected after VPC fates have been determined. 
In this animal the VPCs are in the third and final round of division. The AC 
is closely associated with the vulva at this stage and has a distinctive 
morphology and can be unambigiously identified. The animal is fixed and 
permeabilized by standard methods (Fire et al. 1990). Anterior is right. lOOx 
Neofluor objective. The scale bar is equal to 20 J.LM. D. A Muv L4 
hermaphrodite with staining of the AC. All vulval divisions have been 
completed and vulval morphogenesis has started. The presence of two 
invaginations (m arked by arrowheads) indicates that extra vulval induction 
has occured. 30 minute glutaraldehyde fixation. Anterior is left. 40x 
Neofluor objective and 1.6x optovar. The scale bar is equal to 20 J.LM. 
Methods. All animals were photographed on an Axioplan microscope 
equipped with Nomarski optics on Ektar 25 film. Ventral is down in all 
photographs. Transgenic animals were made using either pRH36, a lacZ 
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cognate ofpRH9, or pRH56, a lacZ cognate ofpRH35. Both transgenes 
contain the same lin-3::lacZ fusion and differ in the amount of upstream 
genomic DNA present (diagrammed in Fig. 2). lacZ is inserted as a 
translational fusion into the first cytoplasmic exon of lin-3. The lacZ cassette 
is from the vector pPD16.51(Fire, et al. 1990) and contains a nuclear 
localization signal, the coding region of lacZ, and a region containing 3' 
untranslated sequence from the unc-54 gene. The fusion transgenes would 
make a protein containing the extracellular domain, including the EGF 
repeat, the transmembrane domain, and the first 12 amino acids of the 
cytoplasmic domain of lin-3. The protein would continue with an arginine 
encoded at the junction, protein encoded by the synthetic linker sequence of 
pPD16.51 including the nuclear localization signal, followed by !}-
galactosidase. Translation of the fusion transgene should stop within the 
lacZ cassette and polyadenylation of the transcript should occur within the 
unc-54 region. The fusion deletes no lin-3 DNA present in the orginal 
transgenes so that internal or 3' enhancer-like sequences, if they exist, would 
still be present in the lacZ fusion. pRH36 was made as follows. The 5.0 kb 
lin-3 genomic BamHI-Hindiii insert ofpRH9 was subcloned into pMob KS (a 
pBluescript derivative lacking the lacZ and F1 sequence (Strathmann, et al. 
1991)) to create pRH54. pRH54 was digested with Ndel, which cuts at a 
unique site within the first cytoplasmic exon of lin-3, and endfilled. This 
fragment was ligated to an endfilled 4.5 kb Sma1Spe1 fragment ofpPD16.51 
to create pRH36. pRH56 was constructed as follows. An upstream genomic 
fragment from Sacl(-4.2 kb) to BamHI(O.O kb) was subcloned as pRH55 into 
pMob KS. The lin-3::lacZ fusion of pRH36 was excised intact as a 9.5 kb 
BamHI Hindiii fragment and subcloned into a Hindiii BamHI fragment of 
pRH55 to create pRH56. 
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Transgenic animals bearing the short (pRH36) construct were generated 
by injection ofpRH36 at 65 ng/).11, pSK+ at 25 ng/).ll and pMH86 at 10 ng/).ll 
into dpy-20(e1282) using the method described in Fig. 2. Transgenic animals 
bearing the long (pRH56) construct were generated by injection of pRH56 at 
90 ng/).ll and pMH86 at 10 ng/).ll into dpy-20. Worms were permeabilized and 
fixed using either a lyophilization protocol (Fire, et al. 1990), which gave 
stronger staining but poorer tissue preservation, or a novel glutaraldehyde 
protocol suggested by Lynn Carta, which gave weaker staining but better 
tissue preservation. To fix worms with glutaraldehyde, the worms were 
washed twice in M9 and were then resuspended in a pre-warmed solution of 
2-3.5% EM grade glutaraldehyde (8% solution from Polysciences Inc. 
Warrington, PA), 100 mM sodium phosphate buffer (pH7 .2), and 4 mM 
MgC12, and incubated for 15-30 minutes at 40°C followed by two washes in 
M9. Longer fixation times left all worms impermeable and shorter fixation 
times would be necessary to achieve staining ofL1s. Worms were stained 
with the regular staining solution of Fire (Fire, et al. 1990) for 112 to 48 hour 
at room temperature for lyophilized worms or 40°C for glutaradehyde-fixed 
worms. Staining of the anchor cell was readily evident under a dissecting 
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During the development of the C. elegans hermaphrodite, the 
anchor cell of the somatic gonad induces the three more proximal of 
six tripotent vulval precursor cells to assume the 1 o and 2° vulval 
fates (Kimble 1981). The lin-3 gene encodes a putative nematode 
member of the Epidermal Growth Factor (EGF) family that genetic 
evidence suggests is the vulval-inducing signal made by the anchor 
cell (AC) (Hill and Sternberg 1992). The EGF-like growth factors can 
act as secreted factors that consists of a single EGF domain. We 
show that a transgene that ectopically expresses an obligate secreted 
version of the EGF domain of the Lin-3 protein can induce vulval 
differentiation, which suggests that Lin-3 can act as a secreted factor 
in a manner analogous to the EGF growth factors. The EGF domain 
of Lin-3 can induce a single VPC, isolated by the ablation of the 
gonad and the other VPCs, to assume either the 1 o or the 2° fate. 
Thus, Lin-3 may be the sole vulval-inducing signal made by the 
anchor cell. 
The vulva of the nematode Caenorhabditis elegans develops post-
embryonically from ectodermal blast cells (P[3-8].p) called Vulval Precursor 
Cells (VPCs) that are located in the ventral epidermis (Sulston and Horvitz 
1977). Each of the VPCs is equivalent in its ability to assume either of three 
developmental fates (Sternberg and Horvitz 1986, Sulston and White 1980). 
The 1 o and 2° fates both produce vulval tissue, although they differ in the 
types ofvulval cells produced. The 3° fate produces non-vulval epidermis. In 
wild-type development, P6.p, which is the VPC closest to the AC, assumes the 
1 o fate, P5.p and P7.p, which are the two lateral neighbors of P6.p, assume 
the 2° fate, and P3.p, P4.p, and P8.p, which are more distal to the AC, assume 
the 3° fate. The fate choice of a VPC is regulated by three intercellular 
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signals (reviewed in (Horvitz and Sternberg 1991)). The AC of the somatic 
gonad is necessary and sufficient to induce the three more proximal VPCs to 
assume vulval fates: if the AC or its precursors are ablated sufficiently early 
in development, then all six of the VPCs assume the 3° fate (Kimble 1981). 
The vulval-inducing signal made by the AC is proposed to be a secreted factor 
because induction occurs without apparent direct cell contact between the AC 
and the VPCs in wild type (Sulston and White 1980). Vulval induction also 
occurs in dig-1 mutant animals in which the AC is displaced to the dorsal 
side of the body away from the VPCs (Thomas et al. 1990). A lateral signal 
among the VPCs regulates the pattern of fates assumed by the VPCs induced 
by the inductive signal (Sternberg 1988). The lateral signal is likely 
mediated by the gene lin-12 which promotes the 2° fate (Greenwald et al. 
1983). An inhibitory signal (Herman and Hedgecock 1990) mediated by a 
pathway of genes that includes lin-15 (Ferguson and Horvitz 1985, Ferguson 
and Horvitz 1989) inhibits the VPCs from assuming vulval fates in the 
absence of the inductive signal. 
Vulval induction is mediated by an Epidermal Growth Factor (EGF) 
signalling pathway. This pathway includes the gene let-23 that is required 
for vulval induction (Aroian and Sternberg 1991, Ferguson and Horvitz 1985) 
and that encodes a nematode homologue of the EGF-Receptor (Aroian et al. 
1990). let-23 is proposed to act in the VPCs and to encode the receptor for the 
inductive signal. A number of genes that encode homologues of signal 
transduction molecules and that act genetically downstream of let-23 have 
been characterized, including: sem-5, which encodes an adapter protein 
containing 2 SH3 domains and a SH2 domain (Clark et al. 1992) ; let-60, 
which encodes a ras protein (Han and Sternberg 1990), and lin-45, which 
encodes a raf serine-threonine kinase (Han et al. 1993). The gene lin-3 is 
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proposed to encode the vulval inducing signal made by the anchor cell (Hill 
and Sternberg 1992). Wild-type activity of lin-3 is required for induction of 
vulval fates (Ferguson and Horvitz 1985). lin-3 encodes a membrane-
spanning protein with a single EGF domain that is a putative nematode 
member of the EGF family of growth factors (Hill and Sternberg 1992). lin-3 
acts genetically upstream of let-23, consistent with the model that lin-3 
encodes a ligand for the receptor encoded by let-23 . In contrast to the 
phenotype of reduction-of-function lin-3 alleles, lin-3 transgenes that contain 
multiple copies of wild-type lin-3 genomic DNA clones can cause greater than 
the normal number of VPCs to assume vulval fates. The trans genes 
apparently act in the ACto induce the VPCs to assume vulval fates since 
ablation of the gonad, which prevents the development of the AC, strongly 
reduces the ability of the transgenes to induce vulva development. Indeed, 
lin-3::lacZ fusion transgenes that retain the ability to induce vulval 
development express p-galactosidase specifically in the AC at the time of 
vulval induction. 
The EGF family of growth factors is a large family of intercellular 
signalling molecules that is mitogenic for many cell types and that induces 
diverse physiological effects on many other cell types (reviewed in (Carpenter 
and Wahl1990)). This family includes EGF (Gregory 1975, Savage et al. 
1972), Transforming Growth Factor-alpha (TGF-a) (Derynck et al. 1984), 
amphiregulin (Shoyab et al. 1989), Heparin-Binding EGF (HB-EGF) 
(Higashiyama et al. 1991), Neu Differentiation Factor (Wen et al. 1992)/ 
heregulin (Holmes et al. 1992), and the predicted protein product of the spitz 
locus of Drosophila (Rutledge et al. 1992). These proteins are structurally 
diverse, but are usually made as membrane spanning proteins, and have in 
common the presence of at least one EGF domain. EGF domains are a 
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sequence motif found in a wide variety of proteins that consists of six cysteine 
residues with semi-conserved spacing. In some cases, the cysteine residues 
are known to form a particular pattern of disulfide bonding. The EGF 
domain is the portion of the growth factor that binds and activates the 
receptor. In many cases the EGF domain is released from the membrane by 
proteolytic processing to produce a secreted factor. For example, the EGF 
domain ofTGF-o: is processed and released as a 50 amino acid factor. These 
factors may not always act as secreted factors, since membrane-bound TGF-o: 
can activate the EGF-R (Brachmann et al. 1989, Wong et al. 1989). 
Based on the prediction that the vulval-inducing signal is a secreted 
factor, and the similarity ofLin-3 to the EGF growth factors, we decided to 
test whether the EGF domain of Lin-3 would be sufficient to induce vulval 
differentiation. Transgenes were produced that express the 63 amino acid 
EGF domain of Lin-3 under the control of an inducible, and tissue-general 
heat shock promoter (Fig. 1). The transgenes also include a signal peptide 
sequence to help ensure that the EGF domain ofLin-3 is secreted. These 
transgenes are known as the Lin-3EGF sense transgenes. Another set of 
transgenes called the Lin-3EGF antisense transgenes contain the same DNA 
sequences, although the DNA encoding the EGF domain of Lin-3 is present in 
the antisense orientation with respect to the translation initiation site. The 
Lin-3EGF antisense transgenes should produce no functional Lin-3 protein 
and thus serve as a control for whether there are any affects on vulval 
development caused by the heat shock procedure that are not due to the EGF 
domain of Lin -3. 
The Lin-3EGF sense transgenes are able to induce vulval 
differentiation whereas the Lin-3EGF antisense transgenes are not able to do 
so (Table 1). In this experiment the transgenes are present in animals that 
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are wildtype at the chromosomallin-3 locus. Animals bearing the Lin-3EGF 
sense transgenes have 192% of the wild-type level ofvulval differentiation 
upon mock-ablation of the gonad and heat shock at the time ofvulval 
induction (Fig 2C). Specifically, in 9 animals all six VPCs assumed vulval 
fates, and in three animals five of six VPCs assumed vulval fates. In these 
animals the inductive signal produced endogenously by the AC is sufficient to 
induce P5.p, P6.p, and P7.p. The induction ofP3.p, P4.p and P8.p in these 
animals, however, must be due to the presence of the Lin-3EGF sense 
transgene. Ablation of the gonadal precursor cells Z[1-4] at hatching 
prevents the development of the AC and in wild type results in all six VPCs 
assuming the 3° non-vulval fate. Vulval differentiation, however, can occur 
independently of the AC in animals bearing the Lin-3EGF sense transgenes. 
In 15 gonad-ablated, heat-shocked animals bearing the Lin-3EGF sense 
transgenes, the level ofvulval differentiation was 198% of the wild-type level 
(Fig. 2D). Animals bearing the Lin-3EGF antisense transgenes behave in a 
manner equivalent to the behavior ofwildtype. In 11 mock-ablated, heat-
shocked animals bearing the Lin-3EGF antisense transgenes, P5.p, P6.p, and 
P7.p assume a normal pattern of vulval fates in response to the inductive 
signal produced by the AC, and the three other VPCs assumed 3° fates (Fig. 
2A). This indicates that neither the antisense transgene nor the heat shock 
conditions interfere with vulval induction. In 12 gonad-ablated, heat-shocked 
animals bearing the Lin-3EGF antisense transgenes, no VPCs assumed 
vulval fates (Fig 2B). This indicates that the ablation protocol is sufficient to 
remove all of the endogenous inductive signal, and that the Lin-3EGF 
antisense transgenes have no ability to induce vulval differentiation. 
Because only the Lin-3EGF sense transgene is able to induce vulval 
development, we believe that it is the production of Lin-3 protein by the 
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transgenes that is responsible for their ability to induce vulval development. 
These results indicate that the 63 amino acid EGF domain of Lin-3 is 
sufficient to induce vulval differentiation in the absence of the normal source 
of the vulval-inducing signal. 
To determine the fate choice of a single VPC in response to the EGF 
domain of Lin-3, and in the absence of lateral signalling between different 
VPCs, single VPCs were isolated by the ablation of the gonadal precursor 
cells and the 5 other VPCs. In response to activation of the Lin-3EGF sense 
transgenes by a mild stress stimulus, isolated VPCs assumed the 3° fate in 9 
animals, the 2° fate in 3 animals, the 1 o fate in 2 animals, and intermediate 
fates with character of both 1 o and 2° fates in 4 animals (Table 2). It was 
previously known that the anchor cell could induce an isolated VPC to 
assume either the 1 o or the 2° fate (Sternberg and Horvitz 1986), and thus 
that lateral signals between different VPCs were not essential to get either 
vulval fate. Our results confirm this observation and indicate that the EGF 
domain of Lin-3 is sufficient to induce both vulval fates. This indicates that 
separate signals from the anchor cell are not required to get the different 
vulval fates and thus, that lin-3 may be the sole vulval-inducing signal made 
by the anchor cell. 
We have made a transgene that should produce an obligate secreted 
form of the EGF domain of Lin-3, which can stimulate vulval differentiation. 
This result suggests that lin-3, like the EGF growth factors, can produce a 
secreted factor that consists of an EGF domain. It has been predicted that 
the vulval-inducing signal made by the AC is a secreted factor, and our 
results support this prediction. However, it is possible that the transgene 
does not act by producing a secreted product. For example, the transgene 
could produce Lin-3 protein in the VPCs that associates with Let-23 
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intracellularly. It has not yet been determined whether the Lin-3 protein 
produced endogenously by the AC is processed to release a secreted factor. 
Expression of the EGF domain of Lin-3 can induce vulval fates in the absence 
of the gonad. It remains possible that there are other factors or accessory 
proteins necessary to induce the VPCs to assume vulval fates, although these 
factors could not be made uniquely by the gonad. It is also possible that there 
are other factors made by the gonad that are normally necessary for vulval 
induction but that they are dispensable for vulval induction if Lin-3 is 
overexpressed. The EGF domain ofLin-3 can induce a single VPC, isolated 
by the cell ablation of the gonad and the other VPCs to assume either the 1 o 
or the 2° fate . Thus both the 1 o and the 2° fate can be specified by Lin-3 
without the action of another signal from the gonad or a second VPC. These 
results suggest that Lin-3 may be the sole vulval-inducing signal made by the 
anchor cell. 
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Tables and Figures. 
Figure 1. Inducible Lin-3EGF transgenes. The vector pRH51 (sense) 
expresses the EGF domain ofLin-3 under the control ofthe heat shock 
promoter hsp16-41. This promoter directs expression in most tissues and 
expresses strongly in the pharynx and the intestine (Stringham et al. 1992) . 
Translation initiates in a synthetic sequence that encodes a signal peptide 
(Perry et al. 1993) and thus the EGF domain of Lin-3 should be secreted. The 
vector also contains the 3' untranslated region of the unc-54 gene and a 
synthetic intron to ensure that the message is stable and is properly 
processed (Fire et al. 1990). The vector pRH52 (antisense) contains the same 
sequences but the DNA encoding the EGF domain of Lin-3 is cloned in the 
antisense orientation with respect to the synthetic signal peptide and should 
produce no functional Lin-3 protein. The sequence of the predicted protein 
produced by pRH51 is shown. The EGF domain ofLin-3 (amino acids 34-96) 
is overlined in bold. The signal peptide is underlined. SSP: Synthetic Signal 
Peptide. 3' UT: 3' untranslated region. Arrowhead, possible cleavage site of 
the signal peptide (von Heijne 1986). 
Methods. The EGF domain ofLin-3 from Val142 to Pro204 was directly 
amplified from a lin-3 eDNA by PCR using the primers V123: 5'-GG CAT 
ATG GTT CGG AAG GAA ATC GAG-3', which adds a Ndel site and initiation 
codon to the 5' end of the product, and P185: 5'- T AGG ATC CTA TGG GGC 
ATA GAA CGC CTG-3', which adds a termination codon and BamHI site to 
the 3' end. The PCR product was endfilled and subcloned into pSK+. The 
vector pRH45 that places the synthetic signal peptide cassette of pPD52.63 
(Perry, et al. 1993) under the transcriptional control of the promoter hspl6-
41 was constructed by subcloning a 970 bp BamHI-Spel fragment of 
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pPD52.63 into a 2.9 kb BamHI-Spei vector fragment of pPD49.83 (A. Fire, 
personal communication). The EGF domain was subcloned as a translational 
fusion into pRH45 by digesting the EGF vector with Ndel and BamHI, end 
filling the product, and gel purifying the insert fragment. The insert was 
subcloned into an end-filled Ncoi digest ofpRH45 to yield pRH51 with the 
EGF insert in the sense orientation and pRH52 with the EGF insert in the 
antisense orientation. The sequence of the translational fusion ofpRH51 and 
the EGF insert has been checked by Sanger dideoxy sequencing. Standard 
molecular biological techniques were performed as described (Sambrook et al. 
1989). 
The transgenes syEx20 and syEx24 were obtained by microinjection of 
pRH52 at 50 ng/J..ll, C14G10(unc-31(+)) at 20 ng/J..ll, and pMob (Strathmann et 
al. 1991) at 30 ng/J..ll, into the syncytial germline (Mello et al. 1991) of unc-
31(e169) mutant animals and examining the progeny for non-Unc-31 animals. 
The transgenes syEx21 and syEx23 were obtained by microinjection ofpRH51 
at 50 ng/J..ll, C14G10(unc-31(+)) at 20 ng/J..ll, and pMob at 30 ng/J..ll, into unc-
31(e169). The transgene syEx42 was obtained by microinjection ofpRH51 at 
7 ng/J..ll , C14G10(unc-31(+)) at 20 ng/J..ll, and pMob at 73 ng/J..ll, into lin-3(n378) 
unc-31(e169). 
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1 ATG CAT AAG GTT TTG CTG GCA CTG TTC TTT ATC 
1 Met His Lys Val Leu Leu Ala Leu Phe Phe Ile 
46 GCA, TCC GCA CTG GCA GTC TCC GAA CCG GTC CTA 
1 6 Ala Ser Ala Leu Ala Val Ser Glu Pro Val Leu 
91 CCA TGT ATG GTT CGG AAG GAA ATC GAG AAG TTG 
31 Pro Cys Met Val Arg Lys Gl u Ile Glu Lys Leu 
136 TGC AAA GAC TAC TGT CAT CAC AAC GCG ACA TGC 
46 Cys Lys Asp Tyr Cys His Hi s Asn Ala Thr Cys 
181 ATA TTC CGT GAA GAT AGA GTT TCA GCA GTT GTT 
61 I l e Ph e Arg Gl u Asp Ar g Val Ser Ala Va l Val 
226 TGT CCA CAG GGT TGG GAA GGC ACT CGT TGT GAT 
76 Cys Pro Gln Gly Trp Glu Gly Thr Arg Cys Asp 
271 CAG GCG TTC TAT GCC CCA TAG 
91 Gln Al a Phe Tyr Ala Pro End 
unc-54 3' UT 
TTT CTG GCA CCA 
Phe Leu Al a Pr o 
GCG TCG ACG GTA 
Ala Ser Thr Val 
AAA GAA GCA AAA 
Lys Glu Ala Lys 
CAC GTG GAA GTG 
His Val Glu Val 
CCT TCT TGC CAT 
Pro Ser Cys His 
CGT CAC TAC GTT 
Arg Hi s Tyr Val 
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Figure 2. Nomarski photomicrographs of animals from Table 1. a . A heat-
shocked animal bearing a Lin-3EGF antisense transgene with an intact 
gonad. The pattern of vulval fates is wild-type with P3.p, P4.p and P8.p 
assuming the 3° fate and P5.p, P6.p and P7.p assuming vulval fates. The AC 
is out of the plane of focus . b. A heat-shocked, gonad-ablated animal bearing 
a Lin-3EGF antisense transgene. All six VPCs have assumed the 3° fate 
(P3.p and P4.p out of the field of view). c . A heat-shocked animal bearing a 
Lin-3EGF sense transgene with the gonad intact. All six VPCs have assumed 
vulval fates (P8.p out of the field of view). d . A heat-shocked, gonad-ablated 
animal bearing a Lin-3EGF sense transgene. One cell of the P5/6(UR) pair 
was also ablated. The remaining 5 VPCs have all assumed vulval fates. 
The fate of the VPCs was determined by examination of the anatomy 
near the time of the L3 lethargus. At this time VPCs that have assumed the 
3° fate will have produced two large epidermal nuclei that have fused to the 
main body epidermis hyp7, and the VPCs that have assumed the 1 o and 2° 
vulval fates will have undergone two to three rounds of cell division. The 
syncytial epidermal nuclei of the 3° fate are denoted with a squares, and the 
smaller vulval nuclei (at the 4 cell stage) are marked by the small 
arrowheads. The line drawings illustrate the inferred lineal history of the 
cells. One round of cell division indicates the 3° fate and 2 rounds of cell 
division indicate a 1 o or 2° vulval fate. The large arrowhead marks the 
position of the AC. Scale bar 20 Jlm. Ventral to the bottom, anterior to the 




• .I • 
~ . \ 
. \~ 
- ~ ... 
"' 
~} ~ ... .. Q. 
( 
; · .fl ~}~ 
C-15 
Table 1. Sufficiency of the EGF domain ofLin-3 to induce vulval 
differentiation. Expression ofthe EGF domain ofLin-3 from a heat shock 
promoter generally induces all six of the VPCs to differentiate as vulval 
tissue and can do so when the the development of the tissue that normally 
induces the vulva has been prevented by the ablation of the gonadal 
precursor cells. The Lin-3EGF antisense transgenes can not induce vulval 
differentiation. When the gonad is present in animals bearing Lin-3EGF 
antisense transgenes, the AC induces the three more proximal VPCs to 
assume vulval fates as in wildtype. Thus, the Lin-3EGF antisense 
transgenes do not dominantly interfere with vulval induction, for example by 
the production of antisense RNA. Three VPCs did not assume vulval fates in 
the mock-ablated, heat-shocked animals bearing the Lin-3EGF sense 
transgenes. In each case this VPC was P3.p and it fused with the syncytial 
epidermis without dividing. P3.p fuses with the syncytial epidermis instead 
of assuming the 3° fate in approximately 50% of wild-type animals. A single 
VPC did not assume a vulval fate in the gonad-ablated, heat-shocked animals 
bearing the Lin-3EGF sense transgenes. This VPC was P8.p and it assumed 
the 3° fate. 
Methods. The gonadal precursor cells Z(1-4) of non-Unc-31 hatchlings were 
ablated with a laser microbeam by standard methods (Avery and Horvitz 
1987, Sulston and White 1980). The gonad ablations were performed 
stringently and as a consequence a P cell was incidentally ablated in some 
animals. The P cells give rise to the VPCs, so that some animals had 5 VPCs 
instead of6 VPCs. The success ofthe gonadal ablation was assayed 12-19 
hours after ablation. Worms were heat shocked in the late L2 to L2 
lethargus, generally 20 hours after ablation of the gonad. Worms were heat 
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shocked for 2 hr at 33° C in sealed worm culture plates suspended in a water 
bath. Induction was measured as described (Aroian and Sternberg 1991) 
such that the percent of induction of an experimental population is equal to 
the (number ofVPCs assuming vulval fates per animal) divided by (3, which 
is the number ofVPCs that assume vulval fates in wildtype,) times 100. 
Animals bearing the Lin-3EGF sense transgenes grew slowly after heat shock 
compared to animals bearing the Lin-3EGF antisense transgenes. The Lin-
3EGF sense transgenes occasionally cause excess levels of vulval 
differentiation when maintained at 20° C. Strains were maintained at 20°C 
as described (Brenner 197 4). 
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Table 1. Sufficiency of the EGF domain of Lin-3 to induce vulval 
differentiation. 
EGF Transgene Gonad n Induced VPCs Total Induction 
Orientation Total VPCs 
Antisense syEx20 + 8 3/6 
syEx24 + 3 3/6 
11 100% 
Antisense syEx20 4 0/5 
syEx20 4 0/6 
syEx24 2 0/5 
syEx24 2 0/6 
12 0% 
Sense sy Ex21 + 5 6/6 
syEx23 + 3 5/6 
syEx23 + 4 6/6 
12 192% 
Sense syEx21 4 5/5 
syEx21 3 6/6 
syEx23 1 415 
syEx23 3 5/5 
syEx23 4 6/6 
15 198% 
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Table 2. Fate choice of isolated VPCs. 
Single VPCs were isolated in animals bearing Lin-3EGF sense 
transgenes by ablation of the gonadal precursors and the 5 other VPCs. In 
response to a mild induction of the transgene, isolated VPCs can assume the 
1°, the 2°, the 3°, or intermediate 1°/2° fates. This indicates that the EGF 
domain of Lin-3 can induce a VPC to assume either the 1 o or the 2° fate in the 
absence of lateral signals from other VPCs. 
Methods. The gonads of non-Unc-31 animals were ablated in the early 
L1 when there were 6-8 gonadal cells and the VPCs were ablated at 19-22 
hours of development. It was noted in previous experiments that the Lin-
3EGF sense transgenes are weakly activated in response to sodium azide 
(data not shown). Thus the transgenes are activated in all the animals 
during the ablation of the VPCs since this procedure exposes the worms to 
5mM sodium azide for 10-15 minutes. The transgene was additionally 
activated in other animals by a 10 minute heat shock of 33°C, at ±2 hours of 
the time of the VPC ablation. Fate is assigned according to the cell lineage of 
a VPC and the morphogenesis of the descendents of the VPC in the L4 stage. 
A wild-type 2° lineage is LLTN and a wild-type 1 o lineage is TTTT. Any 
lineage that had progeny that adhered to the ventral cuticle is considered to 
have 2° character. The morphogenesis of a 1 o lineage is a symmetrical 
invagination and the morphogenesis of a 2° lineage is an asymmetrical 
invagination. Abbreviations. N3: activation of the trans gene by 5 mM 
sodium azide. 10' hs: activation of the transgene by 10 minute exposure to 
33°C. Morph: The morphogenesis of the VPC progeny in the L4 stage. NA: 
Not Applicable. ND: Not Determined. int: intermediate vulval fate with 1 o 
and 2° vulval properties. Lineage abbreviations as in (Sternberg and Horvitz 
1986), L: longitudinal division ofPN.pxx nuclei; 0: oblique division ofPN.pxx 
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nuclei; T: transverse division ofPN.pxx nuclei; D: PN.pxx nuclei divided, axis 
unknown; N: PN.pxx nuclei did not divide; 8: PN.p or PN.px nucelus did not 
divide and fused with synchytial epidermis; Underline: progeny cells adhered 
to the ventral cuticle. 
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Table 2. Fate choice of isolated VPCs. 
Key Trans gene Stimulus Lineage Morph Fate 
1SO syEx23 10'hs LLLL 20 20 
172 syEx23 10' hs TTLL 20 20 
17S syEx23 10' hs LTNO 20 20 
171 syEx42 NS LTTL 20 int 
174 syEx23 10'hs LLTL ND int 
175 syEx23 10'hs LTTL ND int 
127 syEx23 10'hs LTDD hyb int 
128 syEx23 10'hs LTTL ND 10 
166 syEx42 NS TONL 10 10 
n=7 syEx42 NS ss NA so 
n=2 syEx2S 10'hs ss NA so 
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Chapter 4 
The role of lin-3 in vulval precursor cell fate patterning. 
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The C. elegans gene lin-3 encodes the signal made by the 
anchor cell that induces the vulval precursor cells (VPCs) to assume 
vulval fates. The inductive signal has been proposed to be 
distributed in a gradient centered on the anchor cell that establishes 
the graded pattern of fates assumed by the VPCs (Sternberg and 
Horvitz 1986). We examine the pattern and extent of vulval induction 
in hypomorphic lin-3 mutant animals. We find that when vulval 
induction occurs in these animals, that it is usually centered beneath 
the anchor cell. This observation is consistent with the model that 
the inductive signal is distributed in a gradient. We also observe 
non-graded fate patterns, hybrid vulval/non-vulval fates, and 
evidence for cooperativity in the extent of induction. Thus, other 
signals may be modifying the fate choice of the VPCs. 
We also examine the pattern of fates assumed by the VPCs in 
animals bearing lin-3 transgenes that likely overexpress the Lin-3 
protein from the anchor cell. In these animals adjacent VPCs near 
the anchor cell can adopt the 1 o fate. Therefore, high doses of the 
inductive signal can override the action of the lateral signal, 
mediated by lin-12, which normally prevents adjacent VPCs from 
assuming the 1 o fate. Thus, the dose of lin-3 activity is important in 
establishing the proper pattern of vulval fates. 
The vulva of the nematode C. elegans develops post-embryonically from 
a subset of ectodermal blast cells (P[3-8].p) called the Vulval Precursor Cells 
(VPCs), which are located in a longitudinal row within the ventral epidermis 
(Sulston 1976). A variety of experiments suggest that each of the six VPCs is 
equivalent in its ability to assume any of three developmental fates : the 1 o , 
D-S 
the 2°, and the so fates (Sternberg and Horvitz 1986, Sulston and White 
1980). Each fate consists of a unique pattern of cell division and produces a 
unique set of cell types (see figure 2 of chapter 1). The 1 o and 2° fates both 
produce vulval tissue and are called the vulval fates; the so fate produces 
non-vulval epidermis and is called the epidermal fate. In wild-type 
development the six VPCs reproducibly assume a so so 2° 1 o 2° so pattern of 
fates. This pattern of fates is spatially graded beneath the anchor cell as only 
the VPC closest to the anchor cell, P6.p, assumes the 1 o fate. 
The current model for the fate determination of the VPCs, called the 
"three-signal model," is shown in figure 1 (reviewed in chapter 1 and in 
(Horvitz and Sternberg 1991)). This model proposes that the number ofVPCs 
induced to assume vulval fates is set by the level of lin-3 activity produced by 
the anchor cell. The 2° 1 o 2° pattern of fates assumed by the three induced 
VPCs is established by a gradient of lin-3 activity centered on the anchor cell. 
High levels of lin-3 activity promote P6.p to assume the 1 o fate and lower 
levels of lin-3 activity promote P5.p and P7.p to assume the 2° fate. Lateral 
signalling among the VPCs mediated by the gene lin-12 promotes the 2° fate 
and initially acts in proportion to the level of lin-3 activity that each VPC 
receives. Thus P6.p, which receives the most inductive signal, is the VPC 
best able to laterally signal its neighbors to be 2°. A signal mediated by a 
pathway that includes lin-15, and which may arise from the main body 
epidermis inhibits the VPCs from assuming vulval fates in the absence of the 
inductive signal. 
Some features of the "three-signal model" are uncertain. First, the 
relative contribution of the graded distribution of the inductive signal, versus 
the action of the lateral signal, in establishing the 2° 1 o 2° pattern of fates 
assumed by the induced VPCs is unclear. It is possible either that P5.p and 
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P7.p assume the 2° fate because they receive a low dose of the inductive 
signal, or that they assume the 2° fate as the result of lateral interactions 
among the VPCs. Second, it is not clear from the "three-signal model" 
whether lateral signalling would prevent adjacent VPCs from assuming the 
1 o fate if they were both challenged with a high dose of inductive signal. The 
"three-signal model" also makes several predictions about the function of the 
inductive signal that can be tested by examining lin-3 mutations. If the 
inductive signal is distributed in a gradient, then most hypomorphic 
mutations of lin-3 should lower lin-3 activity without disrupting its graded 
distribution. Thus, in hypomorphic lin-3 mutant animals, the residual 
induction of vulval fates should occur preferentially beneath the anchor cell. 
If different doses of lin-3 activity specify the 1 o and 2° fates, then in some 
hypomorphic lin-3 mutant animals, P6.p, which usually assumes the 1 o fate, 
should assume the 2° fate. This chapter presents the current data on VPC 
fate choice in different lin-3 genotypes and discusses the implications of these 
results for vulval fate patterning. 
Results. 
VPC fate patterning in lin-3 hypomorphs. 
It was previously demonstrated that mutations in the gene lin-3 cause 
a defect in the fate determination of the VPCs such that P5.p, P6.p, and P7.p, 
which in wildtype assume the 1 o and 2° fates, instead often assume the 3° 
epidermal fate (Ferguson and Horvitz 1985, Ferguson et al. 1987, Horvitz and 
Sulston 1980, Sternberg and Horvitz 1989, Sulston and Horvitz 1981). As a 
result, lin-3 mutant animals often lack vulval tissue (the vulvaless (Vul) 
phenotype), which results in an inability to lay eggs (the Egl phenotype). We 
have examined the number ofVPCs that assume vulval fates in a variety of 
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hypomorphic lin-3 genotypes (Table 1). Our results confirm and extend the 
previous results. The lin-3 mutations n378, n1058, sy53, and sy91 cause a 
vulvaless phenotype that is recessive to wildtype. In all hypomorphic lin-3 
genotypes examined, the number ofVPCs induced to assume vulval fates is 
equal to, or less than, the number ofVPCs induced in wild-type. Thus 
reduction of lin-3 activity does not result in a Hyper-Induced (Hin) 
phenotype. Some of the larval lethal alleles of lin-3 confer very little or no 
ability to induce vulval fates as measured by their failure to complement the 
hypomorphic alleles. For example, approximately only one in 600 animals of 
the genotype n378/n1059 is able to lay eggs. Thus, the null phenotype of lin-
3 is likely to be a complete absence of vulval induction. Since putative null 
mutations in lin-3 confer lethality prior to the time of vulval development, the 
extent of vulval induction in animals homozygous for null mutations of lin-3 
has not been examined. The smallest genetic deficiency of the lin-3 region, 
sDf64, causes a slightly dominant defect in vulval induction. Thus, it can not 
be used to determine the phenotype of null alleles of lin-3 in complementation 
tests. 
We have examined the pattern ofvulval induction in different lin-3 
hypomorphic genotypes. Figure 2 shows different possible patterns ofVPCs 
assuming vulval and non-vulval fates and a histogram that shows the per 
centage of animals of a particular lin-3 genotype with that pattern of fates. A 
pattern of fates is classified as a graded pattern if the VPCs assuming vulval 
fates are centered beneath the anchor cell, or as a non-graded pattern if there 
are VPCs assuming non-vulval fates closer to the anchor cell than other VPCs 
assuming vulval fates. In n1058, sy91, and n378 mutant animals vulval 
induction, when it occurs, often occurs in a graded pattern (19 of22 n1058 
homozygotes, 29 of 31 sy91 homozygotes and 15 of 18 n378 homozygotes). 
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Since the VPCs respond in a graded manner in the lin-3 mutant animals, lin-
3 activity may be distributed in a gradient in these animals. 
In some hypomorphic lin-3 genotypes, the distribution of VPC fate 
patterns is bimodal such that there is an under-representation of animals 
with an intermediate number ofVPCs induced to assume vulval fates. In 
homozygous sy91 mutant animals, the average level ofvulval induction is 
38%. This is equivalent to an average of one induced VPC per animal, yet 
there are no observed sy91 animals with exactly one induced VPC. Instead 
59% of sy91 mutant animals have induction of0-0.5 VPCs, and 24% ofsy91 
mutants have induction of three VPCs. The distribution ofVPC fate patterns 
is also bimodal in nl 058 mutant animals which have an average of 46% 
induction and in n378 I sy53 animals that have an average level of 55% 
induction. In all of these genotypes there is a high fraction of animals with 
three cells assuming vulval fates. In n378 mutant animals the average level 
of vulval induction is 11% and the fate patterns form a simple distribution in 
which animals with increasing levels of induction are increasingly rare. The 
current data suggest that bimodal distributions ofVPC fate patterns are not 
an allele specific effect but result from certain dose ranges of lin-3 activity. 
Thus, for example, n378 homozygotes do not show a bimodal distribution of 
fates but n378 I sy53 animals have a complex distribution of fate patterns. 
The bimodal distributions of fate patterns suggests that there is cooperativity 
in the extent of vulval induction. 
For some of the animals in figure 2 it could be determined whether an 
induced VPC was assuming the 1 o or the 2° fate. The data for VPC fate 
choice in the hypomorphic lin-3 mutant animals is summarized below and in 
Figure 3. In animals in which only P6.p assumes a vulval fate, P6.p assumes 
either a 1 o fate or a hybrid vulval/non-vulval fa te. In animals in which P6.p 
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and a lateral neighbor are induced, P6.p also assumes either a 1 o fate or a 
hybrid vulval/non-vulval fate. Although the fate ofP6.p could not be 
determined in all animals, there are no animals in which P6.p clearly 
assumed the 2° fate. P5.p and P7.p have not been observed to assume the 1 o 
fate in lin-3 hypomorphic mutant animals. When P6.p is induced P5.p and 
P7.p assume either the 3°, the 2° or hybrid vulval/non-vulval fates. In 
animals in which only P5.p or P7.p is induced, that cell has assumed the 2° 
fate in six cases and hybrid vulval/non-vulval fates in other animals. It is 
thus possible for a single VPC to assume the 2° fate in lin-3 hypomorphic 
mutant animals, and thus there may be a dose of lin-3 activity that specifies 
the 2° fate. P5.p and P7.p may be assuming the 2° fate in these animals in 
response to lateral signals. 
P5.p, P6.p, and P7.p have been observed to undergo hybrid vulval/non-
vulval lineages in lin-3 hypomorphic mutant animals. As discussed in the 
methods, it is hard to assign 1 o or 2° fates to the vulval half of the hybrid 
vulval/non-vulval lineages. Hybrid lineages have been previously observed in 
reduction-of-function mutant animals for other genes required for vulval 
induction (Aroian and Sternberg 1991, Sternberg and Horvitz 1986, 
Sternberg and Horvitz 1989). The existence of hybrid vulval/non-vulval 
lineages is an anomaly in the current model of vulval development in which 
the VPC chooses between one of three discrete fates and the descendants of 
the VPCs are committed to executing the fate chosen by the VPC. Models for 
the existence of hybrid fates are presented in the discussion. 
VPC fate pattern in lin-3 transgenic animals. 
Transgenes that are made up of multiple copies of wild-type lin-3 
genomic DNA clones, which are believed to over-express the Lin-3 protein in 
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the anchor cell, cause up to all six of the VPCs to assume vulval fates (Hill 
and Sternberg 1992). The lineages assumed by the VPCs in lin-3 transgenic 
animals are shown in Table 2A. In 4 of 12 animals bearing the lin-3 
transgene syEx13, adjacent VPCs have assumed the 1 o fate, and in two of 
these animals more than 2 adjacent VPCs have assumed the 1° fate. The 
fates are judged to be 1 o because the VPC granddaughters divide in the 
transverse axis, because the great-granddaughters undergo a morphogenic 
invagination similar to a wild-type 1 o lineage, and because none of the great-
granddaughter nuclei adhere to the ventral cuticle, which is the key property 
of the 2° fate. This result indicates that the lin-3 transgenes can override, or 
interfere with, the lateral signalling among the VPCs that normally prevents 
adjacent VPCs from assuming the 1 o fate. Thus, high levels of lin-3 activity 
may specify the 1 o fate. Adjacent VPCs with the 1 o fate are only seen 
proximal to the anchor cell, which is consistent with the model that adjacent 
1 o fates are specified only by high levels of lin-3 activity. In approximately 
half of the animals, there is a 1 o fate farther from the anchor cell than a 2° 
fate: thus, the VPCs do not always assume a graded pattern of fates in the 
lin-3 transgenic animals. 
The normal pattern of early and late VPC granddaughter divisions is 
sometimes disrupted in the adjacent 1 o lineages. In a wild-type 1 o lineage, 
the granddaughters of the VPC divide in a temporal pattern of"early, late, 
late, early" whereas in lin-3 mutant animals the VPC granddaughters can 
divide in an alternating pattern of "early, late" that runs from one 1 o fate to 
another. An example ofthis is shown in figure 4B in which there is an 
alternating pattern of early and late divisions that runs from P4.p to P6.p. 
This same disruption has been noted in the adjacent 1 o fates found in 
amorphic lin-12 mutant animals (P. Sternberg, personal communication). 
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These results could indicate that cell interactions affect the timing of 
divisions of the VPC granddaughters in the 1 o lineage. 
The lineages of the VPCs in animals bearing lin-3 trans genes and 
hypermorphic lin-12 mutations (lin-12(d))were followed to test ifthe ability of 
the lin-3 transgenes to promote adjacent 1 o fates is epistatic to the ability of 
lin-12(d) mutations to promote the 2° fate. In the lineages of 9 such animals, 
there are no examples in which adjacent VPCs have assumed normal 1 o 
lineages (Table 2B). There are, however, cases in which P6.p is 1 o and P5.p 
or P7. p has assumed a lineage that has properties of both the 1 o and the 2° 
lineages. For example, in animal 5G3, P5.p assumed a lineage which is 1°-
like with the exception that P5.paa(a/p) adhered to the ventral cuticle. This 
result could mean that it is more difficult to specify adjacent VPCs to be 1 o in 
lin-12(d) mutant animals than in animals wild-type for lin-12. Alternatively, 
the absence of animals with clear adjacent 1 o fates could be due to chance, 
since the lin-3 transgenes provide a variable dose of lin-3 activity. Some lin-
12( d) mutant animals bearing lin-3 trans genes display phenotypes that 
correlate with the presence of adjacent VPCs with the 1 o fate. For example, 
adult animals sometimes have large, broad ventral protrusions that can 
result from adjacent VPCs assuming the 1 o fate. Also, some L3 molt animals 
were observed in which the VPC grandprogeny were staggered in the left-
right or dorsal-ventral planes beneath the anchor cell. In wild-type 
development, the VPC grandprogeny remain in a longitudinal row. 
Staggering of the VPC grand progeny has been previously observed in lin-3 
transgenic animals and in amorphic lin-12 mutant animals in which adjacent 
VPCs are assuming the 1° fate. These observations suggest that adjacent 1 o 
fates may be present in this strain. 
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Discussion. 
Fate patterning in lin-3 hypomorphs. 
Graded patterns of induction 
In most hypomorphic lin-3 mutant animals, there is either no vulval 
induction or the pattern of vulval induction is graded such that only the VPCs 
closer to the anchor cell have assumed vulval fates. Thus, in response to 
lowered levels of lin-3 activity, the three VPCs that are induced in wildtype 
do not have an equal chance of assuming vulval fates. P5. p and P7. p are less 
likely to assume a vulval fate than P6.p and usually only assume vulval fates 
in animals in which P6.p has assumed a vulval fate. This observation is 
consistent with the model that lin-3 activity is distributed in a gradient in 
wildtype and that the hypomorphic lin-3 mutations result in a graded 
distribution of lin-3 activity that is reduced in amplitude and extent. Thus, 
in animals with low levels of lin-3 activity there is either no vulval induction, 
or only the VPC closest to the anchor cell receives enough lin-3 activity to 
assume a vulval fate. In those animals with enough lin-3 activity to induce 
either P5.p or P7.p, it is very likely that P6.p will receive enough lin-3 
activity to assume a vulval fate because it is in the center of the gradient. 
The graded patterns ofvulval induction could also be explained by a "two-
step" model of vulval induction in which Lin-3 made by the anchor cell 
induces P6.p to be P, and P6.p induces P5.p and P7.p to be 2°. In this case 
P5.p and P7.p would only assume vulval fates when enough lin-3 activity is 
present to induce P6. p to be 1 o . As is discussed later, the bulk of 
experimental evidence is against the "two-step" model of vulval induction, so 
this explanation is likely to be incorrect. 
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Non-graded patterns of induction 
There are examples of non-graded patterns ofinduction in most 
hypomorphic lin-3 genotypes. The presence of these non-graded patterns in 
lin-3 mutant animals could be due to several effects. First, it is possible that 
lin-3 activity is occasionally distributed in a non-graded manner in the lin-3 
mutant animals and thus that each of the VPCs is responding in proportion 
to the level of lin-3 activity that it receives. Second, it is possible that in some 
animals the level of lin-3 activity is near the threshold for induction of vulval 
fates. IfVPC induction is stochastic at threshold levels of lin-3 activity, then 
in some cases P6.p may, by chance, not assume a vulval fate while its lateral 
neighbors do assume vulval fates, even though P6.p received a slightly higher 
level of lin-3 activity. Third, the non-graded patterns of vulval induction 
could result from lateral signalling among the VPCs that regulates the 
boundary between cells assuming vulval fates and cells assuming non-vulval 
fates. This "boundary" signal could arise from VPCs assuming the 2° fate, 
and direct VPCs receiving even lower levels of lin-3 activity to adopt the so 
fate. Thus, in some cases in which P[5-7].p are receiving low levels of lin-3 
activity, the combined action of the boundary signal arising from P5.p and 
P7.p could direct P6.p to assume the so fate. It might be possible to test 
whether lateral signalling among the VPCs is responsible for the non-graded 
patterns of fate by comparing, for a given lin-3 genotype, the frequency at 
which P6.p assumes a vulval fate when it has lateral neighbors to the 
frequency at which P6.p assumes vulval fates when it does not have 
neighbors. If the frequency at which P6.p assumes a vulval fate is greater 
when it lacks lateral neighbors, then this might indicate that the neighbors 
were inhibiting P6.p from assuming vulval fates. This experiment would be 
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subject to the caveat that P6.p might receive more inductive signal upon 
isolation because it lacks neighbors that absorb the inductive signal. 
Cooperativity in induction. 
In some hypomorphic lin-3 genotypes the distribution ofVPC fate 
patterns does not form a Poisson distribution around a single average value. 
This effect does not seem to be allele-specific and appears to be associated 
with a particular dose range of lin-3 activity. The bimodal distribution of fate 
patterns could indicate that the mechanisms that control the extent of vulval 
induction display cooperativity. This cooperativity could be explained be 
several models. First, the VPCs could decide as a group whether they should 
assume vulval fates. Second, there could be cooperativity in the production of 
the inductive signal. For example, the anchor cell may initially release a low 
level of the inductive signal that is only sufficient to induce the closest VPC. 
When a VPC receives the inductive signal, it signals back to the anchor cell 
and either it or the anchor cell moves to center the anchor cell above the 
induced VPC. Once centered, the anchor cell increases production of the 
inductive signal to a level sufficient to induce three VPCs. Thus, in a 
hypomorphic lin-3 mutant animal, the anchor cell either does not make 
enough lin-3 activity to fully induce P6.p, in which case the level of induction 
stays below one cell, or the anchor cell makes enough lin-3 activity to fully 
induce P6.p, in which case the anchor cell increases its production of lin-3 
activity in response to induction ofP6.p and additional VPCs are induced. 
The third model that could explain cooperativity is that there is a novel 
signal from a cell assuming the 1 o fate that promotes its lateral neighbors to 
assume a vulval fate. In this model, anytime there was enough lin-3 activity 
to fully induce P6.p, then P6.p would instruct its lateral n eighbors to assume 
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vulval fates. This model is essentially a variant of the "two-step" model of 
vulval induction discussed later. 
It should be possible to distinguish among these three models 
experimentally. In the first model in which the VPCs make a cooperative 
decision as a group to respond to the inductive signal, the decision of a 
particular VPC to assume a vulval fate is influenced by its lateral neighbors. 
If this model is correct, then in a lin-3 genotype that displays cooperativity, 
P6.p should assume a vulval fate more often when it has lateral neighbors 
than when its lateral neighbors have been ablated with a laser microbeam. 
In the second model in which there is cooperativity in the production of the 
inductive signal, then cooperativity should be dependent upon the anchor cell. 
Thus, if the VPCs were induced by a mechanism independent of the anchor 
cell, the extent of their induction should not display cooperativity. Thus, for 
example, if the transgenes that express the EGF domain of Lin-3 under the 
control of heat shock promoter (hsp::Lin-3EGF) were activated in a single cell 
(Stringham and Candido 1993), then the extent of vulval induction should 
increase in a non-cooperative manner as the intensity of the laser activation 
is increased. In contrast in the third model in which the cooperativity results 
from lateral signals among the VPCs, then the extent of vulval induction 
should show cooperativity regardless of the source of the inductive signal. In 
this case when the hsp::Lin-3EGF transgenes are activated in a single cell, 
then the extent of induction should increase cooperatively in response to 
increasing doses of the laser activation. 
VPC fate choice in lin-3 hypomorphs 
If different doses of lin-3 activity specify a VPC to assume either the 1 o 
or the 2° fate , then a strong prediction is that P6.p, the only VPC induced to 
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assume the 1° fate in wild-type, should assume the 2° fate in some lin-3 
hypomorphic mutant animals in response to the lowered level of lin-3 
activity. In the hypomorphic mutant animals, P6.p has been observed to 
assume the 3° fate, the 1 o fate, and hybrid vulval/non-vulval fates, but not the 
2° fate (Fig. 3). Thus, the lin-3 hypomorphic mutations have not been 
observed to provide a dose of lin-3 activity that specifies P6.p to assume the 
2° fate, although it is possible that this would be observed if a greater number 
of animals was examined. This result can be interpreted in several ways. 
First, the current model that different doses of lin -3 activity specify the 1 o 
and the 2° fates could be wrong. In this case, lin-3 activity would likely only 
promote a VPC to assume a vulval fate. The decision between the 1 o and the 
2° vulval fate would be made by lateral signalling and in the absence of 
lateral signalling a VPC assumes the 1° fate. This model does not explain 
why isolated VPCs have assumed the 2° fate in other experiments (Hill et al. 
In preparation, Sternberg and Horvitz 1986). A second possibility is that it is 
hard for technical reasons to achieve the dose of lin-3 activity that specifies 
the 2° fate in the lin-3 mutant animals. For example, the dose of lin-3 
activity that promotes the 2° fate could be narrow and it may be difficult for 
P6.p to receive this dose since it is close to the source of Lin-3. Alternatively, 
a feedback mechanism between the anchor cell and P6. p may act to move the 
production of lin-3 activity out of the dose range that specifies the 2° fate. 
Thus, in a lin-3 mutant animal, the anchor cell either does not make enough 
inductive signal to induce P6.p, in which case P6.p assumes the 3° fate. Or 
the anchor cell produces enough inductive signal to induce P6.p, P6.p signals 
the anchor cell that it is induced, and the anchor cell up-regulates production 
of the inductive signal such that P6.p is induced to assume the 1 o fate. If the 
lack ofP6.p assuming the 2° fate in lin-3 hypomorphic mutants is due to 
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feedback mechanisms that involve the anchor cell, then it should be possible 
to achieve the dose of lin-3 activity that specifies the 2° fate from a transgene 
that expresses Lin-3 under the control of a heat shock promoter. There are 
animals in which P5.p or P7.p is the only induced cell and this cell assumes 
the 2° fate. This situation is difficult to interpret, since if the inductive signal 
is distributed in a gradient, then P5.p and P7.p should only assume a vulval 
fate when P6.p is also induced. In this case the VPC may be responding to 
the dose of lin-3 that specifies the 2° fate or it may assume the 2° fate in 
response to lin-3 and lateral signalling among the VPCs. 
The failure to observe P6.p assuming the 2° fate in hypomorphic lin-3 
mutant animals could also be due to the mechanism by which the 2° fate is 
specified. Genetic evidence suggests that activity of the gene lin-12 is 
required to specify the 2° fate (Greenwald et al. 1983). In the current model 
oflateral signalling, lin-12 is normally activated in one cell by a lateral signal 
from a neighboring cell and that the neighboring cell produces the lateral 
signal in response to lin-3 activity. Given these two points, it is unclear how 
an isolated VPC assumes the 2° fate since the 2° fate requires lin-12 activity 
and there is no lateral neighbor to activate lin-12. Although it is relatively 
certain that an isolated VPC is not receiving lateral signal from other VPCs, 
the status of the molecules involved in lateral signalling in the isolated VPC 
is unclear. Thus, an isolated VPC may assume the 2° fate by engaging in 
autocrine signalling between the ligand for Lin-12 and Lin-12, or by 
interacting with cells other than the VPCs. Still this apparent paradox of 
how an isolated VPC assum es the 2° fate could be the problem in specifying 
P6.p to assume the 2° fate in the lin-3 hypomorphic mutant animals. Thus, 
in a particular animal, P6.p may receive a dose of the lin-3 activity that 
normally promotes the 2° fate. However, there is not enough lin-3 activity to 
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induce either P5.p or P7.p to assume a vulval fate. Therefore P6.p receives no 
lateral signal and thus assumes the 1 o fate by default. In this model there 
are doses of lin-3 activity that specify the 2° fate, but the specification of the 
2° fate is a two step mechanism. 
hybrid fates 
Hybrid vulval/non-vulval lineages are seen in many lin-3 hypomorphic 
mutant animals. The existence of these hybrid lineages can not be simply 
explained in the current model of vulval development that a VPC chooses one 
of three fates and that its descendants are committed to executing this fate. 
Hybrid vulval/non-vulval lineages are observed in many other genotypes that 
lower the activity of the vulval inductive pathway and are thus not a unique 
feature of lin-3 mutants. As discussed in the methods section it is not always 
possible to conclude with certainty whether the vulval half of a hybrid lineage 
is half of a 1 o or of a 2° lineage because there is a limited number of cell 
divisions and progeny to examine. The most common hybrid lineage in the 
hypomorphic lin-3 mutant animals is a hybrid lineage ofP6.p that may be a 
1°/3° hybrid. It is not clear from the current data whether the hybrid fates 
are specified by particular dose ranges of lin-3 activity. Nor is it clear how 
the hybrid fates, especially the 1°/3° hybrid, should be classified. 
These hybrid lineages could be explained by several models. First, in 
response to intermediate or low levels of the inductive signal, a VPC could 
choose a fate that is not maintained by its daughters. Second, when there is 
a low level of lin-3 activity, the process of fate determination may not always 
occur before the VPC divides and thus the daughters of the VPC can make 
independent fate choices. Third, the hybrid fates could be generated by a 
hypothetical "boundary" signal that refines the border between vulval and 
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non-vulval cells by instructing cells that receive low amounts of the inductive 
signal to assume the 3° fate. lfthis boundary signal can act on the daughters 
of the VPCs, then a hybrid lineage would result when one of the daughters of 
an induced VPC was specified to assume an epidermal fate by the boundary 
signal. If the hybrid lineages consistently appear in locations that are proper 
for the vulval half of the lineage such that P6. p undergoes hybrid 1°/3 o 
lineages and P5.p undergoes 2°/3° lineages, then this would suggest that the 
hybrid lineages are created by mechanisms that act after the VPCs have 
chosen their fate in response to the inductive and lateral signals. 
summary of patterns in hypomorphs 
If the inductive signal is distributed in a gradient, then when lin-3 
activity is lowered genetically the inductive signal should be distributed in a 
gradient that is reduced in amplitude and extent. A population ofVPCs 
should respond to the residual inductive signal in a spatially graded manner. 
The action of other signals among the VPCs, however, could mask the graded 
response of the VPCs to the inductive signal. Four features of the patterns of 
VPC fate choice in hypomorphic lin-3 mutants are difficult to explain in the 
"three-signal" model: the presence of non-graded fate patterns, the presence 
ofhybrid vulval/non-vulval fates, cooperativity in the extent of induction, and 
the lack of a dose range of lin-3 activity that results in P6.p assuming the 2° 
fate. A hypothetical "boundary signal" that causes some of the VPC 
daughters to assume an epidermal fate after initiating a vulval fate could 
explain both the non-graded patterns of fate and the presence of hybrid 
vulval/non-vulval fates. Positive feedback in the production of the inductive 
signal could explain both the cooperativity in the extent of induction and the 
failure ofP6.p to assume the 2° fate. 
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Consequences of Lin-3 overexpression on fate pattern 
Transgenes made up of multiple copies of lin-3 genomic DNA clones 
are proposed to overexpress the Lin-3 protein from the AC and can cause all 
six of the VPCs to assume vulval fates (Hill and Sternberg 1992). A cell 
lineage analysis of the VPCs in the lin-3 transgenic animals indicates that 
adjacent VPCs close to the anchor cell can both assume the 1 o fate. Thus, the 
lin-3 transgenes overcome the lateral signalling among VPCs that is normally 
sufficient to prevent adjacent VPCs from assuming the 1 o fate. This result 
can be interpreted in two ways. First, a high level of lin-3 activity could 
direct a VPC to assume the 1 o fate, even if the VPC is receiving the lateral 
signal. If so, then the dose of lin-3 activity made by the anchor cell is 
important in establishing the proper 2° 1 o 2° pattern of fates because lateral 
signalling among the VPCs is not sufficient to ensure that only one VPC 
assumes a 1 o fate in response to high levels of lin-3 activity. Second, the lin-3 
trans genes could interfere with the action of the lateral signal. For example, 
when Lin-3 is overexpressed, Lin-3 may bind to Lin-12 and prevent Lin-12 
from being activated by the lateral signal. Thus, adjacent VPCs assume the 
1° fate in response to lin-3 activity because they do not receive the lateral 
signal It would be possible to test the model that lin-3 transgenes interfere 
with the transmission of the lateral signal by examining the epistasis of lin-3 
transgenes with lin-12 mutations that are active in the absence of the lateral 
signal. Transgenes that express the cytoplasmic domain of the Lin-12 protein 
promote the VPCs to assume 2° fate and it is believed that these truncated 
Lin-12 proteins are constituitively active (Roehl and Kimble 1993, Struhl et 
al. 1993). If a high level of lin-3 activity specifies the 1 o fate, then the lin-3 
transgenes should promote adjacent 1 o fates in animals also bearing the lin-
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12 transgenes. If the lin-3 transgenes interfere with the transmission of the 
lateral signal , then the lin-3 transgenes should not cause adjacent 1 o fates in 
animals also bearing the lin-12 transgenes. 
It was previously known that the inductive signal could specify a single 
VPC to assume the 1° fate in animals bearing lin-12( d) mutations since when 
an anchor cell is present in a lin-12(d) mutant animal, P6.p adopts the 1° fate 
(Sternberg and Horvitz 1989). Thus for P6.p, the action of the inductive 
signal in specifying the 1 o fate is epistatic to the lin-12(d) mutation in 
specifying the 2° fate. In this experiment the VPCs are presumably exposed 
to a wild-type dose of lin-3 activity and only a single VPC assumes the 1 o fate. 
Thus, this result does not indicate if the inductive signal is epistatic to the 
action of the lateral signal, i.e., whether the inductive signal could cause two 
adjacent VPCs to assume the 1 o fate. The interpretation of this experiment 
depends upon the nature of the lin-12(d) mutation. If the lin-12(d) mutation 
causes constitutive activation of the lateral signalling pathway, then each lin-
12( d) mutant VPC should act as if its neighbors are assuming the 1 o fate and 
should not be sensitive to the actual state of its neighbors. Since a single lin-
12(d) mutant VPC assumes the 1° fate in response to a high dose ofinductive 
signal, each member of a group of lin-12(d) mutant VPCs should assume the 
1° fate ifthey are exposed to a high dose ofinductive signal. However, ifthe 
lin-12(d) mutant VPCs can still engage in lateral signalling, then lateral 
signalling may be responsible for P6.p assuming the 1 o fate in the lin-12(d) 
mutant animals with anchor cells. In this case it could not be predicted how 
two adjacent VPCs would respond to high levels of the inductive signal. 
Thus, the ability of lin-3 transgenes to specify adjacent P fates in a lin-12(+) 
animal is an important confirmation that the inductive signal is epistatic to 
the lateral signal. 
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Since lin-3 transgenes can cause adjacent 1 o fates in animals wild-type 
for lin-12, and since lin-3 activity can cause P6.p to assume the P fate in lin-
12(d) mutant animals, lin-3 transgenes should be able to promote adjacent 1 o 
fates in a lin-12(d) mutant animal. No adjacent 1° fates have been seen in 
lin-12(d)mutant animals bearing a lin-3 transgene although, in some 
animals, adjacent VPCs both have 1 °-like character. This could suggest that 
it is more difficult for lin-3 transgenes to specify adjacent 1° fates in lin-12(d) 
mutant animals than in lin-12(+) animals. Alternatively, since the lin-3 
transgenes provide variable doses of lin-3 activity, it is possible two VPCs 
were not exposed to a high dose of lin-3 activity in any of the examined 
animals. If it is more difficult for the lin-3 transgenes to specify the 1° fate in 
lin-12(d) mutant animals than in lin-12(+) animals, this would suggest that 
the activity of the lin-12(d) mutation is not equivalent to the activity of wild-
type lin-12 that is activated by the lateral signal. For example, perhaps the 
dominant lin-12 mutations result in stronger activation of the 2° fate than 
wild-type lin-12 activated by the lateral signal. Alternatively, the lin-12(d) 
mutations may be less susceptible to negative regulation in VPCs receiving 
the dose of lin-3 activity that specifies the 1° fate. 
The adjacent 1 o fates observed in lin-3 transgenic animals suggests 
that high doses of lin-3 activity specify the 1 o fate and make a cell 
unresponsive to the lateral signal. This does not rule out the possibility that 
at moderate doses of lin-3 activity a VPC can choose either the 1 o or the 2° 
fate in response to the action of the lateral signal. This appears to happen in 
lin-15 mutant animals. Such animals all six VPCs assume vulval fates due to 
a defect in a presumed inhibitory signal that negatively regulates the basal 
activity of let-23 . Since the inhibitory signal is believed to arise in a spatially 
general manner, the let-23 pathway should be activated at an equivalent level 
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in all of the VPCs in a lin-15 mutant in which the inductive signal is absent. 
In such animals the VPCs assume alternating patterns of 1 o and 2° 
fates (Sternberg 1988). Thus the lateral signal can specify a VPC that has a 
moderate level of activity in the let-23 pathway to assume either the 1 o or 2° 
fate. Although adjacent 1 o fates are observed in lin-3 transgenic animals, the 
adjacent 1 o fates are seen only proximal to the anchor cell. The fate patterns 
of the VPCs distal to the anchor cell in lin-3 transgenic animals can resemble 
the patterns of fates in lin-15 mutant animals such that in about half of the 
lin-3 transgenic animals there is a VPC with the 2° fate closer to the anchor 
cell then the furthest VPC assuming the 1 o fate. Since it is extremely 
unlikely that these alternating patterns of 1 o and 2° fates reflect alternating 
high and low levels of lin-3 activity, it is likely that the lateral signal can 
specify a VPC receiving intermediate amounts of lin-3 to assume either the 1° 
or the 2° fate. This indicates that vulval fate choice is not being set only by 
the absolute amount of inductive signal that the VPCs are receiving. 
Insights into the Hyper-Induced Phenotype. 
Mutations that cause a Hyper-INduced (Hin) phenotype in which 
greater than the wild-type number ofVPCs assume vulval fates have been 
described (Aroian and Sternberg 1991, Ferguson and Horvitz 1985). Several 
properties of Hin mutations distinguish them from multivulva mutations in 
genes such as lin-15. First, Hin mutations are a distinct class ofhypomorphic 
mutations in genes such as let-23, lin-2, lin-7 and lin-10 that are believed to 
have anamorphic vulvaless phenotype (Aroian and Sternberg 1991, G. 
Jongeward, personal communication). Multivulval mutations, however, are 
amorphic as in the case of lin-15, (Ferguson and Horvitz 1989, L. Huang, 
personal communication) or are hypermorphic as in the case of let -60 (Beitel 
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et al. 1990, Han et al. 1990). Second, the ability ofHin mutations to cause 
VPCs to assume vulval fates is dependent upon the inductive signal, whereas 
multivulva mutations can confer vulval fates in the absence of the inductive 
signal. Third, adjacent VPCs can assume the 1 o fate in Hin mutant animals 
and this is infrequently observed in lin-15 multivulva mutant animals. A 
simple interpretation of the Hin phenotype is that it is caused by a defect in 
the negative regulation of the let-23 pathway that renders the VPCs hyper-
sensitive to the inductive signal (G. Jongeward and P. Sternberg, personal 
communication). Thus, additional VPCs assume vulval fates in Hin mutant 
animals because they can respond to a level of the inductive signal that is 
beneath the threshold for induction in wild type. However, the presence of 
adjacent 1 o fates in Hin mutant animals was problematic because it was not 
known ifhyperactivity of the response pathway could cause adjacent VPCs to 
assume the 1° fate. The presence of adjacent 1 o fates also suggested that 
there might be a defect in the lateral signal in Hin mutant animals. Our 
results indicate that high levels of the inductive signal can cause adjacent 
VPCs to assume the 1 o fate. Thus, both the increased extent of vulval 
induction and the presence of adjacent 1 o fates in Hin mutant animals can be 
explained by the model that Hin mutant animals are hyper-sensitive to the 
inductive signal and are responding as if there is too much inductive signal. 
We also note that in all hypomorphic lin-3 genotypes examined, that 
induction ofvulval fates is limited to the cells P5.p, P6.p, and P7.p. This 
suggests, as expected, that there is no dose of lin-3 lower than wild-type that 
results in a Hin phenotype. Thus the Hin mutations do not cause the 
response pathway to act as if it is receiving too little inductive signal. 
Is lin-3 a morphogen? 
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A key issue for explaining VPC fate patterning is whether there are 
distinct doses of lin-3 activity that specify each of the three VPC fates. The 
current "three-signal" model ofvulval induction is ambiguous as to the 
relative contribution of the inductive signal and the lateral signal in 
establishing the 2° 1 o 2° pattern of fates assumed by the three induced VPCs. 
It is possible that the induced VPCs choose their fate primarily in response to 
the absolute concentration of Lin-3 that they receive, the morphogen model. 
Alternatively, it is possible that the induced VPCs choose their fate primarily 
through lateral signalling that measures which VPC is receiving more 
inductive signal and which VPC is receiving less inductive signal, the "lateral 
comparison" model. Two experiments support the morphogen model. First, 
high levels of lin-3 activity can cause adjacent cells to adopt the 1 o fate, which 
suggests that there is a dose of lin-3 activity that instructs a VPC to assume 
the 1 o fate and to ignore input from the lateral signal. Second, isolated VPCs 
that have no neighboring VPCs with whom they can signal, can assume the 
2° fate. This suggests that there is a dose of the inductive signal that can 
specify the 2° fate without input from the lateral signal stating that another 
VPC is receiving more inductive signal. Two observations, however, support 
the "lateral comparison model." First, in hypomorphic lin-3 mutant animals, 
P6.p has not been observed to assume the 2° fate. If an intermediate dose of 
lin-3 activity promotes the 2° fate, it would be predicted that certain 
hypomorphic lin-3 genotypes would commonly expose P6. p to this dose. 
Second, in some cases such as in lin-15 mutant animals, VPCs appear to 
choose between the 1° and the 2° fates in response to lateral signalling and 
not in response to the absolute concentration of inductive signal they receive. 
The relative contribution of the level of the inductive signal and the 
action of the lateral signal in controlling VPC fate choice could be determined 
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by measuring the fate choice of an isolated VPC in response to different doses 
of lin-3 activity and comparing this to the fate choices of groups ofVPCs in 
response to the same doses of lin-3 activity. The current lin-3 genetic 
reagents have limitations for establishing a dose response curve of VPC fate 
as a function of lin-3 activity. The hypomorphic lin-3 mutations have the 
disadvantage that they do not provide a means of challenging any VPC other 
than P6.p with a high dose of lin-3, or a means of controlling lin-3 dose 
independently ofVPC position. Thus for example, it is not possible to 
challenge P5.p and P6.p with the same level of inductive signal to see if the 
lateral signal causes them to assume different fates. The gain-of-function lin-
3 transgenes, which are created by a method that generates high copy 
number extrachromosomal arrays (Mello et al. 1991), also present technical 
difficulties. The existing transgenes do not provide different effective doses of 
lin-3 activity. They are also genetically unstable and do not provide a 
consistent dose of lin-3 activity from one animal to the next. As was seen 
earlier, this complicated comparison of the action of lin-3 transgenes in 
animals of different lin-12 genotypes. 
It should be possible to design lin-3 transgenes that avoid these 
limitations. The transgenes that express the EGF domain ofLin-3 under the 
control of a heat shock promoter (hspLin3) provide a means of controlling the 
dose of lin-3 activity independently of the position of a VPC. These 
transgenes can be activated in a spatially general manner by heat shock of 
the entire animal, or possibly, in a single cell by activation in response to an 
attenuated laser micro beam (Stringham and Candido 1993). Low copy-
number, chromosomally integrated transgenes would provide doses of lin-3 
activity that are lower, and which are more consistent from animal to animal. 
Chromosomally integrated transgenes can be obtained in an oocyte injection 
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protocol (Fire 1986) and low copy number transgenes can be obtained by 
coinjection of a plasmid containing the sup-7 gene, which is lethal at high 
copy number (Fire et al. 1990). 
Low copy number, chromosomally integrated, hspLin3 transgenes 
could be used in experiments that test VPC fate choice in response to 
different doses of lin-3 activity. These transgenes could be tested in gonad-
ablated, reduction-of-function lin-3 mutant animals so that there was no 
source of lin-3 activity other than the transgene. The fate of an isolated VPC 
could be examined upon different amounts of heat shock activation of the 
transgene. Such experiments could define stimulation conditions for 
reference lin-3 transgenes that specify different fates. In particular, these 
experiments would determine whether there is a distinct dose of lin-3 activity 
that consistently specifies the 2° fate. It would then be possible to examine 
the fates assumed by pairs ofVPCs in response to the same stimulation 
conditions to see if lateral signalling among the VPCs modifies fate choice. 
For example, if a pair of VPCs is challenged with the minimal dose of lin-3 
activity that induces an isolated VPC to assume the 1 o fate, will both VPCs 
assume the P fate, or will one of them assume the 2° fate? Likewise, if two 
VPCs are challenged with the dose of lin-3 activity that causes an isolated 
VPC to assume the 2° fate, will both VPCs assume the 2° fate, or will one 
VPC now assume the 1 o fate? The generation of reference transgenes that 
provide consistent doses of lin-3 activity would also be useful in examining 
how different mutations affect the fate choice of the VPCs in response to 
defined induction conditions. 
How do the VPCs respond in a graded manner? 
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In the" three-signal" model ofVPC fate determination, an inductive 
signal is distributed in a gradient around the anchor cell and the VPCs 
choose different fates in response to the amount of inductive signal they 
receive. An interesting problem is how the graded information provided by 
the inductive signal is transmitted within the responding VPCs. The graded 
response of the VPCs could be explained by two models. First, the graded 
information provided by the inductive signal could be conveyed by the graded 
activation of a single response pathway. Thus, each component of the let-23, 
sem-5, let-60, lin-45 pathway would need to activated in proportion to the 
amount of inductive signal that the VPC received. At the end of this 
pathway, high levels of activity would cause the VPC to assume the 1 o fate 
and intermediate amounts of activity would cause the VPC to assume the 2° 
fate. This model makes two predictions about the patterns ofVPC fates in 
different mutant animals. First, if the response pathway carries graded 
information at each step, then hypomorphic mutations that lower the activity 
of the pathway at any step should result in a low average level of vulval 
induction that is preferentially centered around the anchor cell. The fate 
patterns conferred by most mutations that disrupt the response pathway has 
not been extensively examined. In let-23(sy1) homozygotes, however, 
approximately one third of the animals that have vulval induction have 
induction in a non-graded pattern (P. Sternberg, R. Aroian, G. Jongeward, 
personal communication). This could indicate that the let-23 pathway is not 
carrying graded information, or that other interactions among the VPCs is 
disrupting this pattern. Second, since this model implies that high levels of 
activity in the response pathway specify the 1 o fate, gain-of-function 
mutations in any step of the pathway should cause adjacent VPCs to assume 
the 1 o fate. This means that there should be adjacent 1 o fates in let-60 gain-
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of-function mutant animals. The alternative model is that the graded 
information provided by the inductive signal results in the combinatorial 
activation of parallel response pathways. For example, let-23 is activated in 
proportion to the amount of lin-3 activity present and high levels of let-23 
activity in P6.p stimulates two pathways and intermediate levels of let-23 
activity in P5.p and P7.p stimulates a single pathway. Input from both 
pathways in the nucleus of P6. p would specify the 1 o fate; input from one 
pathway in P5.p and P7.p would specify the 2° fate. One advantage of this 
model is that it avoids the prediction that each member of the let-23 pathway 
acts in a graded fashion. Another advantage is that the second signalling 
pathway activated in response to high levels of the inductive signal could be 
the lateral signalling pathway mediated by lin-12. In this case high amounts 
of let-23 activity in P6.p cause activation of the lateral signal which promotes 
P5.p and P7.p to assume the 2° fate. It is unknown how the lateral signalling 
pathway mediated by lin-12 and the inductive signalling pathway of let-23, 
sem-5, let-60, and lin-45 interact. Thus another way of examining how the 
graded information is carried within the VPCs may be to determine at what 
step the let-23 pathway affects the lateral signalling pathway. 
Other Models, Other Signals. 
Two-step models 
The main alternative to the "three-signal model" is a sequential "two-
step model" (Sternberg and Horvitz 1986). In the "two-step model" the AC 
induces P6.p to be 1° and then P6.p sends a signal that induces P5.p and P7.p 
to be 2°. The strongest point of evidence against the two step model is that 
an isolated VPC can assume the 2° fate, indicating that a signal from a VPC 
assuming the 1 o fate is not required for another VPC to assume the 2° fate 
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(Hill, et al. in preparation, Sternberg and Horvitz 1986). The only 
characterized lateral signal that acts between the VPCs is the lateral 
signalling pathway that involves lin-12. This lateral signalling pathway is 
believed to regulate whether VPCs induced by lin-3 activity assume the 1 o or 
2° fate and is not believed to be a signal from a 1 o VPC that induces its 
neighbors to assume the 2° fate since in animals homozygous for amorphic 
lin-12 mutations, the number ofVPCs that assume vulval fates does not 
appear to be decreased (Sternberg and Horvitz 1989). This experiment is 
complicated by the fact that there are multiple anchor cells in amorphic lin-
12 mutant animals. So it remains possible that a decrease in the extent of 
vulval induction due to loss of the lateral signal is counteracted by increased 
production of lin-3 activity. The model that lin-12 has no role in controlling 
the number ofVPCs that assume vulval fates could be confirmed by two 
related experiments. First, the extent of vulval induction could be examined 
in amorphic lin-12 mutant animals in which the development of more than 
one anchor cell has been prevented by ablation of gonadal precursor cells. If 
lin-12 has no role in controlling the extent of vulval induction then exactly 
three VPCs should be induced in amorphic lin-12 mutant animals with only 
one anchor cell. Second, these experiments could be repeated in animals also 
bearing hypomorphic lin-3 mutations. Since these animals produce low 
amounts of the inductive signal, any change in the extent of induction caused 
by the loss of lin-12 activity would be easy to detect. The fact that P5.p and 
P7.p can assume vulval fates in amorphic lin-12 mutant animals indicates 
that they can assume vulval fates without the action of the lateral signalling 
pathway. It remains possible that in wild-type development, P5.p and P7.p 
assume the 2° fate not in response to lin-3 but in response to a lateral signal 
from P6.p. This lateral signal could be mediated by lin-12 or could be a novel 
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signal. It is possible to explicitly test whether P5.p assumes a vulval fate due 
to any lateral signals from P6.p by examining animals that are genetically 
mosaic for let-23. An animal that has wild-type let-23 activity in P6.p and 
which has no activity of let-23 in P5.p serves as a test case. IfP5.p assumes a 
vulval fate in response to the inductive signal, then P5.p will assume a 3° fate 
in this mosaic animal because P5.p will not be able to respond to the 
inductive signal. IfP5.p assumes a vulval fate in response to lateral signals, 
then P5.p will assume the 2° fate in this mosaic animal, because P6.p will be 
induced by the inductive signal and P6.p will be able to laterally signal P5.p 
to assume a vulval fate . 
Boundary signals 
The existence of a "boundary" signal that regulates whether a VPC 
should assume a 3° or 2° fate in response to low levels of lin-3 activity has 
been invoked to explain both the non-graded patterns of vulval induction seen 
in hypomorphic lin-3 mutant animals and the existence of hybrid vulval/non-
vulval fates . The existence of a boundary signal is appealing for theoretical 
reasons, since it would have a similar function in the 2°/3° fate choice that the 
lin-12 lateral signal has in the 1°/2° fate choice. For P6.p and P5.p the 
graded distribution of lin-3 activity should promote P6.p to assume the 1 o fate 
and P5.p to assume the 2° fate. The lin-12lateral signal measures 
differences in the amount of inductive signal received between P5.p and P6.p 
to ensure that P5.p assumes the 2° fate and P6.p assumes the 1 o fate. 
Likewise, for P5.p and P4.p the low levels of lin-3 received by P4.p should 
cause P4.p to assume the 3° fate, but the action of a boundary signal that 
measures that P4.p is receiving less signal than P5.p would ensure that P4.p 
assumes the 3° fate. Some experimental evidence for the existence of a 
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boundary signal has been obtained (J. Simske, and S. Kim, personal 
communication). In animals heterozygous for hypermorphic let-60 mutations, 
there is a low level of constitutive activity in the response pathway of the 
VPCs such that when the inductive signal has been removed by ablation of 
the gonad, an intermediate number ofVPCs assume vulval fates. In such 
animals, P8.p often assumes a vulval fate when it has been isolated by 
ablation of its lateral neighbors, but rarely assumes a vulval fate when it has 
lateral neighbors. This suggests that when a VPC has low levels of activity in 
the let-23 pathway, the decision to assume a vulval fate is influenced by its 
neighbors. An experimental test ofwhether a boundary signal is responsible 
for hybrid fate patterns in hypomorphic lin-3 mutant animals could be a 
useful confirmation that the boundary signal exists. 
Materials and Methods. 
Vulval induction. 
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The extent of vulval induction was determined by examining the 
number and size of nuclei in the ventral epidermis at single time point per 
animal from the late-L3 to mid-L4 developmental stages as in (Aroian and 
Sternberg 1991). At this time the 3° lineage has produced two nuclei and the 
1° and the 2° lineages are undergoing or have completed the third round of 
nuclear divisions. The progeny of the 3° lineage are larger and syncytial and 
the progeny of the 1 o and the 2° lineages are smaller and cellular. The 
number ofVPCs that have assumed vulval fates can usually be determined 
by the number and sizes of the nuclei present. In some cases, it can be 
determined with some certainty whether a VPC has assumed the 1 o or the 2° 
fate. 
A given lin-3 heterozygous genotype was examined by setting up a 
mating in which the desired genotype was the only genotype present with a 
wildtype (non-Unc non-Dpy) phenotype. The general mating is lin-3(allelel) 
I ( lin-3(allelel) OR ( unc-24(e138) mec-3(e1338) dpy-20(e1282))) males by 
lin-3(allele2) dpy-20(e1282) I nTl[ unc(n754d)let ]; + I nTl hermaphrodites. 
nTl[unc(n754d)let] is a chromosomal translocation that suppresses 
recombination in the lin-3 region and which confers dominant Unc and 
recessive lethal phenotypes. Among the F1 self and cross progeny of this 
mating the only worms with a nonUnc non-Dpy-20 phenotype are of the 
genotype lin-3(allelel) I lin-3(allele2). Each lin-3 allele was tested for 
whether it caused a dominant defect in vulval induction by examining the F1 
non-Unc non-Dpy cross progeny of the mating N2 males by lin-3(allelel) dpy-
20(e1282) I nTl[unc(754d) let] hermaphrodites. Hemizygous lin-3 genotypes 
were examined by using the same genetic strategy but with hermaphrodites 
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of the genotype sDf64 unc-31 I nT1[unc(n754d)let]. sDf64 uncovers genetic 
markers that flank lin-3 on the left and right including dpy-20 and let-60 and 
fails to complement lin-3 mutations. 
Lineage analysis. 
Lineages were obtained by direct observation of the nuclear divisions 
in living animals under Nomarski optics as described (Sulston and Horvitz 
1977). Lineages of lin-3 transgenic strains were typically started in the L3 
stage before the second round of cell divisions in the VPC lineages has 
started. At this point the 1 o and 2° lineages are indistinguishable and thus a 
population of worms selected for lineage analysis at this stage should not be 
biased for particular patterns of 1 o and 2° lineages. Starting the lineages at 
the two cell stage is also necessary to ensure that the lineal history of the 
vulval progeny is assigned correctly, since in some lin-3 transgenic animals 
the grand progeny of the VPCs proximal to the AC intermingle and thus their 
lineal history can only be assigned by direct observation of the second round 
of cell division. 
Lineages of heterozygous lin-12 mutant animals bearing lin-3 
transgenes were obtained by examining non-Unc-31 non-Unc-32 non-Dpy-19 
segregants from the strain PS1274 for the presence of an AC. The lineages of 
the VPCs were followed in animals that had an AC and which could thus 
express the lin-3 transgenes. 
Fate assignments ofVPC lineages. 
The wild-type 2° lineage is LLTN and the progeny undergo an 
asymmetric invagination in which the daughter s of the L cells adhere to the 
ventral cuticle . The wild-type 1 o lineage is TTTT and the progeny undergo a 
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symmetric invagination. The following lineage features are considered to 
characteristics of the 2° lineage: i) progeny cells that adhere to the cuticle; ii) 
an invagination that initiates beneath one lateral half of the lineage; iii) VPC 
progeny dispersed at the 4-cell stage; iv) presence of aN-like nucleus that 
remains small, moves dorsal and either does not divide or divides late; v) 
proper division axes. The following lineage features are considered to be 
characteristics of a 1 o lineage: i) lack of adherence to the ventral cuticle; ii) 
an invagination that initiates beneath the two central grandprogeny, iii) 
VPC progeny spaced closely at the 4-cell stage; iv) timing pattern in which 
two outside cells divide well before the two inside cells; v) proper division 
axes. The division axis is not an absolute indicator of fate. For example, 
there are a number of examples in which P3.p or P8.p assumed a fate that is 
typical of a 1 o fate except that the lineage is LTTL. The most important 
feature for assigning the 2° fate is the presence of adherent progeny. 
Otherwise the most important feature for distinguishing 1 o from 2° fates is 
the morphogenesis displayed by the progeny. Progeny of a 1 o lineage should 
invaginate symmetrically and early compared to progeny of a 2° lineage. 
Cells from adjacent 1 o lineages should crowd together and invaginate as a 
group with no attachment to the cuticle. Morphogenesis is sometimes 
ambiguous in multivulva mutant animals because the timing and extent with 
which the progeny of a VPC invaginate is affected by its environment. The 
progeny of a 1 o lineage may invaginate more fully if it is beneath the AC. The 
progeny of a 2° lineage may invaginate more quickly if it is cooperating with a 
1 o fate. 
It is often ambiguous whether the vulval half of a hybrid vulval/non-
vulval fate is 2°-like or 1 °-like fate . Both halves of a 1 o lineage produce 4 
vulval nuclei that do not adhere to the ventral cuticle. The half of the 2° 
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lineage proximal to the anchor cell in wildtype produces 3 non-adherent 
vulval nuclei and the half of the 2° lineage distal to the anchor cell in 
wildtype produces 4 nuclei that adhere to the vulval cuticle. In some 
instances, for example in wildtype at 25°C or in lin-3 transgenic animals the 
half of the 2° lineage proximal to the anchor cell produces 4 vulval nuclei and 
it is not yet evident whether this happens in hypomorphic lin-3 mutant 
animals. Hybrid vulval/non-vulval P6.p lineages often produce 1 syncytial 
nucleus and 4 non-adherent vulval nuclei and thus appear to be hybrid 3°/1 o 
fates. They could, however, be hybrid 3°/2° hybrids in which there is an extra 
division in the 2° part of the lineage. If the vulval cells adhered to the anchor 
cell then this would indicate that they had 1 o character. Hybrid lineages of 
P5.p and P7.p often include 1 syncytial nucleus and three non-adherent 
vulval nuclei and thus appear to be 3°/2° fates. Hybrid fates with 1 syncytial 
nucleus and 4 adherent nuclei have not been noted in hypomorphic lin-3 
mutant animals. 
Strains. 
Strains were maintained at 20° Cas described in (Brenner 1974) . 
BC3203 sDf64 unc-31(e169) I nTl IV;+ I nTl V 
CB169 unc-31(e169) 
CB1417 lin-3 (e1417) 
MT2375 dpy-19(e1259) lin-12(n137) I unc-32(e189) lin-12(n676n909); 
him5(e1467 
N2 
PS97 lin-3(el417); him-5(e1490) 
PS98 lin-3(n378) 
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PSlOO lin-3(n378); him-5(e1490) 
PS377 nTl[unc(n754d) let] lunc-22(s7) unc31(e169) IV; nTl I+ V 
PS472 nTl[unc(n754d)let] llin-3(n1058) IV; nTl I+ V 
PS484 nTl[unc(n754d) let] lunc-24(e138) lin-3(n1059) dpy-20(e1282) IV; 
nTll+ V 
PS519 lin-3(sy91) 
PS877 nTl[unc(n754d)let] l mec-3(e1338) lin-3(sy53) dpy-20(e1282) V; nTl I + 
v 
PS1167 lin-3(sy91); him-5(e1490) 
PS1213 unc-31(e169); syEx13 
PS1232 nTl[unc(n754d)let] I lin-3(n1058) dpy-20(e1282) V; nTl I+ V 
PS1244 nTl[unc(n754d) let] I lin-3(sy91) dpy-20(e1282) IV; nTl I+ V 
PS1245 dpy-19(e1259) lin-12(n137) lunc-32(e189) lin-12(n676n909); unc-
31(e169) 
PS1274 dpy-19(e1259) lin-12(n137) I unc-32(e189) lin-12(n676n909); unc-
31(e169); syEx13 
PS nTl[unc(n754d) let] I lin-3(n378) dpy-20(e1282) IV; nTl I+ V 
PS nTl[unc(n754d)let] lsDf64 unc-31(e169) V; nTl I+ V 
PS unc-31(e169); syls aka VII, putative integrant of syEx13 
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Figures and Tables. 
Figure 1. Three-signal model of VPC fate determination. 
The anchor cell of the somatic gonad is proposed to release the Lin-3 
inductive signal in a gradient. In response, the three more proximal of the 
six Vulval Precursor Cells (VPCs) are induced to assume vulval fates. A 
lateral signal among the induced VPCs promotes the 2° fate and inhibits 
adjacent VPCs from assuming the 1 o fate. The three induced VPCs assume a 
pattern of fates of 2° 1 o 2°. An induced VPC may choose between the 1 o fate 
or the 2° fate either in response to the absolute level of Lin-3 that it receives 
or in response to lateral interactions whose outcome is biased by the graded 
distribution of Lin-3. An inhibitory signal that may arise from the hyp7 
syncytial epidermis prevents the VPCs from assuming vulval fates in the 

























































































































































Figure 2. Patterns of vulval induction in lin-3 hypomorphic mutant animals. 
In the pattern box on the left, each row represents a different pattern 
of VPC fate choice. Each circle represents one of the six VPCs with the circle 
on the left being P3.p and the circle on the right being P8.p. An empty circle 
represent a VPC that has assumed the 3° epidermal fate and a black circle 
represents a VPC that has assumed a 1 o or 2° vulval fate. Circles that are 
half-filled represent hybrid vulval fates. Asymmetric patterns that are 
mirror images of each other are represented as one pattern. For example, an 
animal in which P5.p and P6.p have assumed vulval fates is considered to be 
equivalent in pattern to an animal in which P6.p and P7.p have assumed 
vulval fates. A pattern is considered to be graded when only the VPCs closer 
to the AC have assumed vulval fates. Any pattern that has a VPC with an 
epidermal fate closer to the AC than a VPC with a vulval fate is considered to 
be non-graded. The graded patterns are placed as a series in the top of the 
left box and the non-graded patterns are placed in the bottom of the left box. 
Each box to the right of the pattern box represents a particular lin-3 
genotype. The percentage of animals of that genotype with a given pattern of 
fate choice is represented as a bar on the same line as the given pattern in 
the pattern box. For example, in 66% of n378 homozygote animals no VPCs 
assumed vulval fates. This graphic representation allows a rapid visual 
analysis of the trends in patterning in different lin-3 genotypes. In n378 
mutant animals most induction patterns are graded. The distribution of fate 
patterns is simple with most animals having little of no vulval induction and 
only rare animals having more than 1 induced VPC. In sy91, n1058, and 
n378 I sy53 mutant animals the distribution of fate patterns is complex and is 
not clustered on a single average value. There is a high fraction of animals 
with three induced VPCs in each of these genotypes. 
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Figure 2A. 


























































Figure S. VPC fate choice in lin-3 hypomorphic mutants. For some of the lin-
3 mutant animals in Figure 2, it is possible to determine if an induced VPC 
assumed a 1° or 2° fate. In general P6.p assumes either the 1 o fate, the so 
fate or a hybrid vulval/non-vulval fate, but not the 2° fate; and P5.p and P7.p 
assume either the 2° fate, the so fate or a hybrid vulval/non-vulval fate but 
not the 1° fate. Shown in the figure are the fate choices ofVPCs that are the 
only VPC to assume a vulval fate in an animal, and which have not assumed 
a hybrid vulval/non-vulval fate. P6.p assumed the 1 o fate in the single case in 
which it was the only induced VPC. In the 6 cases in which P5.p or P7.p was 
the only induced VPC it assumed the 2° fate in all six cases. Notably absent 
are cases in which P6.p has assumed the 2° fate. It was not possible to 
determine VPC fate choice in all animals and it is easier to analyze some fate 
patterns then others. Thus there is an observational bias for the frequency of 
some fates if the entire panel of lin-3 mutant animals is considered. The fate 
choice of a single responding VPC though is easy to determine so the 
population of single responding cell animals should not be subject to such 
observational biases. In some lin-3 mutant animals the number and position 

















































































































Figure 4. Lineage diagrams of lin-3 transgenic animals. 
The lineage diagrams of two animals from Table2A is shown. In animal 
3B, P4.p, P5.p, and P6.p have 1° fates. In animal 3D, P4.p, P5.p P6.p and 
P7.p have 1° fates . The pattern of grandprogeny subfates often appears to be 
altered in lin-3 transgenic animals when there are adjacent 1 o fates. In wild-
type the two outer granddaughters are considered to be of one cell type and 
the two inner granddaughters are considered to be of a second cell type. The 
outer granddaughters divide early and the inner granddaughters divide late 
and associate with the AC. In animal 3D, the grandprogeny ofP4.p, P5.p and 
P6.p divide in an alternating pattern of early and late divisions. Alternating 
patterns of early and late divisions have been seen in amorphic lin-12 mutant 
animals in which there are also adjacent 1 o fates (P. Sternberg, personal 
communication). The lineage is represented according to convention (Sulston 
and Horvitz 1977). Vertical lines represent cells and a horizontal line 
represents a cell division The dotted lines indicate condensed time. In 
animal3B, P7.paa ultimately divided in a transverse axis 45 minutes after 
ecdysis. The lineage of animal 3D was started at the 2-cell stage. The 
lineage of animal 3D was stopped for technical reasons. 
Table 1 Extent of vulval induction as a function of lin-3 genotype. 
The number ofVPCs assuming vulval fates in different lin-3 genotypes 
is examined. Abbreviations: self: self progeny of a strain homozygous for a 
viable lin-3 allele. The level of vulval induction in these strains could be 
subject to maternal affects. 1: percentage induction as defined in (Aroian and 
Sternberg 1991), such that I= ( (number ofVPCs assuming vulval fates per 
animal in an experimental population) divided by 3, the number ofVPCs 
assuming vulval fates per animal in wildtype) times 100. Induction can 
range from 0% when no VPCs assume vulval fates to 200% when all six VPCs 
D-46 
assume vulval fates. Wild-type induction of three VPCs is equal to 100% 
induction. Animals heterozygous for the genetic deficiency sDf64 that 
uncovers lin-3 and let-60 have a slight defect in the extent of vulval induction, 
and a defect in the location of induction. In three of these animals P[4-6].p 
assumed vulval fates. It remains to be established whether a defect in the 
positioning of the anchor cell in these animals is responsible for the defect in 
induction. sDf64 also uncovers the let-60 locus which is also required for 
vulval induction. The pattern of fates of the lin-3(-) I lin-3( +) animals are all 
wildtype. n: number of animals examined. let: the given genotype confers 



























































































































































































































































































































Table 1. Extent of vulval induction as a function of lin-3 genotype. 
Paternal 
wild type self 
I n I n 
Maternal 
sy91 100 25 38 51 
n378 100 25 11 53 
n1058 100 25 28 49% 
sy53 100 25 let 
sDf64 26 98 
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Table 2. Vulval lineages of lin-3 transgenic animals. 
A. The lineages assumed by animals bearing the transgene syEx13 
which contains multiple copies of a 5-kb lin-3 genomic clone(Hill and 
Sternberg 1992) are examined. syEx13 can cause all six ofthe VPCs to 
assume vulval fates and is believed to over-express Lin-3 from the AC. 
Adjacent VPCs have 1 o like fates in 4 of 12 syEx13 mutant animals. In two of 
these animals there are at least three contiguous VPCs with the 1 o fate such 
that there is a 1° VPC which has 1 o VPCs for both lateral neighbors. This 
result suggests that the response pathway of the VPCs can not prevent 
adjacent VPCs from assuming 1 o fates in response to high levels of lin-3 
activity. 
B. The fate choice of VPCs in animals bearing the lin-3 transgene 
syEx13 and a hypermorphic lin-12 mutation (lin-12(d))are examined. lin-
12(d) mutations cause all ofthe VPCs to assume the 2° fate, even in the 
absence of the inductive signal. Animals heterozygous for a lin-12(d) and a 
putative null allele of lin-12 were examined because they can have an AC 
whereas lin-12(d) homozygotes never have an AC more infrequently 
(Greenwald, et al. 1983). The ability of the inductive signal produced 
endogenously by the ACto promote P6.p to assume the 1 o fate is epistatic to 
the action of lin-12(d) mutations in promoting the 2° fate (Sternberg and 
Horvitz 1989). In all9 of the lin-12 heterozygous animals that have an AC, 
P6.p assumed the 1 o fate. In six of the animals a VPC in addition to P6.p 
assumed a 1 o or 1 o like lineage, which indicates that syEx13 can override the 
action of the lin-12(d) mutation to promote the 1 o fate. There are no cases in 
which adjacent VPCs assumed 1 o fates in the 9 animals, although in 2 cases, 
(key numbers 5G3, 5D4) P6.p assumed a 1 o fate and a lateral neighbor of 
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P6. p assumed a fate with features of 1 o and 2° fates. These lineages are 1 o 
like in their lineage and morphogenesis except that a single grandprogeny 
adhered to the cuticle. The number of animals lineaged is too small to 
determine if the ability of syEx13 to promote adjacent 1 o fates in a lin-12( d) 
mutant animal is lower that its ability to promote adjacent 1 o fates in an 
animal wild-type for lin-12. In three animals only P6.p assumed the 1° fate. 
syEx13 is lost at a high frequency during mitosis and these animals could be 
chimeras that lack syEx13 in the AC. 
Abbreviations. Lineages are represented as by a single letter code for 
the behavior of each cell (Sternberg and Horvitz 1986). T: PN.pxx nucleus 
divided in a transverse axis. L: PN.pxx nucleus divided in a longitudinal 
axis. 0: PN.pxx nucleus divided in an oblique axis. D: PN.pxx nuclei 
divided but the axis of division was unobserved. N: PN.pxx nuclei did not 
divide or divided more that 30 minutes after ecdysis. S : PN.p or PN.px 
nucleus joined epidermal syncytium. ?: Behavior of cell could not be 
determined, for example, animal lost during lineage. Underline: Progeny of 
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Chapter 5: Summary 
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The gene lin-3 of C. elegans encodes an EGF -like growth factor that 
acts as an inductive signal during development. The gene lin-3 was identified 
in the initial screens for mutants that affected the cell lineage (Horvitz and 
Sulston 1980, Sulston and Horvitz 1981). It was shown that reduction of 
function mutations of lin-3 resulted in a developmental defect in which the 
Vulval Precursor Cells (VPCs) did not assume vulval fates. The VPCs 
normally assume vulval fates in response to an inductive signal from the 
anchor cell of the somatic gonad, and thus lin-3 mutations phenocopy the 
effect of removing the inductive signal by ablation of the anchor cell with a 
laser microbeam (Kimble 1981). Subsequent genetic analysis indicated that 
lin-3 acted early in a genetic pathway of genes required for vulval induction 
(Ferguson and Horvitz 1985, Ferguson et al. 1987). It was ambiguous from 
the available genetic evidence, however, whether lin-3 was the vulval-
inducing signal, and there was some concern whether t he inductive signal 
had been, or could be, genetically identified. It is perhaps fitting from a 
genetic viewpoint, and probably especially to those who performed the initial 
characterization ofthe cell lineage mutants, that mutations in the vulval-
inducing signal have been with the field essentially from the start. This 
thesis presents the molecular cloning of the lin-3 locus and one step forward 
in the genetic analysis of lin-3 function, the demonstration that lin-3 is the 
vulval-inducing signal made by the anchor cell. 
Chapter 1 presents an introduction to the role of lin-3 in vulval 
development and is composed of two distinct parts: section 1 reviews the role 
of each of the three identified signals in determining the fates of the VPCs; 
and section 2 reviews the literature concerning the EGF group of growth 
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factors. Chapter 2 presents the molecular cloning of lin-3 and molecular 
genetic experiments based upon this cloning. Together, these experiments 
demonstrate that lin-3 encodes a vulval-inducing signal. Chapter 3 shows 
that the EGF-like domain of the Lin-3 protein is sufficient to induce both the 
1 o and the 2° vulval fates. These experiments support the model that lin-3 
acts in a manner similar to the EGF-like growth factors and suggest that lin-
3 is the sole vulval-inducing signal made by the gonad. Chapter 4 examines 
the pattern ofvulval fates assumed in mutant animals with reduced lin-3 
activity and with increased lin-3 activity. These experiments ask what 
information is conveyed by the lin-3 signal. This chapter also presents 
possible experiments to further analyze the role of lin-3 in establishing vulval 
fate pattern. 
Section 1 of chapter 1 presents the current "three-signal model" 
(Horvitz and Sternberg 1991) ofVPC fate determination. It presents a brief 
overview of the developmental biology of vulval development and the 
molecular characterization of the genetic pathway of vulval induction. Its 
main focus is the evidence for the three inter-cellular signals believed to 
control VPC fate determination, and the role of each signal in controlling the 
location, extent, and pattern, of vulval induction. The "three-signal model" 
proposes that an inductive signal made by the anchor cell is necessary to 
induce the VPCs to assume the 1 o and 2° fates. The fate of an isolated VPC 
correlates with its distance from the anchor cell (Sternberg and Horvitz 
1986). This result is the basis of the formal model that the inductive signal is 
distributed in a gradient centered on the anchor cell, and that the VPCs 
assume different fates in response to different levels of the inductive signal. 
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This interpretation suggests that the inductive signal plays an important role 
in establishing the pattern ofVPC fates. A lateral signal (Sternberg 1988a), 
likely mediated by lin-12 (Sternberg and Horvitz 1989) acts among the VPCs 
to prevent adjacent VPCs from assuming the 1 o fate. This signal is believed 
to involve a feedback loop between cells that can measure and establish 
differences in the state of adjacent cells (Seydoux and Greenwald 1989, 
Sternberg 1988b). Each VPC is proposed to laterally signal its neighbors to 
be 2° in proportion to the level of inductive signal that it receives. An 
inhibitory signal that may arise from the syncytial epidermis (Herman and 
Hedgecock 1990) and which is mediated by a pathway of genes that includes 
lin-15 (Ferguson and Horvitz 1985, Ferguson and Horvitz 1989) prevents the 
VPCs from assuming vulval fates in the absence of the inductive signal 
(Aroian and Sternberg 1991, Ferguson, et al. 1987). 
The review in chapter 1 incorporates the new data on lin-3 into the 
"three-signal model" including the evidence that lin-3 encodes the vulval-
inducing signal made by the anchor cell. Since lin-3 transgenes can cause up 
to all six of the VPCs to assume vulval fates (Hill and Sternberg 1992), 
whereas reduction-of-function lin-3 mutations prevent the VPCs from 
assuming vulval fates (Ferguson and Horvitz 1985), this suggests that the 
level of lin-3 activity determines the extent of vulval induction. The review 
also notes that adjacent VPCs can assume the 1 o fate in lin-3 transgenic 
animals. This result suggests that high levels of lin-3 activity specify the 1 o 
fate. As lateral signalling among the VPCs can not prevent adjacent VPCs 
from assuming the 1 o fate, this confirms that the dose of lin-3 made by the 
anchor cell plays an important role in establishing the correct 2° 1 o 2° pattern 
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of fates. 
The second section of chapter 1 reviews the literature on the EGF-like 
growth factors. The EGF-like growth factors are inter-cellular signalling 
molecules that can act as secreted factors, but which are made as membrane 
bound precursors. As a group, these precursors contain essentially no 
sequence in common outside of the sequence of a structural domain called the 
EGF repeat (reviewed in (Carpenter and Wahl1990)). EGF repeats are a 
structural motif that consist of six cysteine residues with semi-conserved 
spacing. The Lin-3 protein is a membrane-spanning protein with essentially 
no sequence similarity to any other protein. It does, however contain a single 
EGF repeat and thus its lack of sequence similarity makes it a respectable 
citizen of the EGF-like growth factor family. Many aspects ofthe molecular 
biology of the EGF-like growth factors are likely relevant for the function of 
lin-3. First, the EGF repeat of the growth factors is the ligand domain and is 
sufficient by itself to activate the EGF-Receptor. It is confirmed in chapter 3 
that the EGF repeat of the Lin-3 protein is sufficient to induce vulval 
development. Second, processing of the EGF repeat from the membrane 
bound precursor does not appear to be necessary to activate the growth factor 
(Brachmann et al. 1989, Mroczkowski et al. 1989, Wong et al. 1989). Thus, it 
is possible that Lin-3 could act either as a membrane-bound ligand or as a 
secreted factor in the development of different tissues of C. elegans. Third, 
the processing of the EGF-like growth factors appears to be a regulated event. 
The regulation ofwhere and when Lin-3 is processed could control the 
developmental specificity of lin-3. Fourth, in mammals there are multiple 
EGF-like growth factors that can act as ligands of the EGF-R. This raises the 
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possibility that there are multiple lin-3 -like proteins that act in the 
development of C. elegans. It should be noted that lin-3 and the gene let-23 
that encodes the putative receptor for Lin-3 have a similar range of 
phenotypes. Thus, there is currently no genetic evidence that the receptor 
encoded by let-23 has multiple ligands. 
On the other hand, the analysis of lin-3 function should have relevance 
for the study of the EGF -like growth factors of mammals. First, the function 
of the EGF-like growth factors in development is largely unknown and the 
role of lin-3 in development and be studied genetically. Second, the proteins 
involved in the processing of the EGF-like growth factors have not been 
identified. It might be possible to identify these proteins, or other proteins 
important in EGF-like growth factor function, by isolating genetic 
suppressors ofreduction-of-function and gain-of-function lin-3 genotypes. 
Third, lin-3 shows alternative RNA-splicing that should result in proteins 
that differ in the region between the EGF domain and the transmembrane 
domain. This is where the membrane-bound precuror would be processed to 
release the EGF repeat. NDF/heregulin/GGF also show variable splicing in 
this region (Holmes et al. 1992, Marcchionni et al. 1993, Wen et al. 1992). It 
will be interesting to see if this alternative splicing is used to control growth 
factor activity in C. elegans and mammals. 
Chapter 2 presents the molecular cloning of the lin-3 locus. A 
transposon-induced allele of lin-3 was obtained in a non-complementation 
screen for new alleles of lin-3. The transposon insertion syP 1 was shown to 
be genetically inseparable from the vulvaless phenotype of the transposon-
induced allele. The DNA sequence flanking syP 1 was directly amplified from 
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genomic DNA by inverse PCR and was used to isolate genomic DNA clones. 
A 3.3-kb genomic region was shown to be sufficient for DNA-mediated 
transformation rescue of lin-3 mutations. The nucleotide sequence of this 
3.3-kb region and of homologous cDNAs was determined. This region could 
encode a membrane-spanning protein of over 400 amino acids that contains a 
single EGF repeat in the amino terminal domain. The identification of this 
transcription unit as lin-3 was confirmed by two facts. First, a second DNA 
polymorphism associated with the mutation lin-3(n1058) is present in this 
genomic region. Second, the introduction of site-directed mutants that would 
disrupt the disulfide-bonding pattern of the EGF repeat abolished the ability 
of the DNA clones to rescue lin-3 mutations. 
The molecular cloning of lin-3 generated multicopy lin-3 transgenes 
that confer a strong multivulva phenotype. The multi vulva phenotype of the 
transgenes was a significant breakthrough and was important for 
demonstrating that lin-3 could act as a vulval-inducing signal. The evidence 
that lin-3 is a vulval inducing signal is as follows. First, the vulvaless 
reduction-of-function and multivulva gain-of-function lin-3 phenotypes 
together suggest that the extent of vulval development is sensitive to the dose 
of lin-3 activity. Second, the Muv phenotype of the trans genes enables a 
direct test of genetic epistasis between lin-3 and let-23. The vulvaless 
phenotype of a strong reduction-of-function mutation in let-23 is epistatic to 
the multi vulva phenotype of the lin-3 transgenes. This suggests that lin-3 is 
an upstream activator of let-23 and is consistent with the model that lin-3 
encodes a ligand for the EGF-Receptor-like protein encoded by let-23. Third, 
ablation of the gonadal precursor cells reduces the ability of the lin-3 
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transgenes to stimulate vulval development suggesting that lin-3 acts in the 
gonad and not in the VPCs to stimulate vulval development. Fourth, a lin-
3::lacZ fusion transgene that contains the EGF repeat ofLin-3 and that 
retains the ability to induce vulval fates is expressed specifically in the 
anchor cell at the time of vulval development. 
The third chapter describes the construction of transgenes that express 
a secretable version of the EGF domain of Lin-3 under the control of a tissue 
general heat shock promoter. These transgenes can induce vulval 
development when the entire gonad has been destroyed at hatching with a 
laser micro beam. This surgery prevents the development of the anchor cell 
and removes the normal source of the vulval-inducing signal. This result 
indicates that Lin-3 is sufficient, at least when overexpressed, to replace the 
function of the anchor cell in inducing vulval fates. This result also indicates 
that the EGF domain of Lin-3 can induce vulval development without the rest 
of the Lin-3 protein. This indicates that Lin-3 can function in a manner 
analogous to the EGF-like growth factors. Single VPCs isolated by the 
ablation of the gonad and the five other VPCs can assume either the 1 o or the 
2° vulval fates in response to these Lin-3 transgenes. This result confirms 
that Lin-3 can specify either vulval fate without the action of a lateral signal 
from one VPC to another VPC. The results presented in this chapter suggest 
that lin-3 is the sole vulval-inducing signal made by the anchor cell. 
The fourth chapter returns to the issues raised in the introduction and 
examines the question of what information is carried by the inductive signal. 
In particular, are there distinct doses of lin-3 activity that specify a VPC to 
assume the 1° or the 2° fate? It is noted that in lin-3 transgenic animals that 
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adjacent VPCs can assume the 1 o fate and thus that the lin-3 transgenes 
override, or interfere with, the lateral signal among the VPCs that normally 
inhibit adjacent 1 o fates. This result suggests that a high dose of lin-3 
specifies the 1 o fate. Specification of the 2° fate appears to require activity of 
the gene lin-12 (Greenwald et al. 1983) and Lin-12 protein is probably 
activated in wild-type development by lateral signalling among the VPCs. 
This could indicate that the 2° fate is specified not by a particular dose range 
of lin-3 activity but rather by the combinatorial action of both the lateral and 
the inductive signal. However, isolated VPCs have been observed to assume 
the 2° fate (Hill et al. in preparation, Sternberg and Horvitz 1986) which 
indicates that lateral signalling between VPCs is not required to get the 2° 
fate. This result indicates that there are situations in which the inductive 
signal can specify the 2° fate, either independently of lin-12, or perhaps by 
activating the Lin-12 protein within that cell. It has not been demonstrated 
if there is a dose of lin-3 activity that consistently specifies the 2° fate. 
Moreover, it appears that in certain dose ranges of the inductive signal that 
the lateral signal can specify a cell to assume either the 1 o or the 2° fate . 
Experiments that would test if there are different doses of lin-3 activity that 
specify different fates are described in chapter 4. 
Chapter 4 also presents the data from the analysis of the fate patterns 
assumed by the VPCs in hypomorphic lin-3 mutant animals. This analysis 
tests two possible predictions of the "three-signal model." First, if there is a 
distinct dose of lin-3 activity that specifies the 2° fate, then P6.p should be 
consistently exposed to this dose range in some lin-3 genotypes. This has not 
been observed, although it is possible that this is because an insufficient 
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number of animals has been examined. Second, if the inductive signal is 
distributed in a gradient, then the VPCs should still respond in a graded 
fashion as the activity of the inductive signal is genetically lowered. In some 
reduction-of-function genotypes the VPCs usually respond in a graded 
manner. However, the VPCs behave in ways that suggest that VPC fate 
determination is not as simple as stated in the "three-signal model." These 
behaviors seem to be particularly pronounced in lin-3 genotypes that have 
average levels ofvulval induction that are 35% of the wild-type level. These 
behaviors include non-graded patterns of vulval induction in which VPCs 
further from the anchor cell assume vulval fates while VPC closer to the 
anchor cell assume epidermal fates; hybrid vulval/non-vulval fates; and 
apparent cooperativity in the extent of induction. Explanations for these 
effects and experiments to test these models are given in chapter 4. A 
"boundary signal" that regulates the decision of a VPC receiving low levels of 
the inductive signal to assume a vulval or non-vulval fate could explain the 
hybrid fates and the non-graded patterns of induction. The apparent 
cooperativity in the extent of vulval induction could result from positive 
feedback loops in the production of the inductive signal, or from lateral 
signals that act among the VPCs. 
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